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ABSTRACT 
Three hypotheses were tested in the present studies: 1. Prostaglandin E? (PGE2) and 
Fza (PGFza ) produced during tumor promotion are key factors suppressing liver-associated 
natural killer cell activity, a proposed biomarker of carcinogenesis. 2. Reaction of 
fumonisin B; (FBi) with glucose may prevent FBi hepatotoxicity, tumor development and 
changes in bio markers associated with carcinogenesis, such as natural killer cell activity, in 
rats. 3. Increased fat and energy intake promote FB; hepatocarcinogenesis and inhibit the 
liver-associated natural killer (NK) cell activity in association with increased PGE? and 
PGFza- Before testing these two hypotheses, immune function as well as concentrations of 
PGE2 and PGFza were compared between Fischer 344/N (F344/N) and Spague-Dawley 
(SD) rats to determine which strain was more appropriate for testing the hypotheses. 
Hepatic NK cell activity was compared in 9 week old male and female F344/N and 
Sprague Dawley(SD) rats. Natural killer cells were stained using an anti-NKR-Pl 
monoclonal antibody and quantitated by flow cytometry. SD rats exhibited significantly 
greater total hepatic NK activity(p<0.001 ) than F344/N rats, and male rats had 
significantly greater total hepatic NK activity than female rats. There were no strain or 
gender differences in the concentration of hepatic PGE%. No strain difference was found in 
the concentration of hepatic PGF?a, but the hepatic PGF^ concentration in female rats was 
two-fold of that in male rat (130 vs 60ng/g). Prostaglandin E? (10ng/ml and 25ng/ml) 
significantly inhibited hepatic natural killer cell(NK) activity in vitro compared with 
untreated cells from both genders and strains(p<0.05). In contrast, 50ng PGF^/ml and 
lOOng PGFic/ml significantly stimulated hepatic NK activity compared with untreated 
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hepatic cells from both F344/N and SD rats. Prostaglandin E2 and F2a had opposite effect 
on liver-associated NK cell activity. 
The reaction of the primary amine of fumonisin B| (FB[) with glucose was 
hypothesized to detoxify this mycotoxin. Eighty 10-day old female F344/N rats were 
injected intraperitoneally with diethylnitrosamine (DEN, 15mg/kg body weight). At 4 
weeks of age, the weaned rats were randomly assigned to one of the 4 treatment groups (20 
rats/group): the group fed basal diet, the group fed FB;-glucose (containing the reaction 
mixture of 25ppm FB% with glucose), the group fed 8ppm (residual amount of free FBi in 
the FBi-glucose mixture) or the group fed 25 ppm FBi. The group fed FB,-glucose did not 
showed increased plasma total cholesterol concentration, alanine aminotrasferase (ALT) 
activity compared with control group. No development of Gamma-glutamyltrasferase 
(GOT)- and placental glutathione trasferase (PGST)-positive altered hepatic foci (AHF) in 
FBi-glucose group. The concentration of endogenous hepatic PGE2, PGE2a, sphinganine 
(Sa), sphingosine (So) and S a/So were not different for the control group. In comparison 
with the rats fed basal diet or FBi-glucose (the products of reacting 25ppm FB, with 
glucose), the rats fed 8ppm FBi and 7% fat or 25ppm FBi and 7% fat showed greater ALT 
activity and endogenous production of PGE2 at 20 weeks of age. But only half the rats fed 
25ppm FBi and 7% fat developed GGT- and PGST-positive AHF, and the area of AHF 
were less than 1%. And the tumor developed in all rats stayed at preneoplasia stage. The 
hepatic natural killer cell activity did not differ among all the groups at any time point, 
although increased PGE2 accompanied fumonisin promotion of carcinogenesis. 
VI 
Prostaglandin E? and p2a did not seem to be modulators of hepatic NK activity in this 
study. 
We hypothesized that greater dietary fat and energy intake promote FB, 
carcinogenesis, and the inhibition of NK cell activity paralleled the development of 
preneoplasia. Twenty four 10-day old female F344/N rats were injected intraperitoneal^ 
with diethylnitrosamine (DEN, 15mg/kg body weight). At 4 weeks of age, the weaned rats 
were randomly assigned to one of 4 treatment groups with 6 rats each.Greater PGST- but 
not GGT- positive foci were observed in the rats consuming high fat, high energy and FBi 
than in rats fed FBi and low fat diet. The greater inhibition of total NK activity was also 
observed in the rats fed high fat, high energy and FB i compared with the rats fed low fat, 
low energy and FB;. Increased PGEi paralleled the extent of preneoplasia and inhibition of 
NK activity. Prostaglandin E? seemed to be a modulation factor of NK activity in the 
present study. But, in our previous study, we observed the increase of PGEo, but we did not 
find the inhibition of NK activity. These findings suggested that some other factors, such 
as glycosphinglipid, than PGEi produced by preneoplasms seemed to be more important 
down-regulators of NK activity as they occur during progression of carcinogenesis. 
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GENERAL INTRODUCTION 
Results from four studies are presented in this dissertation. The immune function 
and the physical concentration of prostaglandin E2 and prostaglandin Foa were compared 
between F344/N and SD rats in the first study. The effects of prostaglandins on liver-
associated natural killer cells were investigated by co-culture hepatic natural killer cell 
with different concentration of prostaglandins in the second study. The detoxification 
effect by reacting FBi with D-glucose was evaluated in the third study. The effect of 
increased fat and energy intake on FBi hepatocarcinogenesis was investigated in the fourth 
study. 
Study 1. Sprague -Dawley rats have greater liver-associated natural killer cell 
activity than do F344/N rats, although a greater proportion of lymphocytes are 
natural killer cells in F344/N rats 
The use of an animal carcinogenicity bioassay in assessing the oncogenic risk 
involved with chemical exposure is an important and necessary process, but presents many 
difficulties in interpretation when extrapolating to humans (Gergory., 1988). There are 
large inter-species, and inter-strain and gender variations in the incidence of some tumors. 
Variable tumor formation may be related to factors, including: organ/strain specific 
oncoviruses, hereditary disorders (Drinkwater et al., 1989), or differing immune 
capabilities, such as hepatic natural killer cell(NK) activity (Lee et al., 1999). F344/N and 
SD rats were included in this study as these are two rodent strains predominantly used in 
carcinogenicity bioassays, and there is a large database on cancer development in these 
strains. In one study, newborn F344/N and SD rats were irradiated with whole body single 
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doses of 3Gy gamma rays with or without intraperitoneally-injected diethylnitrosamine 
(DEN) (15 mg/kg body weight) within 1 h of irradiation. Tumor development was 
promoted with 0.05% phénobarbital. In groups treated with radiation alone or radiation 
combined with DEN, F344/N rats had threefold greater development of placental S-
glutathione transferase-positive (GST-P+) altered hepatic foci (AHF, biomarkes of 
preneoplasia and neoplasia) than did SD rats. In SD rats, females had 1.5 greater induction 
of GST-P+ AHF than did males (Lee et al., 1998). In another study in which 
hexachloro benzene was fed to male and female F344/N rats for 15 weeks, 100% of 
surviving females had multiple liver tumors which were strongly y-glutamyl transferase 
(GGT) positive and histologically classified as neoplastic nodules or hepatocellular 
carcinomas. In contrast, only 16% of males developed tumors which were smaller and 
fewer in number than those in females (Smith et al., 1985). 
The capacity to mediate MHC-unrestricted cytotoxicity against certain tumor cells 
without apparent prior sensitization has by definition been primarily ascribed to NK cells 
(Trinchieri et al., 1989). NK cells are phenotypically and functionally distinct population 
of lymphocytes with morphology characteristic of large granular lymphocytes Trinchieri et 
al., 1989; Whiteside et al., 1990). In rats, high density cell surface expression of NKR-P1 
antigen( i.e. NKR-Plbnghl) is an exclusive property of all mature NK cells (Chambers et al., 
1989; Brissette-Storkus et al., 1994). NKR-P1 is also expressed on a subset of T cells, but 
with a 2- to 10- fold lower density(i.e., NKR-P1 dim) than on NK cells (Chambers et al., 
1989; Brissette-Storkus et al., 1994). Some subsets of NKR-Pldim lymophocytes are 
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capable of mediating NK-like cytotoxicity, particularly after incubation in 1000U/ml 
interleukin-2(IL-2) for five days (Brissette-Storkus et al., 1994). 
Attention has focused on the role of the liver as a tumor killing organ. Hepatic NK 
activity is much higher than in peripheral blood and spleen preparations (Vanderkerken 
et al., 1993). The liver also harbors the largest population of fixed macrophages (Maker 
et al., 1986). These tumoricidal cells may affect metastasizing tumors in addition to 
resident hepatic tumors (Lukomaska et al., 1987). However, the role of impaired natural 
immunity in chemically-induced hepatocarcinogenesis is still unclear. Neonatal B6C3F1 
mice were given a single carcinogenic dose of diethylnitrosamine (DEN) and the time-
response kinetics for the early (altered foci) and late (adenomas/carcinomas) phases of 
hepatocellular carcinogenesis were compared to changes in hematopoiesis and immune 
functions associated with immune surveillance and natural resistance (Germolec et al., 
1988). Increases in hematopoiesis occurred just prior to or concurrent with the 
appearance of hepatocarcinomas, while increased macrophage and natural killer cell 
cytotoxicity and suppression of cell-mediated immunity occurred following tumor 
appearance and progressed with increasing tumor burden. Neither immunological nor 
hematopoietic changes were associated with early phases of hepatocarcinogenesis, as 
monitored by the appearance of AHF. Although changes in hematopoiesis may represent 
an early indicator for hepatocarcinogenesis in the mouse tumor model, the data suggest 
that altered immune surveillance and natural resistance are not factors in the 
development of chemically induced hepatocellular tumors, and the changes in immune 
function are probably secondary to tumor development. Neither immunological nor 
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hematopoietic changes were associated with early phases of hepatocarcinogenesis, as 
monitored by the appearance of AHF (Germolec et al., 1988). In male F344/N rats given 
40ppm DEN in drinking water for 10 weeks, as GST-P+foci developed, splenic NK 
activity changed. After 5 weeks, DEN-treated and control rat spleen NK activity was 
similar, but at 10 weeks, NK activity was significantly greater in DEN treated rats 
compared with control rats. At 20 weeks, DEN-treated rats had significantly lower NK 
activity than did controls (Lee et al., 1998). This suggests an interaction between 
chemical carcinogenesis and NK activity. Lu et al. (1997) also showed that chemical 
carcinogenesis (initiation by DEN, 15mg/kg at 10 days of age, and promotion by 
fumonisin B1 (50mg/kg diet)) caused significantly decreased NK activity after 4 weeks 
of development of AHF (Lu et al., 1997). 
We propose that liver-associated NK activity will be greater in SD than in F344/N 
rats and in males than in females, due to greater liver associated NK cell numbers, even 
after covariation for body weight. This proposed difference in NK activity might partly 
explain some previous findings of gender and strain difference in susceptibility to 
carcinogenesis. 
Study 2. Opposing effects of prostaglandin E% and F2a on rat liver-associated natural 
killer cell activity in vitro 
The suggestion that prostaglandins may play a role in immune response/tumor cell 
interactions is based upon several observation. First, a variety of prostaglandins are 
produced both by cells that are themselves active in the expression and regulation of 
immune response activity (Tomar et al., 1981) as well as by a number of tumor targets 
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(Karmali et al., 1980; Goodwin et al., 1981). Carcinogenesis may be associated with 
increased prostaglandin production by neoplastic organs, such as during promotion of rat 
hepatocarcinogenesis by fumonisin B (Lu et al., 1997). Second, the production of 
prostaglandins has been found to increase as a result of direct contact between effector 
lymphocytes and tumor targets (Owen et al., 1980). Third, prostaglandins at levels 
produced during these interactions have been shown to influence the ultimate expression in 
vitro of lymphocyte and macrophage cytotoxicity against tumor targets (MaCarthy et al., 
1981; Koren et al., 1981). 
Prostaglandins mediate inter- and intracellular communication, as may stimulate 
hepatocyte proliferation (Miura et al., 1979; Andreis et al., 1981). The concentration of 
PGE equivalents in rat liver in vivo was increased during liver regeneration. This 
stimulation of prostaglandin synthesis was confirmed in vitro by the ability of 
homogenates of regenerating liver tissue to synthesize PGE% and PCFo» from arachidonate. 
Indomethacin prevented these prostaglandin changes, and the subsequent increase in DNA 
synthesis (MacManus et al., 1976). During the regeneration of mammalian liver after a 
70% partial hepatectomy (PHx), Kupfer cells produced significantly elevated PGE?, and 
in vivo Kupfer cell PGE? blockade by indomethacin (5 mg/kg) significantly (P < 0.05) 
inhibited hepatic regeneration (Goss et al., 1982). The association of neoplastic tumors 
with increased levels of prostaglandins (Robertson et al., 1986; Bennett et al., 1975) 
provided the rationale for investigating their role in turmorigenesis. Animal and human 
tumors contain high levels of prostaglandins, particularly those of the E series that have 
been shown to significantly affect cell proliferation and tumor growth and suppress 
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immune responsiveness. DNA synthesis of hepatocytes in primary culture was 
significantly enhanced by addition of PGE? (2-200 nmol/L). Intracellular cAMP level in 
the hepatocytes increased during culture, and cAMP increase was enhanced by PGEi-
Prostaglandin E? production in the liver increases hepatic regeneration and PGE, enhances 
the proliferation of hepatocytes by a seemingly cAMP-dependent specific receptor-
mediated process (Tsujii et al., 1993). At concentrations of 10~12-10"9 moI/L, PGFia and 
PGF20C very intensely stimulated both the DNA-synthetic and mitotic activities of 
hepatocytes in 4-day-old primary cultures of neonatal rat liver. DNA replication was more 
intensely enhanced by PGFza than PGFia, whereas mitotic activity was nearly equally 
affected by the two prostaglandins (Armato et al., 1983). Thus enhanced PGE, and PGFia 
may promote hepatocarcinogenesis by stimulating DNA synthesis and proliferation of 
hepatocytes. 
A high level of PGE? in the portal vein suppresses liver-associated immunity and 
promotes liver metastases (Okuno et al., 1995). Some in vitro experiments showed a 
similar phenomenon. The ability of Syrian hamster tumor cells of the same origin but with 
different degrees of malignancy to secrete prostaglandin E was studied following their in 
vitro contact with Syrian hamster natural killer cells (NK cells). Syrian hamster NK cells 
were shown to lose cytotoxic activity significantly after their contact with malignant tumor 
cells. Short-term in vitro contact of malignant tumor cells with human and Syrian hamster 
NK cells resulted in a rapid PGE secretion into the culturing medium. Therefore, PGE? 
may promote tumor progression by inhibiting immune function. The effect of PGFia on 
NK cells is still not clear. The regulatory effects of prostaglandins on immune response 
7 
appear to be mediated by the production of cyclic AMP (Robison et al., 1971). PGE? 
activates adenylate cyclase with a subsequent rise in cyclic AMP (Smith et al., 1971), 
which acts as a "second messenger". Cyclic AMP itself is an inhibitor of lymphocyte 
activation (Melmon et al., 1974). The presence of receptors for PGE, and PGE? on the 
lymphocyte surface had been demonstrated, while there were no binding sites for PGA, 
PGFia or PGFia • Henney and Lichtenstein, using splenic lymphocytes from mice 
immunized with an allogeneic mast cell tumor (Henney et al., 1971), suggested that 
elevated cyclic AMP content of cytolytic lymphocyte might inhibited their ability to kill 
target cells. As a test of this hypothesis, prostaglandins were shown to inhibit lymphocyte 
cytolytic activity (Henney et al., 1972). The relative potency of seven prostaglandins in 
inhibiting cytolytic activity correlated very well with their potency in stimulating cyclic 
AMP accumulation in lymphocytes: Ei=E2>Ai=A2>Fia=F2a= 0 (Lichtenstein et al., 1972). 
But effects of PGs on NK cells could be mediated in other ways. 
We suggest that prostaglandin regulation of immune response might partly explain 
some previous findings of gender and strain difference in susceptibility to carcinogenesis. 
Effects ofPGF2aon NK activity have not been well characterized. To that end, we 
hypothesize that high levels of PGF2a, as found in female rat liver, may inhibit liver 
associated NK activity, an effect similar to that of PGE2. 
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Study 3. Reacting of fumonisin with glucose prevents promotion of 
hepatocarcinogenesis in female F344/N rats while maintaining normal hepatic 
sphinganine: sphingosine 
The carcinogenic and toxic effects of fumonisin Bi (FB[), a mycotoxin produced by 
the commonly occurring com fungi, Fusariam moniliforme and Fusarium proliferatum, 
have been studied intensively. Fumonisin Bi (69.3|iM/kg, 50ppm) was hepatocarcinogenic 
in rats fed the toxicant for approximately two years (Gelderblom et al., 1991). The 
incidence of F. moniliforme in com for human consumption has been correlated with the 
incidence of esophageal cancer in Transkei, Southern Africa (Marass et al., 1981) and in 
China (Yang et al., 1980). The concentration of FBi in com reached approximately 11.1 
|imol/kg in areas of southern Africa where human esophageal cancer rate was 
high(Sydenham et al., 1990). Com products for human and animal consumption were 
determined to have FBi concentration between 0.3-4.2 {imol/kg in the U.S. (Hopmans et 
al., 1993; Murphy et al., 1991; Syndenham et al., 1991). 
Several bio markers have been used to study FB[ hepatocarcinogenicity. Fumonisin 
Bi-pro mo ted rat hepatocarcinogenesis was readily quantified by measuring placental 
glutathione S-transferase (PGST) positive altered hepatic foci (AHF) (Lebepe-Mazur et al., 
1995) and y-glutamyltransferase (GGT)-positive AHF (Gelderblom et al., 1988). Plasma 
alanine aminotransferase (ALT) activity was increased during fumonisin hepatotoxicity 
(Voss et al., 1993), and hepatocarcinogenesis in rats (Hendrich et al., 1993). Increased 
plasma total cholesterol was observed in FBi-treated vervet monkeys (Fincham et al., 
1992), and in rats (Hendrich et al., 1993) in short term studies. Greater hepatic 
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prostaglandin Fia production was also observed in FB i tumor promotion in rat liver (Lu et 
al., 1997). In vivo administration of 50ppm FB i significantly suppressed hepatic natural 
killer (NK) cell activity while stimulating hepatic preneoplasia (Lu et al., 1997). Natural 
killer cell activity suppression by FBi during tumor promotion may be mechanistically 
significant, but this remains to be determined. Thus numerous possible bio marker of FBi 
toxicity and tumor promotion may be used to probe mechanism of action of mycotoxin. 
Recent studies regarding the biological effects of fumonisins indicated that they 
selectively inhibit ceramide synthase, a key enzyme in the sphingolipid biosynthetic 
pathway (Wang et al., 1991). It was suggested that the subsequent accumulation of the 
sphingoid bases, sphinganine (Sa) and sphingosine (So), could have an important role in 
the toxicological effects of fumonisin in the kidney and the liver of rats (Norred et al., 
1991; Yoo et al., 1992). In addition, as the sphingoid bases are important regulators of 
cellular growth and differentiation (Merrill et al., 1991), the continued disruption of 
sphingolipid biosynthesis has been implicated in the hepatocarcinogenicity of fumonisin 
(Schroeder et al., 1994). 
Currently, there has been increased attention directed at reducing the human and 
animal exposure to these fungal toxins. Biological, chemical, and physical processes have 
been explored to salvage fumonisin-contaminated com. Thermostability of FB, proved to 
be great. When dry com was heated at 50, 75, 100 and 125°C for 40 minutes, only a small 
amount of FBi was lost (Dupuy et al., 1993). Treatment of fumonisin-contaminated com 
with 2% ammonia for 4 days, a process that detoxified aflatoxin Bi, led to slight reduction 
in the concentration of FB; without decreasing its toxicity in rats (Norred et al., 1991). 
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Nixtamalization, the traditional process to produce masa or tortilla flour, reduced the 
amount of FBi by hydro lyzing FBi to hydro ly zed FBi (HFBi ), but HFBi was similar in 
toxicity to FBi when the nutritional status of rats was adequate (Hendrich et al., 1993). In 
vitro toxicity studies of several FBi analogs showed that the analogs containing FBi amine 
groups and the tricarballylic side chains were more toxic than analogs containing only the 
tricarballylic side chains (Kraus et al., 1992), and naturally occurring N-acetyl -FB, was 
not toxic (Gelderblom et al., 1993). Therefore, the primary amine of FB, is likely to be 
critical for its toxicity. Murphy et al. (1995) reported a method to detoxify FB, by 
derivatizing the amine group with a reducing sugar, fructose, in a nonenzymatic browning 
reaction. Diethylnitrosamine-initiated (15 mg/kg body weight) male F344/N rats were fed 
for 4 weeks either 69.3 pM FB, or 69.3 {iM FB, reacted with fructose (FB,—fructose). Rats 
fed FB[ had significantly increased levels of several markers of hepatocarcinogenicity, 
while rats receiving FB[— fructose showed no signs of hepatocarcinogenicity or 
hepatotoxicity(Lu et al., 1997). A more practical and efficient method to block FB/s 
amine group by reacting the amine group with glucose had been developed in Dr. 
Murphy's lab (Lu., 2000) .The FB,-glucose reaction was more complete than the reaction 
with fructose, and the reaction products were more easily isolated than FB [-fructose 
products. It was hypothesized that modifying FBi with glucose would prevent promotion 
of hepatocarcinogenicity by FB i. Our experiment was designed to test the effectiveness of 
this detoxification method by examining effects of FBi -glucose on several markers of FBi 
promotion of hepatocarcinogenesis. 
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Study 4. Increased dietary fat and energy intake during fumonisin promoted 
hepatocarcinogenesis increase hepatic prostaglandins, sphinganine, and development 
of placental glutathione trasferase (+) foci, while inhibiting natural killer cell number 
FBi toxicity and carcinogenicity were evaluated in female F344/N rats (Lu et al., 
1997), initiated by diethylnitrosamine (DEN, 15mg/kg body weight) at 10 days of age, and 
given free access to the control diet (AIN93, 7% soybean oil + 13% beef tallow) or 
treatment diet (AIN93, 7% com oil +13% beef tallow + 69.3|imol FBi/kg diet) for 5 
weeks, FBi - fed rats developed altered hepatic foci (AHF), and hepatic NK activity in FBi 
—fed rats was significantly inhibited as compared with the control group. When female 
F344/N rats were initiated by DEN (15mg/kg bw), and given free access to control diet 
(AJN93, 7% soybean oil) or the same diet containing 25ppm FB, for 16 weeks, only half of 
the animals of the FBi —fed rats developed GGT- and PGST-positive foci (Liu et al., 2001), 
and no difference in hepatic NK cell activity was observed between control and FBi -fed 
rats. These two experiments suggested that there was an interaction between dietary fat and 
FBi carcinogenesis, as reflected in the altered hepatic foci and hepatic NK activity. 
Evidence from experimental animal models strongly suggests that liver-
associated NK cells and Kupffer cells are the first line of defense against blood-borne 
metastasizing solid tumor cells invading the liver. Thus NK cells protect the parenchyma. 
The primary role of NK cells in neoplasia is directed against blood-borne tumor cells 
during the intravascular phase of tumor metastasis(Winnock et al., 1993). In male 
F344ZN rats given 40ppm DEN in drinking water for 10 weeks, as GST-P+foci 
developed, splenic NK activity changed. After 5 weeks, DEN-treated and control rat 
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spleen NK activity was similar, but at 10 weeks, NK activity was significantly greater in 
DEN treated rats compared with controls. At 20 weeks, DEN-treated rats had 
significantly lower NK activity than did controls (Lee et al., 1998). This suggests an 
interaction between chemical carcinogenesis and NK activity, at the very early stage of 
carcinogenesis, the NK cell activity may not change or even increase, with the 
progression of neoplasia, the inhibition of NK cell activity occurs, and may parallel the 
development of neoplasia. 
Increased dietary fat increased the development of mammary tumors induced by 
chemical carcinogens in rats (Aksoy, et al., 1987; Aylsworth et al., 1986). Hopkins and 
Carrol (1979) reported that in rats initiated with 7,12-dimethylbenz[a]anthracene one week 
before dietary treatment, rats fed 3% sunflower seed oil and 17% of either tallow or 
coconut oil developed twice as many tumors as those fed 3% sunflower seed oil. Rats were 
first intubated with diethylnitrosamine (DEN, 10 mg/kg) 20 hr after partial hepatectomy; 1 
week later, rats were fed one of three purified diets (a low-fat diet similar to the AIN-76 
diet, a high saturated fat diet, or a high polyunsaturated fat diet) with or without 0.05% 
phénobarbital in the diet for 10 months. Increasing the fat level of the diet did not increase 
the number of GGT-positive foci arising spontaneously or induced by DEN alone. When 
phénobarbital was present in the diet, both high-fat diets enhanced the induction of GGT-
positive foci. Increasing the dietary fat level, may enhance promotion of liver foci by 
phénobarbital ( Glauert et al., 1986). We hypothesized that greater dietary fat and energy 
intake promotes FB i carcinogenesis, the inhibition of NK cell activity parallels the 
development of preneoplasia, and the inhibition of NK activity may be modulated by 
13 
prostaglandins and/or sphingolipids which had been observed to accumulate in previous 
experiments of FBi carcinogenesis ( Lu et al., 1997; Liu et al., in press). 
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Reacting of fumonisin with glucose prevents promotion of hepatocarcinogenesis in female 
F344/N rats while maintaining normal hepatic sphinganine: sphingosine ", was accepted 
by Journal of Agricultural and Food Chemistry. The manuscript of Study 4, " Increased 
dietary fat and energy intake during fumonisin promoted hepatocarcinogenesis increase 
hepatic prostaglandins, sphinganine, and development of placental glutathione trasferase 
(+) foci, while inhibiting natural killer cell number", will be submitted to Carcinogenesis. 
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LITERATURE REVIEW 
Fumonisins, a group of structurally related mycotoxins which were first identified in 
1988 (Gelderblom et al., 1988), are produced by the com fungi Fusarium verticillioides 
and Fusarium proliferatum. Fumonisin Bi (FBi), a major member of the fumonisin family, 
caused equine leukoencephalomalacia (ELEM) (Kellerman et al., 1990; Wilson et al., 
1992) and porcine pulmonary edema (PRE) (Harrison et al., 1990), and was hepatotoxic 
and hepatocarcinogenic in rats (Gelderblom et al., 1988 and 1991). Fumonisins have been 
categorized as Class 2B probable human carcinogens (IARC 1993). The occurrence of 
F. verticillioides containing FBi was associated with a relatively high rate of human 
esophageal cancer in southern Africa (Sydenham et al., 1990). Although more than ten 
years have passed since the discovery of fumonisins, the molecular mechanisms of their 
toxicity remain unclear (Wang et al., 1996). 
Fumonisins: Discovery and Distribution 
The fungus Fusarium verticillioides Sheldon is one of the most prevalent seedbome 
fungi associated with com intended for human and animal consumption throughout the 
world (Marasas et al., 1984a). The fumonisins, food-bome carcinogenic mycotoxins ,were 
first isolated from cultures of F. verticillioides strain MRC 826 by Gelderblom et al. 
(1988a). According to the taxonomic system of Nelson, Marasas and coworkers, at least 
some strains of six additional Fusarium species also produce fumonisins: F. anthophilum, 
F.dlamini, F.Napiforme, F.nygamai, and F.subglutinans. In addition to fumonisins, strains 
of F.verticillioides and closely related species also produce several other mycotoxins and 
phytotoxins at high levels in laboratory culture. The toxicity of these other secondary 
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metabolites has had much less study and their role in animal toxicoses and human 
exposure risk, if any, remains unclear. These components include the fusarins, potent 
mutagens; moniliformin, a potent avian toxin; the naphtazarine pigment complex, a group 
of linear aromatics known to be phytotoxins, but untested for animal toxicity; fusaric acid, 
1- carboxy-4-butene-pyridine, a known phytotoxin of unknown animal toxicity. Toxicity 
data and reports on the concentrations of these compounds in naturally contaminated com 
samples are much less available than data on fumonisins (Plattner et al., 1996). 
The discovery of fumonisins began with observation that F. verticillioides was 
involved in widespread field outbreaks of animal diseases occurring in the United States in 
the early 1900s. Fusarium verticillioides was the fungus most commonly found in moldy 
com and was implicated as the cause of the disease "moldy com toxicosis" (Peters, 1904). 
Butler (1902) reproduced leukoencephalomalacia (LEM) in horses with naturally 
contaminated moldy com in United States. In the 1980s, the occurrence of F.verticillioides 
in com was correlated with high rates of human esophageal cancer in Transkei, South 
Africa and in China, where com is a major dietary staple (Marass et al., 1981 ; Yang, 
1980). 
Gelderblom et al. (1986) utilized a cancer initiation/promotion bioasssay, which was 
based on a chemical carcinogenesis model established by Pitot et al. (1978), to evaluate the 
cancer promoting ability of strain MRC 826 of F.verticillioides isolated from Transkeian 
com. Hepatectomized rats were initiated with diethylnitrosamine (DEN, 30mg/kg body 
weight) and then fed a diet containing culture material of F.verticillioides strain MRC826 
at a level of 2% for 14 weeks. Gamma-glutamyltransferase (GGT)-positive preneoplastic 
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altered hepatic foci (AHF), developed , indicating the cancer promotion activity of strain 
MRC 826. A similar assay with shorter promotion was later used to screen 10 toxic 
strains of F.verticillioides, isolated from corn from a high-risk area for esophageal cancer 
in the Transkei, for their cancer promoting activity in rats Gelderblom et al. (1988a). After 
initiation with diethylnitrosamine (DEN, 200mg/kg body weight), a diet containing 5% 
culture material was fed for four weeks. The presence of y-glutamyltranspeptidase (GGT) -
positive foci in the liver was taken as an indication of tumor-promoting activity. Three out 
of the ten tested F. verticillioides strains showed such activity, which was correlated with 
toxicity expressed as reduction of body weight gain. This observation, the development of 
progressive toxic hepatitis and the induction of GGT-positive foci was also observed in the 
rats without DEN initiation, but with far less pronounced development of GGT-positive 
foci in rat liver (Gelderblom et al., 1986). Fusarium verticillioides com culture fed to rats 
before a single dose of DEN caused an increase in the number of placental glutathione S-
transferase (PGST)-positive AHF in rat liver, another indicator of hepatocarcinogenesis 
(Lebepe et al., 1991). These results suggest that in addition to cancer promoting activity, 
F. verticillioides has cancer co-initiating activity as well. Gelderblom et al. (1988b) used 
this short-term cancer bioassay mentioned above as a monitoring system to isolate the 
mycotoxins fumonisin Bi and B?. Cultured material of F. verticillioides MRC826, grown 
on com, was extracted with ethyl acetate and methanolrwater (3:1). The cancer-promoting 
activity was observed in the methanol:water extract and remained in the aqueous phase 
after partition with chloroform. This fraction was further fractionated using an Amberlite 
XAD-2 column, silica gel column and finally a CI8 reverse phase column. Purified FB% 
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had cancer promoting effect in rats when fed for four weeks at level of 0.1% in the diet 
which was associated with a toxic effect as shown by a significant reduction in weight 
gain. 
Bezuidenhout et al. (1988) chemically characterized the fumonisins, a family of 
structurally related mycotoxins. The molecules, determined by *H and I3C NMR, were 
diesters of propane-1,2,3-tricarboxylic acid and either 2-amine- or 2-acetylamino-12, 16-
dimethyl-3,5,10,14,15-pentahydroxyicosane with both C-14 and C-15 hydroxyl groups 
esterified with propane-1,2,3-tricarboxylic acids. Fumonisin B, has hydro xyl groups at 
both C-10 and C-5. Fumonisins Bi and B3 lacked hydroxyl groups at C-10 and C-5, 
respectively, whereas both hydroxyl groups were replaced by hydrogens on fumonisin B4. 
Fumonisin Ai and A? were N-acetates of fumonisin B| and B2, respectively. Most of the 
naturally produced fumonisins in com cultures of F.verticillioides strain MRC 826 were 
fumonisins 61,62, and B3 (Bezuidenhout et al., 1988; Cawood et al., 1991). Besides 
Fusarium verticillioides, a closely related species, Fusarium proliferation, was also 
frequently isolated from shelled com, which was capable of producing fumonisins 61,63, 
and 63 too ( Ross et al., 1991). 
Sydenham et al. (1991) assessed the occurrence of F61 and F6? in com foods from 
the U.S., South Africa, Canada, Egypt, and Peru. Commeal samples were found to contain 
F61 in ranges of l-2790ng/g for the U.S., 0-475ng/g from South Africa, 0-660ng/g for 
Peru, 1780-2980ng/g from Egypt, and 0-50ng/g from Canada. Shepard et al.(1996) 
surveyed com and corn-based products to determine the extent of possible F61 exposure. 
Compiled data from 6razil, Italy, South Africa, and the U.S. for FBi levels in feeds 
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implicated in equine leukoencephalomalacia ranged from 0.2 to 130 |ig/g. Levels of FBi 
for porcine pulmonary edema in Brazil and U.S. ranged from 3-330 fi-g/g. [Food samples 
from areas of the Transkei region of South Africa with high rates of esophageal cancer 
ranged from 0-117.5 fig/g. Food samples from high esophageal cancer reg: ions of China 
ranged in FBi contents from < 0.10 to 154.9|ig/g. An extensive summary oaf corn products 
meant for human consumption from around the world from com meal, grits, flour, 
breakfast cereal, to milk demonstrated a range of FB [ levels from 0 to 16|mg/g (Shephard et 
al., 1996). 
Fumonisins exist throughout the world food supply, varying in contamination 
severity, regional location, and in food items produced from contaminated com. Classified 
as a Class 2B probable human carcinogen (IARC, 1993), fumonisins are otf potential 
concern to human health. It is important to monitor fumonisin contamination. 
Detoxification of mycotoxin-contaminated grain is of particular interest to prevent harm to 
humans or animals and economic loss. 
Fumonisin Toxicity and Carcinogenesis 
Equine leukoencephalomalacia (ELEM) 
Fumonisins have been shown to be toxic to a variety of species in a range of 
concentrations. Equine leukoencephalomalacia is a neurotoxic disease thatt affects horses, 
donkeys and mules. Typical signs of ELEM include uncoordination, aimless walking, 
blindness, and head pressing (Wilson et al., 1990). The causative agent of ELEM was 
found by Wilson and Maronpot (1971) when they isolated F.verticillioides- as the 
predominant contaminant of moldy com that was associated with many cases of ELEM, 
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and reproduced ELEM in donkeys by feeding F.verticillioides corn culture material 
(Wilson and Maronpot 1971). Marasas et al. (1988) conducted neurotoxicity tests with FBi 
to determine the effects of feeding FB, -containing culture material to horses. Effects of 
intravenous dosing of horses with purified FB[ were studied. Two horses were dosed by 
stomach tube with FBi -containing F.verticillioides culture material six times over seven 
days at either 2.5g culture material/kg/day or 1.25g culture material/kg/day. The horse 
dosed with 2.5g culture material/kg/day developed severe hepatosis and mild edema of the 
brain stem, and the horse dosed with 1.25g culture material/kg/day developed moderate 
edema of the brain stem and mild hepatosis. An additional horse dosed intravenously seven 
times with 0.125mg FBi over nine days developed leukoencephalomalacia in the brain 
stem. Marasas et al.(1988) concluded that low FBi doses caused mild liver injury and 
severe brain lesions while high FB[ doses caused severe liver injury and mild brain lesions. 
Reproduction of ELEM in ponies fed fumonisin-contaminated com screenings associated 
with a previous outbreak of ELEM was reported. Typical lesions of ELEM were present in 
the brains of ponies which exposed to FB[ for different phases (Ross et al. 1993). 
Porcine pulmonary edema (PPE) 
Porcine pulmonary edema was associated with occurrence of F.verticillioides when 
2 pigs developed the disease following feeding on bulk culture material of com 
contaminated with F.verticillioides (Kriek et al., 1981). Harrison et al. (1990) induced PPE 
and hydrothorax in three pigs which were intravenously adminstered FB[ or FB? and 
compared to one control pig adminstered saline. One pig each was administered O.4mg FBi 
/kg for four days, 0.174mg FBi /kg body weight for seven days, and 0.3 mg FB2/kg for 
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five days. The high FB i dose caused pulmonary edema as previously noted in field cases, 
whereas the lower FBi dose and the FB?dose did not. Harrison et al. (1990) identified FB, 
as the agent responsible for causing pulmonary edema/hydrothorax in swine . Haschek et 
al.(1992) analyzed the toxicity of FB[ in intravenously dosed pigs and total fumonisin 
toxicity of FB[ + FBa, in pigs fed contaminated com screenings. Two female, weanling 
pigs were dosed with FB i intravenously at either 0.88 mg/kg/day for nine days or 1.15 
mg/kg/day for four days. Three pigs were fed com screenings contaminated with FB ; and 
FBi at total doses of 5.5 mg/kg/day for five days, 4.5 mg/kg/day for six days, or 6.6 
mg/kg/day for 15 days. Both pigs dosed intravenously developed liver and pancreatic 
lesions, but only the pig dosed intravenously with 0.88 mg FB i /kg/day developed PPE. All 
pigs fed contaminated corn meal demonstrated liver and pancreatic changes, and pigs fed 
doses of 5.5 mg/kg/day and 4.5 mg/kg/day developed pulmonary edema. Haschek et al. 
identified the liver, lung, pancreas as primary target organs in pigs. 
Ruminant toxicity of FBs 
Osweiler et al. (1993) investigated the effects of com screenings, naturally 
contaminated with fumonisins, on calves. Cattle appeared to be much less susceptible to 
fumonisins than horses and swine. Some change in liver function and immune function 
were found in calves receiving the highest dose of FB, (148 mg/kg diet) but they all 
appeared healthy. Fumonisin containing com culture material was found to be acutely 
toxic to sheep by Edrington et al. (1995) when dosed intraruminally. Liver and kidney 
function were affected in all lambs and deaths occurred in the medium and high dose 
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groups. However, the doses used in this study were extremely high (11, 22 and 45 mg FBi 
/kg BW). 
Toxicity ofFBs in poultry 
Several reports have been made on fumonisin toxicity in poultry. Weibking et 
al.( 1993a) reported histological liver lesions when young broiler chicks were fed diets 
containing >225mg FBi / kg diet from F.verticillioides com culture material for 21 days. 
Dietary levels of lOmg purified FBi / kg diet fed for 6 days, or 30mg FB, /kg diet from 
F.verticillioides culture material fed for 2 weeks, resulted in diarrhea, deceased body 
weight, and change in serum chemistry (Espada et al., 1994). One hundred mg FB i /kg diet 
from culture material, fed for 3 weeks., caused liver damage and altered serum chemistry 
in female turkey pouts (Weibking et al., 1993b). Ducklings fed rations containing 100, 
200, and 400 mg FB, /kg diet had decreased weight gain and increased weights of liver, 
heart, kidney and pancreas in a dose-dependent fashion. Mild to moderate hepatocellular 
hyperplasia was found in all ducklings fed FBi (Bermudez et al., 1995). Because the levels 
of fumonisins used in poultry were relatively high, poultry may be more resistant to the 
toxic effects of FBj than other animals. 
Developmental toxicity ofFBs 
Fumonisin Bi is fetotoxic to rats. Lebepe-Mazur et al.(1995) reported that rat fetuses 
from mothers fed with 60 mg FB; /kg body weight on days 8-12 of gestation had 
significantly lower body weight by 21% and impaired bone development. Golden Syrian 
hamster orally gavaged with culture material containing fumonisins (0.25- 18mg FBi /kg 
BW) or pure FB, (12mg/kg BW and 18mg/kg BW) did not exhibit maternal toxicity based 
on weight gain, serum aspartate aminotrasferase activity or total bilirubin ( Floss et al., 
1994). With increased FBi doses, more fetuses were lost per litter. At 12 mg FB[ /kg, all 
hamsters fetuses were died. This suggested that prenatal exposure to aqueous culture 
extracts containing fumonisin or pure FBi were detrimental to fetal hamster survivability in 
the absence of maternal toxicity. 
Organ toxicity ofFBs 
Fumonisin B| is nephrotoxic to rats and rabbits. FBi toxicity was examined using 
gavage administration of purified toxin to female Sprague-Dawley rats. For 11 consecutive 
days each rat received a single dose of FB, at the following concentrations: control 
(saline), 1, 5, 15, 35, or 75 mg FB,/kg body weight/d. Kidneys and bone marrow were 
most sensitive to FB i exposure. Changes in renal morphology were observed from 5 to 75 
mg FB i/kg/d, accompanied by transient changes in urine osmolality and urine enzyme 
levels. Increased cellular vacuolar ion was the primary change associated with bone-
marrow toxicity, starting at doses of 5 mg FBj/kg/d. Hepatotoxicity was indicated by 
reduced liver weight, elevated serum ALT, and mild histopathological changes occurring 
at doses of 15 mg FBi/kg/d and higher (Bondy et al., 1998). Fumonisin B| was shown to 
inhibit renal proximal tubule cell (RPTC) regeneration in cell cultures of rabbit RPTC 
following mechanical injury (Counts et al., 1995). Cultures were treated with treated with 
lfiM and 2 |±M FBi after a Teflon policeman were used to swipe RPTC monolayers, 
removing -24% of the area. ljiM FBi (lfiM) significantly inhibited the regeneration of 
RPTC as compared with control group on day 7, and exposure to 2 (J.M FBi was cytolytic 
and resulted in degeneration of the culture monolayer after 3 days (Counts et al., 1995). 
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The fumonisins are not very toxic to primary rat hepatocytes in culture with a CD50 dosage 
of 1OOOfiM and 500[iM for FB, and FB2 respectively (Gelderblom et al., 1993). The water 
solubility of fumonisins appears to be the reason for the low cytoxicity as the more polar 
FBi is less cytotoxic than the less polar FB?. The irreversible nature of the interaction of 
fumonisins with cellular membranes (Cawood et al., 1994) suggested that a slow 
accumulation of fumonisins in the cell precipitates hepatoxicity and nephrotoxicity. 
Immunotoxicity ofFBs 
There have been very few studies that address directly the potential for fumonisins 
to modify immune response in vivo. Nonetheless, there are many studies with fumonisins 
or fumonisin-containing diets that either altered function of blood cells in vitro or changes 
in hematological parameters in vivo. Macrophage phagocytic function was down-regulated 
in vitro by FBi (500 jiM/ L) (Qureshi et al., 1992) as was lymphocyte proliferation in 
response to lipopolysaccharides (LPS) (Dombrink-Kurtzman et al., 1994). 
Immunosuppression in chickens was produced in birds fed maize cultured with 
F.verticillioides (MRC826) (Marijanovic et al., 1991). The broiler chicks fed diets 
containing lOmg FBi /kg diet had reduced spleen and or/ bursa weights and altered 
hematological parameters (Espada et al., 1994). In vivo administration of 5Oppm FB, 
significantly suppressed hepatic natural killer (NK) cell activity while stimulating hepatic 
preneoplasia (Lu et al., 1997; Liu et al., 2001), and the production of hepatic PGE2 
increased in both studies. Prostaglandin E2 was observed to inhibit hepatic NK lytic 
activity when hepatic NK cell was co-cultured with PGE? ( lOng/mL or 25ng/ml) (Liu et 
al., 2000). This suggested that PGE, might be one of the modulator of NK activity., 
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Ceramide is an important signalling molecule and recognition site in the cellular immune 
response (Merrill et al., 1997a). Ceramide is the activator of the transcription factors, NF-
KB. Activation of NF-KB occurs in mature T and B cells in response to antigen stimulation, 
in macrophages exposed to cytokines, as well as in many non-lymphoid cell types exposed 
to cytokines (Ballou et al., 1996). Fumonisins are inhibitors of ceramide synthase and can 
reduce the production of ceramide (Merrill et al., 1993a; 1993c). Fumonisin may inhibit 
the immune function through the inhibition of ceramide production. Tumor cells can 
produce a large amount of glycosphingolipids, and glycosphingolipids had been observed 
to suppress the proliferation of a variety of T and B lymphocytes induced by lectins, 
antigens, and interleukin-2 ( Jackson et al., 1987), as well as inhibition of T helper cells 
and cytotoxic effector function (Offher et al., 1987), and the production of 
glycosphingolipids may increase during the FB carcinogenesis. The change of 
prostaglandins (Lu et al., 1997; Liu et al., 2000), as well as other factors which may change 
during fumonisin carcinogenesis, such as ceramide, glycosphingolipids, might be 
important modulation factors of immune function. 
Carcinogenicity ofFBs 
Fumonisin B, is hepatotoxic and hepatocarcinogenic in rats. Culture material of 
strain MRC 826 of F.verticillioides fed to rats at 8% by weight of diet caused cirrhosis, 
nodular hyperplasia and bile-duct proliferation in the liver, and was lethal to all rats. The 
culture material was also hepatocarcinogenic, causing hepatocellular carcinoma and 
ductular carcinoma (Marasas et al., 1984). Gelderblom et al (1988) identified fumonisins 
as cancer promoting agents in rats. Male BD IX rats initiated with an intraperitoneal 
injection of DEN at 200 mg/kg body weight were fed for four weeks with a diet of 5% 
lyophilized F.verticillioides culture material in rat mash or 0.1% FB i. Control rats were 
administered dimethyl sulfoxide (DMSO) instead of DEN following by promoting 
treatment. Rats fed 0.1% FB, developed GGT positive AHF, whether initiated with DEN 
or given DMSO vehicle, with significantly greater GGT positive AHF in DEN-initiated 
rats. Using the same chemical model established in the above study, initiation of rats with 
DEN at 15 mg/kg body weight followed by 34-.7 (J.mol FB, /kg diet promotion for 15 
weeks, Liu et al. (2001) demonstrated that FB a caused the development of PGST — and 
GGT-positive AHF, early indicators of FB, carcinogenesis. In another experiment, a diet 
containing 50 (imol FB, /kg diet was fed to 25 rats for 18-26 months. A group of control 
rats received no FB,. Ten of 15 FB, -treated rats that died or were killed after 18 months of 
treatment developed primary hepatocellular carcinoma (Gelderblom et al., 1991). Howard 
et al.(2001) fed FB, to female and male F344/N rats and B6C3F1 mice for two years. 
Female rats were fed 0, 5, 15, 50, and 100 ppm FB,; male rats were fed 0, 5, 15, 50, and 
150 ppm FB,; female mice were fed 0, 5, 15, 50, and 80 ppm FB,; male mice were fed 0, 
5, 15, 80, and 150 ppm FB,. Fumonisin B, was not tumorigenic in female F344 rats with 
doses as high as 100 ppm. Including FB, in the diets of male rats induced renal tubule 
adenomas and carcinomas in 0/48, 0/40, 9/48, and 15/48 rats at 0, 5, 15, 50, and 150 ppm, 
respectively. Including up to 150 ppm FB, in the diet of male mice did not affect tumor 
incidence. Hepatocellular adenomas and carcinomas were induced by FB, in the female 
mice, occurring in 5/47, 3/48, 1/48, 19/47, and 39/45 female mice that consumed diets 
containing 0, 5, 15, 50, and 80 ppm FB,, respectively. This study demonstrates that FB, is 
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a rodent carcinogen that induced renal tubule tumors in male F344 rats and hepatic tumors 
in female B6C3F1 mice. 
Detoxification of Fumonisin 
Biological, chemical, and physical processes have been explored to salvage 
fumonisin-contaminated com. Thermostability of FB, proved to be great. When dry com 
was heated at 50, 75, 100 and 125°C for 40 minutes, only a small amount of FB, was not 
detected, more than 90% of FB, was recovered after 16 h at 50°C (Dupuy et al., 1993). 
Dupuy et al. (1993) concluded that additional detoxification procedures would be required 
to reduce or eliminate FB% as no heat treatments completely eliminated FB, . 
Co-contamination of com with aflatoxin and fumonisins prompted research into 
possible detoxification of fumonisins by ammoniation, the standard detoxification method 
used for aflatoxin-contaminated com (Norred et al., 1991). Treatment of fumonisin-
contaminated com with 2% ammonia at low pressure for 4 days, a process that detoxified 
aflatoxin Bi, led to slight reduction in the concentration of FBi without decreasing its 
toxicity in rats (Norred et al., 1991). Voss et al.(1992) examined the effects of 
ammoniation on FB[ in com and F.verticillioides com culture material. Com and culture 
material were treated with 2% ammonia and incubated at 50°C. Male SD rats were fed 
diets 10% in com, ammoniated com, culture material, or ammoniated com culture material 
for four weeks. FBi content of culture material was not significantly reduced by 
ammoniation. Serum alanine aminotransferase, aspartate aminotransferase, alkaline 
phosphatase, and y-glutamyl transpeptidase levels were significantly greater in rats fed 
either the ammoniated or non-ammoniated F.verticillioides culture material. Voss et al. 
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(1992) concluded that the ammoniation procedure used to detoxify aflatoxin-contaminated 
com did not significantly reduce FB i content or toxicity of F.verticillioides culture 
material. 
Bothast et al.(1992) examined the possibility of ethanol fermentation to utilize 
contaminated grains. No FB, was found in distilled ethanol. Bothast et al.(1992) suggested 
that ethanol fermentation of FB i -contaminated grain would allow use of contaminated 
com, but concern remained with spent grains as they are used in animal feeds. The 
detection of FB i in spent grains after fermentation, but detection of very little FBi in com 
used for ethanol fermentation, suggested that FB% was conjugated through the amine group, 
preventing detection prior to fermentation. Increased fumonisin contents after fermentation 
indicates a potential human and animal hazard that needs to be addressed for undistilled, 
fermented products. 
Nixtamalization, the traditional process to produce masa or tortilla flour, reduced 
the amount of FBi by hydro lyzing FB[ to hydro lyzed FBi (HFBi ). To evaluate if this 
traditional process decreased the toxicity of F.proliferatum fermented com, male F344/N 
rats were initiated with 15mg/kg DEN 10 days of age. At weaning, animal were randomly 
assigned to 8 groups of 6 each to evaluate the effect of F. proliferatum fermented com, 
with or without nixtamalization and nutrient supplementation. After 4 weeks feeding, the 
animals fed nixtamalized F. proliferatum com containing 10 mg HFBi/kg had decreased 
body weight, increased relative liver weight, total cholesterol and ALT activity. However, 
these changes were less than those observed in animals fed F. proliferatum com containing 
50mg FB i /kg. The animals fed the nixtamalized diet with or without nutrient supplements 
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developed adenoma. These data suggested that HFB, was similar in toxicity to FBi when 
the nutritional status of rats was adequate (Hendrich et al., 1993). 
In vitro toxicity studies of several FB, analogs showed that the analogs containing 
FB, amine groups and the tricarballylic side chains were more toxic than analogs 
containing only the tricarballylic side chains (Kraus et al., 1992), and naturally occurring 
N-acetyl —FB, was not toxic (Gelderblom et al., 1993). Therefore, the primary amine of 
FB, is likely to be critical for its toxicity. Murphy et al. (1995) reported a method to 
detoxify FB t by derivatizing the amine group with a reducing sugar, fructose, in a 
nonenzymatic browning reaction. Diethylnitrosamine-initiated (15 mg/kg body weight) 
male F344/N rats were fed for 4 weeks either 69.3 flM FB, or 69.3 (iM FB, reacted with 
fructose (FB i -fructose). Rats fed FB, had significantly increased levels of several markers 
of hepatocarcinogenicity, whereas rats receiving FB, — fructose showed no signs of 
hepatocarcinogenicity or hepatotoxicity (Lu , Thesis). A more practical and efficient 
method to block FB,'s amine group by reacting the amine group with glucose had been 
developed in Dr. Murphy's lab (Lu, Thesis) .The FB,-glucose reaction was more complete 
than the reaction with fructose, and the reaction products were more easily isolated than 
FBi-fructose products. 
Fumonisin Bioavailability 
The metabolism of fumonisin has been studied by using 14C-FB i, which permits 
rapid analysis of the biological disposition of this compound. In fasted rats, Norred et al. 
(1993) detected 80% and 2.3% of FBI administrated by gavage (1.4 jimol of 14C-FBI /kg 
bw) in feces and urine, respectively. Liver, kidney, and blood retained a total of 0.6% of 
34 
the dose 96h after treatment. In fed rats at 24h after a dose administered by gavage 
(10.4p.moI of 14C-FBi /bw), Shephard et al. (1992) detected 100% and trace levels of FBi 
in feces and urine, respectively. Trace levels of 14C-FB i v/ere detected in liver, kidney, and 
blood of these rats. Biliary excretion of FB has been suggested by observations of fecal 
recovery of 14C-FB given by intravenous or intraperitoneal routes (Norred et al., 1993; 
Shephard et al., 1992). Shephard et al. recovered 67% of an intraperitoneal dose (10.4fJ.mol 
of I4C-FB I /bw) after 24 h in bile whereas 0.2% of a 0.4 {iml dose administered by gavage 
was detected in bile of fed rats (Shephard et al., 1994). 
The excretion of FBi, hydro lyzed FB, (HFB,), and FB i -fructose adducts was 
determined in male F344/N rats by Hopmans et al. (1997; Dantzer et al., 1999). Rats were 
dosed by gavage with 0.69, 6.93 or 69.3ji.mol/kg of body weight FBi.H FBi, or FBi — 
fructose. Average total FBi backbone excretion in feces was 101, 76, and 50% of the dose 
for FBi, HFBi, and FBi —fructose, respectively. Average total FBi backbone excretion in 
urine was 2.7%, 5.0%, and 5.3% of the dose for FBi.HFBi, or FBi - fructose. In another 
experiment, the excretion of FBi, HFBi, and FB% —fructose were determined in both male 
and female F344/N rats (Dantzer et al., 1999).Urinary excretion of FB;, and FBi —fructose 
was 0.5% and 4.4% of the total dose, respectively, and was similar between male and 
female rats. Urinary excretion of HFB i was significantly greater in female rats as 
compared with male rats (17.3% vs 12.8% of the total dose, respectively). The three 
fumonisin compounds had a similar biliary excretion with a mean of 1.4% of the dose 
excreted at 4 h after dosing. The HFB [ was absorbed to a greater extent than FB i suggested 
that tricarballylic acids limited FBi absorption by increasing polarity. The loss of two 
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tricaballylic acids would render HFBi a considerably less polar molecule with the GI tract 
environment, possibly facilitating its absorption. Although absorption of the FB, - fructose 
was greater than FBi, the formation of the adduct may detoxify FB, by masking the 
primary amine group, leaving the molecule unable to exert its toxic effects. 
Mechanism of Fumonisin Toxicity and Carcinogenicity 
The fumonisins are non-mutagenic when tested in the Salmonella mutagenicity test 
(Gelderblom et al., 1991) and lack genotoxicity in in vitro DNA repair assays in primary 
rat hepatocytes (Gelderblom et al., 1992: Norred et al., 1992). The lack of mutagenesis by 
the fumonisins was confirmed when different concentrations, ranging from 0.7 to 500ug 
per plate, were tested against strains TA100 and TA98 in the presence and absence of 
Aroclor 1245 induced S9 enzyme fraction. Fumonisin B, also failed to induce micronuclei 
and did not alter the mitotic activity of primary rat hepatocytes. Despite the fact the 
fumonisins were negative in various genotoxicity and mutagenicity assays. Howard et al. 
(2001) showed that FB, is a rodent carcinogen that induced renal tubule tumors in male 
F344/N rats and hepatic tumors in female B6C3F1 mice in a two-year cancer bioassay 
study. Gelderblom et al. (1992; 1994) hypthesized that FB, mimics genotoxic carcinogens 
with respect to the induction of preneoplastic hepatocytes in rat liver. This was 
substantiated by the observation that FB, induces two important enzymes, GGT and PGST 
(Lu et al., 1997), which are accepted histogical markers for putative preneoplastic lesions 
initiated by genotoxic carcinogens. Feeding experiments with fumonisins in rats indicated 
that an increase in cell proliferation is also likely to play a critical role in the induction of 
the preneoplastic phenotype as hepatoxicity, and the resultant regenerative cell 
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proliferation, is a prerequisite for initiation (Gelderblom et al., 1994). The only difference 
noticed thus far in the induction of resistant phenotype between the fumonsins and other 
genotoxic carcinogens lies in the kinetics of the cancer initiation step. It is know that, with 
genotoxic carcinogens, cancer initiation is normally completed within a matter of hours or 
a few days (Farber et al., 1989). However, single and/or multiple dosages of fumonisins in 
the presence of a stimulus for regenerative cell proliferation failed to effect initiation 
(Gelderblom et al., 1992). A recent study showed that prolonged exposure of rats to 
fumonisin FBi or even a single gavage dosage, effectively inhibits compensatory 
hepatocyte proliferation following partial hepatectomy (Gelderblom et al., 1994). In this 
regard, fumonisin B i resembles many other carcinogens which are all potent inhibitors of 
normal cell proliferation (Farber 1990). Since regenerative cell proliferation is sometimes a 
prerequisite for cancer initiation (Cayama et al., 1978), it was suggested that inhibitory 
effect of FBi could explain the fact that FBi is a slow cancer initiator (Gelderblom et al., 
1994). All these suggested that the cancer initiating potential of fumonisins is that the rate 
limiting step for cancer induction may be the induction of cell death and the resultant 
compensatory cell proliferation, and the inhibitory effect of fumonisin on cell proliferation 
could delay and /or inhibit cancer initiation of this mycotoxin. 
Contribution of sphingolipid metabolites to FBj toxicity and carcinogenesis 
The fumonisins bear a remarkable structural similarity to sphingosine and 
sphinganine, which led many to hypothesize that the mechanism of action of fumonisins 
may be via disrruption of sphingolipid metabolism. The cellular target of fumonisins has 
been found to be the enzyme ceramide synthase, which catalyzes the addition of a fatty 
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acid to sphinganine in the de novo biosynthesis of sphingolipids, and in the reacylation of 
long-chain bases that arise from sphingolipid turnover (Wang et al., 1991; Merrrill et al., 
1993a and 1993b). The inhibition is competitive with both the long-chain (sphingoid) base 
and fatty-acyl-CoA (Merrill et al., 1993), which indicates that fumonisins may inhibit 
ceramide synthase by interacting with both the binding site for sphinganine(sphingosine) 
and the site for the fatty-acyl-CoA. It is possible that fumonisins also inhibit other 
enzymes that interact with either long-chain bases or fatty acyl-CoA, To test this 
possibility, fumonisin B, has been tested with sphingosine kinase and serine 
palmitoyltransferase ( Wang et al., 1991), and neither enzyme was inhibited by the 
levels(lgM FBi) that result in complete inhibition of ceramide synthase. 
The disruption of sphingolipid biosynthesis would be predicted to have profound 
effects on cells because these compounds have important roles in membrane and 
lipoprotein structure, cell-cell communication, interaction between cells and the 
extracellular matrix, and as second messengers for a wide range of factors (Merrill et al., 
1993a and 1993c). Two likely explanations for the toxicity and carcinogenicity of FBi after 
inhibition of sphingolipid biosynthesis by this mycotoxins have been proposed. First, the 
accumulation of free sphinganine(and possibly its metabolites, such as the l-phosphate)is 
growth inhibitory and cytotoxic for the cells. Long-chain (sphingoid) bases are well known 
to be growth inhibitory and cytotoxic (Merrill et al., 1983); therefore, the accumulation of 
sphinganine (and sometimes sphingosine) might lead to cell death. The cellular target that 
accounts for these effects of long-chains is unknown, but there are a number of candidates. 
Long-chain bases have been shown to inhibit protein kinase C, to activate phospho lipase 
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D, and to activate or inhibit other enzymes of lipid signaling pathways, to inhibitthe 
Na+/K+ ATPase, to induce dephosphoryiation of retinoblastoma protein( a key regulator 
of the G to S transition of the cell cycle), to induce release of Ca2+ from intracellular stores 
(apparently via sphingosine 1 -phosphate), and to affect a large number of other cell 
regulatory systems. In addition, sphingosine has been observed to indue apoptosis in 
thymocytes ( Bai et al., 1990) and neutrophils (Ohta et al., 1994). Second, the loss of 
complex sphingolipid biosynthesis would be expected to alter cell behavior, and could lead 
to cell death based on findings with mutants in serine palmitoyltransferase, the initial 
enzyme of sphingolipid biosynthesis (Hanada et al., 1990). At low dosages, fumonisins 
appear to be mainly tumor promoters (Gelderblom et al., 1988). Tumor promoters are often 
mitogens, it has been found that sphingosine and sphingosine 1-phosphate can induce 
DNA synthesis in growth-arrested Swiss 3T3 cells (Zhang et aL, 1990 and 1993). 
Therefore, it was hypothesized that fumonisins might induce DNA synthesis via the 
accumulation of sphinganine (Schroeder et al., 1994J. Merrill et al (1995) demonstrated 
that addition of fumonisin B| to Swiss 3T3 cells elevates sphinganine and induces an 
increase in [3H]thymidine incorporation into DNA. Furthermore, both were blocked by 
addition of an inhibitor of serine palmitoyltransferase ((3-fluoro-L-alanine), which 
established that this effect of fumonisins is due to sphinganine accumulation, not the 
depletion of complex sphingolipids. In vivo, fumonisin acting as a mitogen could increase 
the probability of, or irreversibly lock in , a spontaneous genomic error. It has been 
proposed that mitogenesis increases the cancer risk by increasing the probability of DNA 
damage being converted to mutations, making DNA more sensitive to being damaged, 
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increasing gross chromosomal alterations, and increasing expression of oncogenes(Ames 
et al., 1990). 
The free sphingosine and sphinganine accumulation in lymphocytes was shown to 
inhibit DNA synthesis and to disrupt lymphocyte proliferation in response to mitogens and 
T-dependent anitgens (Martinova 1996; Martinova et al., 1991; 1995). Sphingosine has 
been found to inhibit EL-8-induced and integrin-dependent lymphocyte migration. 
Sphingosine also prevents both the MHC-restricted and non-restricted cell adhesion, and it 
inhibits cytotoxic lymphocyte proliferation in response to IL-2 and in mixed lymphocyte 
culture (Borchardt et al., 1994). In normal T lymphocytes and T helper cell clones, the 
selective activation of cAMP-dependent knase type I was found to block the signals 
transducing through TCRZCD3 complex. In transformed Swiss 3T3 fibroblasts, cAMP 
accumulation may activate the MAPK kinase cascade, Gl/S-phase transition and cell 
differentiation (Spiegel et al., 1994). Sphingolipid balance defines the proliferation of 
murine cytotoxic lymphocytes (Yatomi et al., 1996 ). The mitogenic or suppressive effect 
of sphingolipids on lymphocyte proliferation is dependent on the cell cycle and additional 
signal pathways in the cell. Sphingolipid cross-talk with the cAMP system in lymphocytes 
(that suppresses the TCR/CD3 signaling in normal cells and up-regulates this in 
transformed cell lines ) may explain both the mitogenic and inhibitory effect of 
sphingo lip ids on immune cells. 
The precise mechanism by which disrupted sphingolipid metabolism contribute to 
the increased organ toxicity and neoplasia in rodents is unclear. The balance between the 
intracellular concentration of sphingolipid effectors that protect cells from apoptosis 
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(decreased ceramide, increased sphingosine 1-phosphate) and the effectors that induce 
apoptosis (increased ceramide, increased free sphingoid bases) will determine the observed 
cellular response, and the balance between the rates of apoptosis and proliferation might be 
one of the critical determinants in the process of tumorigenesis. 
The contribution of prostaglandins to fumonisin Bx toxicity and carcinogenesis 
The idea that prostaglandins may play a role in immune response/tumor cell 
interactions is based upon several observations. First, a variety of prostaglandins are 
produced both by cells that are themselves active in the expression and regulation of 
immune response activity (Tomar et al., 1981; Sinder et al., 1982) as well as by a number 
of tumor targets (Karmali et al., 1980; Goodwin et al., 1981). Carcinogenesis may be 
associated with increased prostaglandin production by neoplastic organs, such as during 
promotion of rat hepatocarcinogenesis by fumonisin Bi (Lu et al., 1997). Second, the 
production of prostaglandins has been found to increase as a result of direct contact 
between effector lymphocytes and tumor targets (Owen et al., 1980). Third, prostaglandins 
at levels produced during these interactions have been shown to influence the ultimate 
expression in vitro of lymphocyte and macrophage cytotoxicity against tumor targets 
(MacCarthy et al., 1981 ; Koren et al., 1981). 
Prostaglandins mediate inter- and intracellular communication, as may stimulate 
hepatocyte proliferation (Miura et al., 1979; Andreis et al., 1981). The concentration of 
PGE equivalents in rat liver in vivo was increased during liver regeneration. This 
stimulation of prostaglandin synthesis was confirmed in vitro by the ability of 
homogenates of regenerating liver tissue to synthesize PGE? and PGFia from arachidonate. 
41 
Indomethacin prevented these prostaglandin changes, and the subsequent increase in DNA 
synthesis (MacManus et al., 1976). During the regeneration of mammalian liver after a 
70% partial hepatectomy (PHx), Kupfer cells produced significantly elevated PGE2, and 
in vivo Kupfer cell PGE2 blockade by indomethacin (5 mg/kg) significantly (P < 0.05) 
inhibited hepatic regeneration (Goss et al., 1993). The association of neoplastic tumors 
with increased levels of prostaglandins (Robertson et al., 1986; Bennett et al., 1975) 
provided the rationale for investigating their role in tumorigenesis. Animal and human 
tumors contain high levels of prostaglandins, particularly those of the E series that have 
been shown to significantly affect cell proliferation and tumor growth and suppress 
immune responsiveness. DNA synthesis of hepatocytes in primary culture was 
significantly enhanced by addition of PGE2 (2-200 nmol/L). Intracellular cAMP level in 
the hepatocytes increased during culture, and cAMP increase was enhanced by PGE?. 
Prostaglandin E2 production in the liver increases hepatic regeneration and PGE2 enhances 
the proliferation of hepatocytes by a seemingly cAMP-dependent specific receptor-
mediated process (Tsujii et al., 1993) At concentrations of 10~9 -10"12mol/L, PGF[tt and 
PGF20C very intensely stimulated both the DNA-synthetic and mitotic activities of 
hepatocytes in 4-day-old primary cultures of neonatal rat liver. DNA replication was more 
intensely enhanced by PGF2« than PGFia, whereas mitotic activity was nearly equally 
affected by the two prostaglandins (Armato et al., 1983). Thus enhanced PGE2 and PGF2a 
may promote hepatocarcinogenesis by stimulating DNA synthesis and proliferation of 
hepatocytes. 
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A high level of PGE2 in the portal vein suppresses liver-associated immunity and 
promotes liver metastases (Okuno et al., 1995). Some in vitro experiments showed a 
similar phenomena. The ability of Syrian hamster tumor cells of the same origin but with 
different degrees of malignancy to secrete prostaglandin E was studied following their in 
vitro contact with Syrian hamster natural killer cells (NK cells). Syrian hamster NK cells 
were shown to lose cytotoxic activity significantly after their contact with malignant tumor 
cells. Short-term in vitro contact of malignant tumor cells with human and Syrian hamster 
NK cells resulted in a rapid PGE secretion into the culturing medium. Therefore, PGE2 
may promote tumor progression by inhibiting immune function. The effect of PGF%a on 
NK cells is still not clear. The regulatory effects of prostaglandins on immune response 
appear to be mediated by the production of cyclic AMP (Robison et al., 1971). PGE? 
activates adenylate cyclase with a subsequent rise in cyclic AMP (Smith et al., 1971), 
which acts as a "second messenger". Cyclic AMP itself is an inhibitor of lymphocyte 
activation (Smith et al., 1971; Melmon et al 1974). The presence of receptors for PGE; and 
PGE, on the lymphocyte (B & T cell) surface had been demonstrated, while there were no 
binding sites for PGA, PGFia or PGF20- - Henney and Lichtenstein, using splenic 
lymphocytes from mice immunized with an allogeneic mast cell tumor (Henney et al., 
1971), suggested that elevated cyclic AMP content of cytolytic lymphocytes might 
inhibited their ability to kill target cells. As a test of this hypothesis, prostaglandins were 
shown to inhibit lymphocyte cytolytic activity (Henney et al., 1972). The relative potency 
of seven prostaglandins in inhibiting cytolytic activity correlated very well with their 
potency in stimulating cyclic AMP accumulation in lymphocytes: E1=E?>At =A?>F 1 o=F2a 
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~ 0 (Lichtenstein et al., 1972). By co-culturing the liver associated natural killer cells of 9 
week-old rats of both genders of F344/N and SD rats with prostaglandins, Liu et al. (2000) 
showed that prostaglandin E? significantly inhibited hepatic natural killer cell(NK) activity 
in vitro compared with untreated cells from both genders and strains, and 25ng PGEi/ml 
inhibited NK activity significantly more than did lOng PGEi/ml. In contrast, 50ng 
PGFzc/ml and lOOng PGF^/ml significantly stimulated hepatic NK activity compared with 
untreated hepatic cells from both F344/N and SD rats. 
Lu et al.(1997) showed that elevation of hepatic prostaglandin paralleled the 
induction of AHF in rat liver, indicating that increased prostaglandin production was 
related to promotion of rat hepatocarcinogenesis caused by FB i. At the same time, the 
inhibition of hepatic natural killer cell activity was observed with the increasing of hepatic 
prostaglandins and the induction AHF in rat liver under effect of FB,. The inhibition of 
FBi hepatocarcinogenesis was observed when the female SD rats were supplemented with 
14% dietary menhaden oil, which can inhibit the production of prostaglandins. Lee (2000) 
showed that the induction of hepatic AHF in female SD rats fed with 14% menhaden oil 
and 50ppm FB, was significantly lower as compared with the group fed with 14% lard and 
50ppm FBi. Hepatic PGEi and PGFia in first group was significantly lower than in the 
second group. 
These studies suggested that elevation of hepatic prostaglandins faciliates tumor cell 
proliferation, and promotes the development of neoplasia. Prostaglandins may also exert 
indirect effects on proliferation of tumor cells by suppressing the local immune response, 
because prostaglandins were able to make macrophages and/or lymphocytes less sensitive 
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to various stimuli (Schultz et al., 1978), and PGE, suppressed NK cells and lymphokine-
activated killer cells. 
The effect of total dietary fat on carcinogenesis 
The amount of dietary fat has profound effects on the development of mammary 
tumors in mice and rats. Increased dietary fat was reported to increase the development of 
mammary tumors in experimental animal models. Many studies reported accelerated 
mammary tumorigenesis with increases in the quantity of ingested fat used unsaturated fatty 
acids derived from vegetable products, such as, com oil, sunflower seed oil, etc. (Branden et 
al., 1986). Studies also reported enhanced mammary tumorgenesis with increased quantities 
of saturated fatty acids such as lard and beef tallow. Aksoy et al.(1987) reported the 
influence of isocalorically fed diets (containing different amounts of fat) on tumor incidence 
and parameters of fat metabolism in female Sprague-Dawley rats. Comparisons were made 
between rats induced with methylnitrosourea (25 mg/kg body wt) and untreated controls 
(Group I). The animals received either control diets (3.9% fat by weight, Groups I and II) or 
fat-enriched diets (10.7%, Group III; 15.6%, Group IV; 21.4%, Group V) over a period of 
180 days. At the termination of the experiment, intake of the diet containing 10.7% fat by 
weight (24% fat per total calories) was associated with the highest tumor incidence. This 
study suggested increased fat intake increased neoplasia independent of the effect of energy 
intake. Another experiment studied weanling 21-day-old female Sprague-Dawley rats 
divided into different dietary treatment groups and allowed to feed ad libitum on one of the 
following diets: 5% (normal fat) com oil; 20% (high fat) com oil; 20% palm oil; 20% beef 
tallow; or 20% lard. At 52 days of age, all rats were given p.o. 7.5 mg 7,12-
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dimethylbenz(a)anthracene (DMBA). One week following DMBA administration, all rats 
were switched to the 5% corn oil control diet and were maintained on this diet for the 
duration of the experiment. Rats fed a 20% lard diet during the treatment period showed a 
significant increase in mammary tumor incidence and number 19 weeks after DMBA 
administration, when compared to all other dietary treatment groups. Rats fed a 20% beef 
tallow diet during this same time period also demonstrated enhanced mammary tumor 
development, during the 10- to 19-week time period after DMBA. Mammary tumor 
development in rats fed 20% com oil or palm oil diets during this treatment period was 
similar to that of control fed 5% com oil. In conclusion, high dietary intake of lard and beef 
tallow, but not vegetable fat, fed from weaning until only 1 week after DMBA 
administration, significantly enhances mammary tumorigenesis in rats. The mechanism(s) 
by which animal fat induces this stimulation is not clear, but it did not appear to result from 
endogenous or exogenous endocrine stimulation, because estrogens, which are potent 
stimulators of mammary tumor growth and development in rats, were not different among 
the groups (Sylvester et al., 1986). Birt et al. (1990) reported that an enhancement of 
pancreatic carcinogenesis induced by N-nitrosobis(2-oxopropyl)amine (BOP) in hamsters 
fed diets containing high levels of beef tallow. They compared diets high in com oil with 
those high in beef tallow in the enhancement of pancreatic carcinogenesis. Pancreatic 
cancer was induced with 20 mg BOP/kg body wt, s.c. administered at 8 weeks of age. One 
week later, hamsters were assigned to one of five diet treatments: (i) 4.3% com oil 
(control); (ii) 20.5% com oil (high com oil); (iii) 0.5% com oil + 3.8% beef tallow (low 
beef tallow); (iv) 0.6% com oil + 19.9% beef tallow (high beef tallow); and (v) 5.1% com 
oil + 15.4% beef tallow (high fat mixture). These diets were fed until the study ended 84 
weeks after BOP treatment. Hamsters were pair fed to consume the same calorie allotment 
as the control com oil group. By the end of the experiment, BOP-treated hamsters that were 
fed diets containing beef tallow were consistently heavier than those fed com oil. Pancreatic 
adenoma incidence and multiplicity were higher in hamsters fed beef tallow than those fed 
com oil diets. Carcinoma in situ multiplicity was elevated in hamsters fed high-fat diets 
irrespective of the nature of fat fed. Pancreatic adenocarcinoma multiplicity was elevated in 
hamsters fed the low- or high-beef tallow diets compared with the low- or high-com oil 
diets. This experiment suggested that greater total amount of dietary fat promote the 
carcinogenesis when animal were fed isocalorically. Rats were first intubated with 
diethylnitrosamine (DEN, 10 mg/kg) 20 hr after partial hepatectomy; 1 week later, rats were 
fed one of three purified diets (a low-fat diet similar to the AIN-76 diet, a high saturated fat 
diet, or a high polyunsaturated fat diet) with or without 0.05% phénobarbital in the diet for 
10 months. Increasing the fat level of the diet did not increase the number of GGT-positive 
foci arising spontaneously or induced by DEN alone. When phénobarbital was present in 
the diet, both high-fat diets enhanced the induction of GGT-positive foci. Increasing the 
dietary fat level, may enhance promotion of liver foci by phénobarbital ( Glauert et al., 
1986). 
How increased quantities of dietary fat enhance the tumorigenic process is not clear. 
But virtually all studies reporting a significant enhancing effect of dietary fat on 
experimental mammary tumorigenesis compared very low levels of fat with high levels, 
i.e., 0.5-5% fat versus 20-30% fat, and the animals consuming the low levels of fat may not 
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have received adequate quantities of an essential lipid such as lino le ic acid. Intensely 
proliferating mammary tumors may need greater quantities of this nutrient compared with 
normal tissue (Clifford, 1992 ). 
In order to determine the degree of energy restriction necessary to achieve 
significant inhibition of mammary tumor promotion in rats treated with 7,12-
dimethylbenz[a]anthracene (DMBA). A control group of rats was fed a diet containing 5% 
corn oil ad libitum. Four other groups were pair-fed to the controls; these rats were 
subjected to energy restriction of 10, 20, 30, or 40%. Weight gains among the groups were 
proportional to energy intake. The differences in weight were due primarily to reductions 
in body fat stores. Tumor incidence was reduced slightly by 20% calorie restriction and 
significantly by 30 and 40% restriction. There were also reductions in number of tumors 
per tumor-bearing rat and in mean tumor weight. The groups subjected to 30 and 40% 
energy restriction had significantly reduced serum levels of insulin in the fasting state. 
These data suggest that body weight, body fat, and fasting serum insulin correlate with 
susceptibility to mammary tumor promotion and that insulin may be a growth factor for 
DMB A-induced tumors ( Klurfeld et al., 1989). In order to study if moderate degree of 
caloric restriction, 25%, would inhibit tumor growth in rats fed the equivalent of 20% 
dietary fat which approximates human consumption in affluent countries, rats were fed 
diets ad libitum that contained 5, 15 or 20% com oil. Groups of rats were pair-fed to the 
last 2 groups, but subjected to a 25% caloric restriction. These groups were fed 20 or 
26.7% com oil so that absolute fat intake in the paired groups was identical. Significant 
inhibition of tumor incidence, tumor weight, tumor burden, body fat deposition, and 
48 
fasting serum insulin were observed in the 2 calorically restricted groups. This experiment 
concluded that moderate caloric restriction is significantly more effective in inhibiting 
tumor growth than is the promoting effect of diets high in fat. Total body weight, body fat 
and serum insulin concentrations may be better correlates of risk of developing mammary 
tumors than is dietary fat (Klurfeld 1989). 
Lu et al. (1997) reported that feeding 7% soybean oil and 14% beef tallow to DEN 
(15mg/kg bw)-intiated and 50ppm FB i —promoted female F344/N rats for 5 weeks caused 
all animals developed GGT- and PGST- positive altered hepatic foci, and the hepatic NK 
activity was inhibited by 50ppm FBi. Liu et al. (2001) reported that feeding 7% soybean 
oil only as dietary fat to DEN ( 15mg/kg)-intiated and 25 ppm FBi -promoted female 
F344/N rats for 16 weeks caused only half of the animals to develop PGST- and GGT-
positive foci, and the NK activity was not different among groups. These two experiments 
suggested that there was an interaction between dietary fat and FBi carcinogenesis, as 
reflected in their effects on the altered hepatic foci, and hepatic NK activity. 
The relationship between dietary fat and calories in mammary tumorigenesis in 
rodents was examined in lots of studies. Caloric restriction has a significant and consistent 
inhibitory activity on the development of rodent mammary tumors. The restriction of 
caloric consumption suppressed the development of mammary tumors in experimental 
animals and appeared to block the difference in mammary tumorigenesis between rats fed 
low- and high-fat diets. In carcinogen-treated rats, reducing energy consumption by 25% 
(Cohen et al., 1988) or as little as 12% ( Welsch et al., 1990) of that consumed by ad 
libitum —fed controls negated the significant mammary tumor stimulation of a high fat diet. 
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Furthermore, carcinogen-treated rats fed low- and high-fat diets and restricted in food 
consumption to a level equivalent to that consumed by the animals consuming the least 
amount of food showed no differences in mammary tumor development ( Thompson et al., 
1985). It appeared that enhancement of mammary tumorigenesis in rodents by low- or 
high-fat depended on an ad libitum feeding protocol. In summary, high caloric density 
appears to contribute more than the high dietary fat to the development of cancer. 
Natural killer cells and carcinogenesis 
Natural killer cells comprise a heterogeneous population of large granular 
lymphocytes, appoximately 5-10% of peripheral blood mononuclear cells, that are known 
to participate in both homeostatic and inflammatory host defense functions (Herberman et 
al., 1981; Robertson et al., 1990; Trinehieri et al., 1989). These cells spontaneously lyse 
a variety of parasites, fungi, bacteria, virally infected cells, and certain transformed cell 
populations, and are considered to play a role in the early protection against microbial 
infections and tumor cell development in a host before the development of specific 
immunity (Herberman et al., 1981; Whiteside et al., 1994). NK cells are mostly found 
circulating in the blood; however, under certain inflammatory conditions or in response to 
the administration of a biologic response modifier such as interleukin-2 (IL-2), interferon-y 
(INF-y), these cells preferentially traffic to several organ sites, including the liver, spleen, 
and the peritoneal cavity ( Pilaro et al., 1994; Allavena et al., 1997). This organ-specific 
trafficking is believed to be owing to the local release of various cytokines and other 
inflammatory mediators. Moreover, considerable evidence has accumulated to demonstrate 
that the cytokine-induced augmentation of organ-associated NK cell function can 
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contribute to nonspecific anti-metastatic response observed in a number of immunotherapy 
studies(Allavena et al., 1997). Moreover, the ability of NK cells to secrete various 
cytokines including IFN-y, tumor necrosis factor (TNF), and granulocyte —macrophage 
colony-stimulating factor (GM-CSF) is believed to play a central role in the regulation of 
both the immune response and hematopoiesis (Holmberg et al., 1981). Indeed, studies 
within several experimental immunodeficient animal models have clearly demonstrate the 
importance of INF-y production by infiltrating NK cells in preventing overwhelming 
infection from several obligate intracellular pathogens (Glimpel et al., 1988). Additionally, 
the production of both IFN-y and TNF-a by NK cells appear to play a role in the 
pathogenesis of septic shock. 
The capacity to mediate Major Histocompatibility ( MHC )-unrestricted cytotoxicity 
against certain tumor cells without apparent prior sensitization has by definition been 
primarily ascribed to NK cells (Trinchieri 1989). NK cells are phenotypically and 
functionally distinct population of lymphocytes with characteristic morphology of large 
granular lymphocytes (Trinchieri 1989; Whiteside et al., 1990). In rats, high density cell 
surface expression of NKR-Pl antigen( i.e. NKR-Plbnght) is an exclusive property of all 
mature NK cells (Chambers et al., 1989; Brissette-Storkus et al. 1994). NKR-Pl is also 
expressed on a subset of T cells, but with a 2- to 10- fold lower density (i.e., NKR-Pl dim) 
than on NK cells (Chambers et al., 1989; Brissette-Storkus et al. 1994). Some subsets of 
NKR-Pldim are capable of mediating NK-Iike cytotoxicity, particularly after incubation 
with high concentration of IL-2 (Brissette-Storkus et al. 1994 ) 
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Wisse and Daem (1970) described the presence of cells with a lymphoid 
morphology and characteristic cytoplasmic granules in the sinusoids of perfused rat liver. 
They called these cells "pit cell". In 1983, Kaneda et al (1983) proposed that pit cells may 
represent NK cells. Independent studies demonstrated that NK cells can indeed be isolated 
from rodent liver (Wiltrout et al., 1984; Cohen et al., 1985). Natural killer cells can be 
isolated from normal liver by two methods, namely enzymatic digestion of the liver, and 
"sinusoidal lavage"(Bouwens et al., 1987). The sinusoidal lavage method to isolate hepatic 
NK cells has several advantages to the enzymatic dissociation method: 1. It is faster and 
does not require the equipment for centrifugal elutriation. 2. Its reproducibility is high and 
does not depend on the activity of the batch of enzymes. 3. It does not damage the cells 
due to the proteolytic activity of enzymes. With this sinusoidal lavage method, an average 
of about 30% of the isolated mononuclear cells were identified as NK cells. This result 
demonstrated that an NK cell-enriched lymphocyte population is present in normal rat 
liver, because in peripheral blood less than 8% of the mononuclear cells are NK cells, and 
in the spleen this frequency is even lower. The total number of NK cells in the liver is also 
high in comparison to other anatomical Iocations(Bouwens et al., 1987 ). In athymic nude 
rats, a significantly higher number of NK cells can be isolated from the liver as compared 
to normal rats (Bouwens et al., 1987 ). 
Foreign antigens, damaged cells, viruses and gut-derived microbial products such as 
endotoxins are cleared and detoxified by cells lining the liver sinusoids ( Nolan 1989 ). 
Since the liver is a major organ site for metastasis of tumor cells (Vidal-Vanaclocha 1993), 
attention has been recently directed to the role of cells from the liver sinusoids in the 
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defense against invading tumor cells ( Tzung 1992). Rappaport et al. (1973 ) defined 
different zones in the liver according to certain anatomical properties. Zone 1 is the region 
surrounding the portal vein while zone 3 encompasses the central vein. The 
nonparenchymal liver cells, such as liver-associated NK cells and Kupffer cells are more 
abundant in zone 1 than in zone 3 (Barbera-Guillem et al., 1991). Hepatocyte regeneration 
following injury and adult reactive hematopoiesis both begin in zone 1. More importantly, 
metastatic tumor cells developed colonies only in zone 1 (Vidal-Vanaclocha et al., 1990). 
Consequently, liver associated-NK cells and other nonparenchymal liver cells in zone 1 of 
the liver may play a critical role in control of implantation and the growth of metastatic 
solid tumor cells. 
Evidence from experimental animal models strongly suggests that liver-associated 
NK cells and Kupffer cells are the first -line defense against blood-borne metastasizing 
solid tumor cells invading the liver and thus protect the parenchyma. The primary role of 
NK cells in neoplasia is directed against blood-borne tumor cells during the intravascular 
phase of tumor metastasis(Winnock et al., 1993). The number of metastatic foci in the liver 
increases dramatically after tumor cell inoculation when in vivo liver associated NK 
activity is ablated by anti-asialoGMl antiserum [anti-AsGml] ( Wiltrout et al., 1985 ). On 
the other hand , reconstitution of NK cells restores both tumor cell clearance and 
antimetastatic efficiency(Barlozzari et al., 1985). 
Purified rat liver-associated NK cells but not splenic NK cells Iyse syngeneic 
mammary and colon tumor cells in vitro (Bouwens et al., 1988 ). Vanderkerken et al 
(1990) have further divided rat liver-associated NK cells into high and low density NK 
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cells. High density NK cells from rat liver which resemble NK cells from peripheral blood 
are less cytotoxic in vitro than low density NK cells from rat liver against YAC-lcells and 
CC531 colon carcinoma cells. However, only the low density rat liver NK cells lyse P815 
tumor cells. According to these investigation (Vanderkerken et al., 1993), the immature 
high density NK cells migrate to liver from the blood, interact with Kupffer cells and other 
NPC in vivo, differentiate and become mature, highly cytotoxic low density liver NK cells. 
Attention has focused on the role of the liver as a tumor killing organ. The hepatic 
NK activity is much higher than in peripheral blood and spleen preparation(Vanderkerken 
1993). The liver also harbors the largest population of fixed macrophages(Malter et al., 
1986). These tumoricidal cells may affect metastasizing tumors in addition to resident 
hepatic tumors(Lukomska et al., 1987). However, the role of impaired natural immunity in 
chemically-induced hepatocarcinogenesis is still unclear. 
Lu et al. (1997) reported that feeding 7% soybean oil and 14% beef tallow to DEN 
(15mg/kg bw)-initiated and 50ppm FBi -promoted female F344/N rats for 5 weeks caused 
all animals to develop GGT- and PGST- positive altered hepatic foci. The hepatic NK 
activity in the treatment group was significantly inhibited as compared with control group, 
and hepatic PGE%and PGFia were significantly increased in FB, —fed rats compared with 
controls. Liu et al. (2001) reported that feeding a diet containing 7% soybean oil (AJN 93) 
to DEN ( 15mg/kg)-initiated female F344/N rat promoted with 25ppm FB[ for 16 weeks 
caused only half of the animals to develop PGST- and GGT-positive foci, and no 
difference of hepatic NK cell activity was observed between control and FBi fed rats. 
These two experiments suggested that there was an interaction between dietary fat and FBi 
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carcinogenesis, as reflected in their effects on the altered hepatic foci, and hepatic NK 
activity. It seemed that increased preneoplasia and high levels of PGE? and may signal to 
decrease NK cell activity. We hypothesized that NK activity decreases with the 
development of FBi carcinogenesis and the increase of prostaglandins , sphingo lipids as 
well as other factors produced during FBi carcinogenesis may down-regulate hepatic NK 
activity during FB i carcinogenesis. 
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SPRAGUE-DAWLEY RATS HAVE GREATER LIVER-ASSOCIATED NATURAL 
KILLER CELL ACTIVITY THAN DO F344/N RATS, ALOTHOUGH A GREATER 
PROPORTION OF LYMPHOCYTES ARE NATURAL KILLER CELLS IN F344/N 
RATS 
A paper submited to Comparative Immunology, Microbiology and Infectious Diseases 
Hongjun Liu, Joan E. Cunnick, and Suzanne Hendrich 
ABSTRACT 
Strain and gender differences in cancer incidence are proposed to be due partly to 
difference in immune function. In this study, the percentage of liver-associated total 
lymphocytes composed of natural killer cells and their activity were compared in 9 week 
old male and female F344/N and Sprague Dawley(SD) rats. Natural killer cells were stained 
using an anti-NKR-Pl monoclonal antibody and quantitated by flow cytometry. Two 
populations were found to stain positively: the NKR-P lbnght population, which represents 
natural killer cells with a high density of staining for NKR-Pl, and an NKR-P ldim 
population, which is a subset of T cells that express a low density staining for NKR-Pl. 
F344/N rats had a greater hepatic NKR-P lbnght percentage of total leukocytes than did SD 
rats (PcO.OOl). No gender difference was found in the NKR-P lbnght percentage. The NKR-
Pldim population was not significantly different between F344/N and SD rats, but the 
F344/N male rats exhibited a significantly higher NKR-Pldim population than F344/N 
females. After covariance of liver NK activity with the percentage of NKR-P lbnght 
Leukocytes, F344/N and SD rats exhibited similar lytic activity per NK cell. There was no 
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gender difference in liver-associated NK activity. After covariance with body weights, SD 
rats exhibited significantly greater total hepatic NK activity(p<0.001) than F344/N rats, and 
male rats had significantly greater total hepatic NK activity than female rats. Thus, SD rats 
would experience greater total liver-associated NK activity which may partly explain their 
lesser cancer susceptibility than do F344/N rats under some conditions. 
Key words: F344/N, Sprague-Dawley, Natural killer cell, NKR-Plbnght, NKR-Pldim, 
INTRODUCTION 
The use of an animal carcinogenicity bio assay in assessing the oncogenic risk 
involved with chemical exposure is an important and necessary process, but presents many 
difficulties in interpretation when extrapolating to humans [1], There are large inter-species, 
and inter-strain and gender variations in the incidence of some tumors. Variable tumor 
formation may be related to factors, including: organ/strain specific oncoviruses, hereditary 
disorders [2], or differing immune capabilities, such as hepatic natural killer cell(NK) 
activity [3], F344/N and SD rats were included in this study as these are two rodent strains 
predominantly used in carcinogenicity bioassays, and there is a large database on cancer 
development in these strains. In one study, newborn F344/N and SD rats were irradiated 
with whole body single doses of 3Gy gamma rays with or without intraperitoneally-injected 
diethylnitrosamine(DEN) (15 mg/kg body weight) within 1 h of irradiation. Tumor 
development was promoted with 0.05% phénobarbital. In groups treated with radiation 
alone or radiation combined with DEN, F344/N rats had threefold greater development of 
placental S-glutathione transferase-positive (GST-P*) altered hepatic foci (AHF, biomarkes 
of preneoplasia and neoplasia) than did SD rats. In SD rats, females had 1.5 greater 
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induction of GST-P4" AHF than did males [4]. In another study in which hexachlorobenzene 
was fed to male and female F344ZN rats for 15 weeks, 100% of surviving females had 
multiple liver tumors which were strongly y-glutamyl transferase (GGT) positive and 
histologically classified as neoplastic nodules or hepatocellular carcinomas. In contrast, only 
16% of males developed tumors which were smaller and fewer in number than those in 
females [5]. 
The capacity to mediate MHC-unrestricted cytotoxicity against certain tumor cells 
without apparent prior sensitization has by definition been primarily ascribed to NK cells 
[6]. NK cells are phenotypically and functionally distinct population of lymphocytes with 
morphology characteristic of large granular lymphocytes [7,8]. In rats, high density cell 
surface expression of NKR-P1 antigen( i.e. NKR-Plbnght) is an exclusive property of all 
mature NK cells [9, 10]. NKR-P1 is also expressed on a subset of T cells, but with a 2- to 
10- fold lower density(i.e., NKR-P1 dim) than on NK cells [9, 10]. Some subsets of NKR-
Pldim lymophocytes are capable of mediating NK-like cytotoxicity, particularly after 
incubation in 1000U/ml interleukin-2(IL-2) for five days [10]. 
Attention has focused on the role of the liver as a tumor killing organ. Hepatic NK 
activity is much higher than in peripheral blood and spleen preparations [11], The liver 
also harbors the largest population of fixed macrophages [12]. These tumoricidal cells 
may affect metastasizing tumors in addition to resident hepatic tumors [13]. However, the 
role of impaired natural immunity in chemically-induced hepatocarcinogenesis is still 
unclear. Neonatal B6C3F1 mice were given a single carcinogenic dose of 
diethylnitrosamine (DEN) and the time-response kinetics for the early (altered foci) and 
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late (adenomas/carcinomas) phases of hepatocellular carcinogenesis were compared to 
changes in hematopoiesis and immune functions associated with immune surveillance and 
natural resistance [14]. Increases in hematopoiesis occurred just prior to or concurrent 
with the appearance of hepatocarcinomas, while increased macrophage and natural killer 
cell cytotoxicity and suppression of cell-mediated immunity occurred following tumor 
appearance and progressed with increasing tumor burden. Neither immunological nor 
hematopoietic changes were associated with early phases of hepatocarcinogenesis, as 
monitored by the appearance of AHF. Although changes in hematopoiesis may represent 
an early indicator for hepatocarcinogenesis in the mouse tumor model, the data suggest 
that altered immune surveillance and natural resistance are not factors in the development 
of chemically induced hepatocellular tumors, and the changes in immune function are 
probably secondary to tumor development. Neither immunological nor hematopoietic 
changes were associated with early phases of hepatocarcinogenesis, as monitored by the 
appearance of AHF [14]. In male F344/N rats given 40ppm DEN in drinking water for 10 
weeks, as GST-P+foci developed, splenic NK activity changed. After 5 weeks, DEN-
treated and control rat spleen NK activity was similar, but at 10 weeks, NK activity was 
significantly greater in DEN treated rats compared with control rats. At 20 weeks, DEN-
treated rats had significantly lower NK activity than did controls [15]. This suggests an 
interaction between chemical carcinogenesis and NK activity. Lu et al. [16] also showed 
that chemical carcinogenesis (initiation by DEN, 15mg/kg at 10 days of age, and 
promotion by fumonisin B1 (50mg/kg diet)) caused significantly decreased NK activity 
after 4 weeks of development of AHF [16]. 
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We propose that liver-associated NK activity wQl be greater in SD than in F344/N 
rats and in males than in females, due to greater liver associated NK cell numbers, even after 
covariation for body weight. This proposed difference in NK activity might partly explain 
some previous findings of gender and strain difference in susceptibility to carcinogenesis. 
MATERIALS AND METHODS 
Animals 
The experimental procedures were approved by the Iowa State University Animal 
Care Committee. In 3 replicate experiments, six week old male and female F344/N and 
Sprague Dawley rats (n= 4 of each strain /gender) were given free access to diets (AIN-
93G) and water for 3 weeks in an animal facility with a 12-h light/dark cycle maintained at 
22-25°C and 50% humidity. Body weight and feed intake were recorded weekly. 
Liver perfusion 
Rat livers were perfused with 40ml of Hank's Balanced Salt Solution (HBSS, 
supplemented with 25mM Hepes and 0.1% EDTA). Approximately 12 ml of perfusate was 
concentrated to 3 ml and laid on 3 ml Accupaque density gradient media (Accurate 
Chemical Co., Westbury, NY), then centrifuged at 1500rpm for 10 minutes. The 
mononuclear cells at the interface were collected, and washed two times, once with 
HBSS(with 25mM Hepes) and once with complete medium (RPMI-1640, supplemented 
with 50fig/ml gentamicin, 25 mM Hepes, 2mM L-glutamine, and 10% fetal bovine serum 
(FBS)). Cells were enumerated on a Celltrack II (Nova Biomedical, Waltham, MA). 
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Natural killer cell assays 
Natural killer cell assays were performed as previously described [17]. Cells were 
plated in triplicate at the following effector to target ratios in 96 well plates: 25:1, 12.5:1, 
6.25:1, 3:1. The target cells for the assay were YAC-1 cells (ATCC Co, Rockville, MD) 
(8xl03/well) which had been labeled with 200|iCi 51Cr. The amount of 51Cr released by 
dying cells was counted using a Gamma Trac 1191 (TM Analytic, Inc., Elk Grove Village, 
IL). Lytic units were calculated using a computer program based on the equation of Pross 
and Maroun [18]. 
Fluorescent staining of lymphoid cells 
Leukocyte suspensions were diluted with an equal volume of cold PBS/0.1% azide 
and incubated at 4°C (5min). Separate aliquots were stained with 0.2jig/2xl05 cells of anti-
rat NKR-P1 A-Biotin(mAb 3.2.3), or an equivalent amount of isotype control antibody 
(murine IgGl-biotin). A second step of 0.1 {ig strep-AvidinCychrome was used(All from 
Pharmingen, San Diego,CA). All incubations were performed at 4°C in the dark for 30mins, 
and washed with PBS/0. l%azide. The contaminating red blood cells were lysed using 
ammonium chloride buffer(PH=7.4).Cells were fixed with PBS/1% paraformaldehyde prior 
to analysis using an EPICS -XL-MO flow cyto meter (Coulter, Miami,FL) .Gates were 
defined to distinguish three cell populations: NKR-P lbnght, NKR-P ldim and negative [17] 
Statistical analysis 
Data from three replicate experiments were combined for analysis. A two-way 
ANOVA was used to assess strain and gender relationships for the percentage of 
Leukocytes that carry NKR-P lbnght and NKR-P 1 d,m population markers. The hepatic NK 
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exhibited by F344/N and SD rats was compared using ANCOVA by adjusting for the 
percentage of NKR-P lbnsiu population. Total hepatic NK numbers were compared between 
strain and gender using a two-way ANOVA combined with covariance for the body weight. 
RESULTS 
NKR-Plbright and NKR-Pldim population in F344/N and SD rats 
The flow cytometric analysis using mAb 3.2.3 (NKR-P 1) revealed two distinct 
subsets of rat hepatic mononuclear cells expressing variable levels of NKR-P 1 in both 
F344/N and SD rats. A representative flow cytometric histogram chart illustrates that NKR-
P1 was expressed at high levels (NKR-P lbnght) (Gate C) and at low levels (NKR-P ldim) 
(Gate B) in a clearly defined populations of cells(Figure 1). The NKR-Plbnght population has 
been identified as the population causing NK associated lytic activity [19]. The NKR-P ldim 
population have been linked to NK-T cells and can have NK-like cytolytic function under 
activation by IL-2 [10]. The percentage of hepatic NKR-P lbnght was significantly greater in 
F344/N than in SD rats(p<0.001). Both F344/N male and female rats exhibited significantly 
greater hepatic NKR-P lbnght percentage than male and female SD rats (p<0.001)(Fig 2). 
There was no significant difference between male and female rats, nor was there a strain by 
gender interaction. The percentage of NKR-P ld,m population was not significantly different 
between F344/N and SD rats(Fig 3). But F344/N male rats exhibited a significantly greater 
NKR-Pldun population than the F344/N female rats (P<0.01). Based on the percentage of 
NKR-P lbnght in leukocytes and the total leukocytes in the hepatic perfusate, we calculated 
the total hepatic NK cells in F344/N and SD rats. After co variance of the total hepatic NK 
cell number with body weight, Sprague-Dawley rats had significantly greater total number 
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of hepatic NK cells than F344/N rats(p<0.001) (Fig 4). The male rats of both strain 
exhibited significantly greater total number of hepatic NK cells than female rats after 
co variance for body weight (p<0.01). 
Liver-associated NK activity in F344/N and SD rats 
F344/N rats exhibited significantly greater levels of liver NK activity than SD rats 
before co variance with the percentage of the NKbnght population (p<0.001)(Fig 5A). But 
the NK activity was not significantly different between male and female rats, After 
co variance of the liver NK activity with the percentage of NKR-P lbnght in leukocytes, 
F344/N rats and SD rats exhibited similar lytic activity per NK cell (Figure 5B). Again there 
was not a difference in NK activity between male and female rats, nor gender by strain 
interaction. 
DISCUSSION 
In this study, the percentage of two subsets of normal hepatic mononuclear cells 
which express NKR-P 1 on the cell surface, NKR-P lbnght and NKR-P ldim were compared 
between F344/N and SD rats. Virtually all basal NK cell lytic activity is associated with 
NKR-P ibnght cells [20]. NKR1-Pldim cells lack lytic activity against NK targets. However, 
after incubation with IL-2 and subsequent removal of contaminating NKR-P lbnght cells, the 
NKR-P ldim cells can demonstrate the ability to lyse YAC-1 target cells and mediate reverse 
antibody-dependent cellular cytotoxicity (rADDC) via NKR-P 1 [10] F344/N rats 
exhibited a significantly greater percentage of NKR-P lbnght cells than did SD rats (Fig.2), 
F344/N also exhibited significantly greater hepatic NK lytic activity than SD rats before 
covariance with the percentage of NKR-P lbnght population (Fig 5A). After co variance with 
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the percentage of the NKR-P lbright population, the hepatic NK cells exhibited similar lytic 
activity on a per cell basis in F344/N and SD rats (Fig 5B). We also observed that male 
F344/N rats had a significantly greater percentage of NKR-P ldim lymphocytes than female 
F344ZN rats (Fig 3). A sexual dimorphism in natural killer cell activity has been observed 
during tumor metastasis in F344/N rats [21]. Syngeneic mammary tumors (MADE 106) 
were used to assess the host anti-metastatic activity. Prepubescent (36 days of age) female 
rats exhibited greater splenic NK lytic activity than prepubescent males. After the onset of 
puberty (63 days of age), the males surpassed the females in NK activity, and at maturity 
(140 days of age) displayed greater splenic NK activity than females. Both NKR-P lbnght and 
NKR-P ld,m populations may contribute to the gender difference in NK activity during tumor 
metastasis observed in F344/N rats [21], as we observed greater NKR-Plbnght and NKR-
Pld,m populations in male than in female F344/N rats. Activated NKR-P ldim cells can lyse 
tumor cells in vitro [10, 19, 22]. With the progression of tumors, there is a production of 
endogenous EL-2 cytokine which can stimulate the activity of the NKR-P ldim cells. 
Intraportal inoculation of CC531 adenocarcinoma cells into syngeneic rats caused an 
increase of liver macrophage cell number [23], and macrophages can stimulate T-cell 
proliferation and IL-2 production [24]. Once activated, the NKR-Pldim lymphocytes can 
perform tumor cytotoxic activity and secrete cytokines. It would be expected that male 
F344/N rats may exhibit higher liver NK lytic activity than female F344/N rats during 
carcinogenesis, which may explain a lower incidence of tumor formation or lower growth 
rate of tumors. 
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Our data also suggested that males exhibited significantly greater total hepatic NK 
activity than females of both SD and F344/N strains. These data may support some findings 
that females are more susceptible to liver tumors than males under the effect of some 
hepatocarcinogens in both SD and F344/N strains [4, 25]. Sprague-Dawley rats initiated by 
DEN, and additional weekly application of polychlorinated biphenyl (50 or 100 mg/kg 
body wtVweek, for 7 weeks) demonstrated an enhanced number of ATPase-deficient islands 
in males 3-fold and in females9-fbld. The total area occupied by AHF increased 4-fold in 
males and 15-fold in females. The Number and area of GGT-positive AHF were similarly 
enhanced [26]. It has been suggested that tumor development and immunocompetence are 
affected by the estrous cycle, and sex hormones have been shown to modulate lymphokine 
production, neuroendocrine activity and immunity. IN female rats inoculated intravenously 
with MADB106 tumor cells, a syngeneic mammary adenocarcinoma cell line that 
metastasizes only to the lungs, susceptibility to metastatic development was found to be 
significantly higher during pro-estrus and estrus than during metestrus and diestrus, when 
estrogn levels are low [27]. The number and activity levels of circulating blood NK cells 
(NKR-P lbnght) indicated the estrous-dependent alterations in the number of NK cells and 
suggested a diminished NK activity per NK cell during pro-estrus/estrus [27], the same 
phases that were characterized by greater susceptibility to metastatic development. These 
findings support a causal relationship between a short-term exposure to elevated 
estradiol/low progesterone levels and decreased resistance to tumor metastasis, and it is 
hypothesized that an alteration in large granular lymphocyte (LGL) /NK cell activity 
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underlies these effects [27]. Thus, sex hormones may play a role in affecting NK activity in 
male and female rats. 
Experiments suggest that NK cells are important effector cells against bone marrow 
grafts, bact&rial infections and viral hepatitis [28]. NK cells in neoplasia are primarily 
directed against blood-borne tumor cells during the intravascular phase of tumor 
development [29]. The number of metastatic foci in the liver of mice increased dramatically 
after tumor cell inoculation when in vivo liver-NK activity is ablated by anti-asialoGMl 
antiserum [3-0]. Newborn females SD rats initially given a single intraperitoneal injection of 
15 mg DENVkg and phénobarbital (PB) administered in drinking water, demonstrated that 
GST-P+ hepatocytes increased with age in DEN-treated rats. The NK activity of DEN-
treated rats did not significantly differ from that of control rats until week 12, but it 
progressively decreased from week 15 to 30. These results indicate that changes of NK 
activity are inversely correlated with the induction of preneoplastic hepatic foci. This strong 
correlation of decreased NK activity with enhanced induction of GST-P+ foci suggests that 
NK activity Is important in the early progression of hepatocarcinogenesis in rats [3]. This 
strong inverse relationship between NK activity and the induction of preneoplastic hepatic 
foci was also observed in rat carcinogenesis initiated by DEN and promoted by fumonisin 
B1 [16]. On the other hand, reconstitution of NK-depleted rats with purified NK cells 
restores both tumor cell clearance and anti-metastatic efficiency. Wistar Furth rats 
pretreated w~ith rabbit anti-asialo GM1 serum exhibited a diminished ability to destroy 
circulating MADB106 mammary adenocarcinoma cells, which in turn caused an increased 
incidence of experimental pulmonary metastasis. When large granular Iymphocytes(LGL), 
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highly enriched in NK activity, were transferred into NK-depressed rats, the ability of these 
rats to inhibit the development of pulmonary metastases was partly or fully restored [31]. 
There is wide variation in the tumor incidence between F344/N and SD rats. Sprague 
Dawley rats have greater forestomach cancer incidence than F344/N rats under the effect of 
butylated hydroxyanisole [32]. Sprague Dawley rats also showed greater susceptibility to 
urinary bladder tumors than F344/N rat under the effect of N-butyl-N-(4-hydroxybutyl) 
nitrosamine [33]. But F344/N rats exhibited greater susceptibility to hepatocellular tumors 
than did SD rats when treated with DEN [34]. F344/N rats exhibited relatively high 
susceptibility to promotion by the liver carcinogens 2-acetylaminofluorene (2-AAF) and 
phénobarbital [35], with a hundred fold increase in lesion area being observed after 2-AAF 
treatment compared with Lewis and SD cases. Our data showed that there is no difference 
in hepatic NK lytic activity between F344/N and SD or male and female rats per NK cell. 
But SD rats had significantly greater total hepatic NK cells than F344/N rats after 
co variance with their body weight. This suggested that SD rats had significantly greater 
total hepatic NK activity than F344/N rats. We propose that the difference of total hepatic 
NK activity between SD and F344/N rats may play an important role in explaining the strain 
difference in hepatocarcinogenesis between these strains. 
In summary, we examined hepatic NK populations for function and receptor density 
in both F344/N and SD rats. The decreased total NKR-P lbnght and NKR-P ldim populations 
may partially explain the greater hepatocarcinogenesis in F344/N female than male rats. The 
significantly greater total NK activity in SD rats may contribute to the decreased 
susceptibility to hepatocarcinogenesis of SD rats compared with F344/N rats. 
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Figure 1: Representative graph of flow cytometry of liver-associated mononuclear 
cells that express NKR-P 1 antigen. Gate B represents the NKR-P ldltn population, 
Gate C represents NKR-P lbnght population. Gate E represents the total population 
that express NKR-P 1 antigen. 
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F344/m F344/f SOm SOf 
Figure 2: Comparison of the percentage of hepatic NKR-P lbnght cells in F344/N and SD 
rats . /m = male, If = female. (N=12/group). 
a Significantly different compared with SD/m and SD/f groups, (P<0.05) 
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Figure 3 : Comparison of the percentage of hepatic NKR-P ldim cells in F344/N and SD 
rats (N=12/group). /m=male , /f=female 
a Significantly different compared with F344/m group, (P<0.05) 
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Figure 4: Comparison of the total hepatic NKR-Plbnght population in F344/N and SD rats 
(N=12/group). /m=male, /f=female. 
a Significantly different compared with F344/f and F344/m groups , (p<0.01) 
b Significantly different compared with females of same strain. 
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Figure 5 A: Hepatic NK activity in F344/N and SD rats at 9 wks of age prior to co variance 
with the percentage of NKR-P lbnght cells (N=8 per/group ) . Activity is expressed as lytic 
units, calculated from the specific lysis curve(/m = male, /f = female). 
a Significantly different compared with SD/m and SD/f groups , (P<0.05) 
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5B: Hepatic NK activity of F344/N and SD rats at 9 wks of age after co variance with the 
percentage of NKR-P lbnght population ( N=8/group). Activity is expressed as lytic units. 
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OPPOSING EFFECTS OF PROSTAGLANDINS E2 AND F2a ON RAT LIVER-
ASSOCIATED NATURAL KILLER CELL ACTIVITY IN VITRO 
A paper published in Prostaglandins, Leukotrienes and Essential Fatty Acids 
Hongjun Liu1, Joan E. Cunnick2, & Suzanne Hendrich1 * 
ABSTRACT: 
Strain differences in cancer incidence are proposed to be due partly to difference in 
immune function. As potential cancer associated immunological regulators, the 
concentration of hepatic prostaglandins E2(PGE2 ) and F2a(PGF2a) were compared in 9 
week old male and female F3447N and Sprague Dawley(SD) rats. There were no strain or 
gender differences in the concentration of hepatic PGE2. No strain difference was found in 
the concentration of hepatic PGF2a, but the hepatic PGF2a concentration in female rats was 
two-fold of that in male rat(130 vs 60ng/g). Prostaglandin E2 significantly inhibited hepatic 
natural killer cell(NK) activity in vitro compared with untreated cells from both genders and 
strains(p<0.05), and 25ng PGE2/mI inhibited NK activity significantly more than did lOng 
PGE2/ml (P<0.05). In contrast, 50ng PGF2a/ml and lOOng PGF2a/ml significantly stimulated 
1 Department of Food Science and Human Nutrition, "Department of Microbiology, Iowa 
State University, Ames, Iowa 50011. * To whom correspondence should be addressed : 
Suzanne Hendrich, Department of Food Science and Human Nutrition, 1127 Human 
Nutrition Science Building, Iowa State University, Ames, Iowa, 50010. Telephone: (515) 
294-4272; email: shendric@iastate.edu 
hepatic NK activity compared with untreated hepatic cells from both F344/N and SD rats. 
This study suggests that prostaglandins may have negligible net effect on NK activity 
associated with rat liver, and may be unlikely to mediate cancer-related immune function. 
INTRODUCTION 
The use of an animal carcinogenicity bioassay in assessing the oncogenic risk 
involved with chemical exposure is an important and necessary process, but presents many 
difficulties in interpretation when extrapolating to humans1. There are large inter-species, 
inter-strain and gender variations in the incidence of some tumors. Variable tumor 
formation may be related to factors, including: organ/strain specific oncoviruses, hereditary 
disorders2, or differences in some possible regulatory factors, such as prostaglandins, as 
well as their effects on immune capabilities, such as hepatic natural killer cell(NK) activity. 
F344/N and SD rats were included in this study because these are two rodent strains 
predominantly used in carcinogenicity bioassays, and there is a large database on cancer 
development in these strains. In one study, newborn F344/N and SD rats were irradiated 
with whole body single doses of 3Gy gamma rays with or without intraperitoneally-injected 
diethylnitrosamine (DEN) (15 mg/kg body weight) within 1 h of irradiation. Tumor 
development was promoted with 0.05% phénobarbital. In groups treated with radiation 
alone or radiation combined with DEN, F344/N rats had threefold greater development of 
placental S-glutathione transferase (GST-P+) hepatic foci than did SD rats. In SD rats, 
female rats had significantly greater induction of GST-P+ hepatic foci than did males3. In 
another study in which hexachlorobenzene was fed to male and female F344/N rats for 15 
weeks, 100% of surviving females had multiple liver tumors which were strongly gamma-
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glutamyl transpeptidase (GGT) positive and histologically classified as neoplastic nodules or 
hepatocellular carcinomas. In contrast, only 16% of males developed tumors which were 
smaller and fewer in number than those in females4. Females had greater hepatic stearate, 
arachidonate and PGF2a than did males when F344/N rats were fed diets with 9% of energy 
(en%) from linoleate and 15.5, 20, 30 or 40 en% fat5. It is hypothesized that greater tumor 
promotion in females may be related to their greater levels of PGF2a, a cell proliferative 
factor6. 
The suggestion that prostaglandins may play a role in immune response/tumor cell 
interactions is based upon several observation. First, a variety of prostaglandins are 
produced both by cells that are themselves active in the expression and regulation of 
immune response activity7"8 as well as by a number of tumor targets9"10. Carcinogenesis 
may be associated with increased prostaglandin production by neoplastic organs, such as 
during promotion of rat hepatocarcinogenesis by fumonisin Bu. Second, the production of 
prostaglandins has been found to increase as a result of direct contact between effector 
lymphocytes and tumor targets12. Third, prostaglandins at levels produced during these 
interactions have been shown to influence the ultimate expression in vitro of lymphocyte 
and macrophage cytotoxicity against tumor targets13"14. 
Prostaglandins mediate inter- and intracellular communication, as may stimulate 
hepatocyte proliferation15"16. The concentration of PGE equivalents in rat liver in vivo was 
increased during liver regeneration. This stimulation of prostaglandin synthesis was 
confirmed in vitro by the ability of homogenates of regenerating liver tissue to synthesize 
PGE2 and PGF2afrom arachidonate. Indomethacin prevented these prostaglandin changes, 
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and the subsequent increase in DNA synthesis17. During the regeneration of mammalian 
liver after a 70% partial hepatectomy (PHx), Kupfer cells produced significantly elevated 
PGE2, and in vivo Kupfer cell PGE2 blockade by indomethacin (5 mg/kg) significantly (P < 
0.05) inhibited hepatic regeneration18. The association of neoplastic tumors with increased 
levels of prostaglandins19"20 provided the rationale for investigating their role in 
turmorigenesis. Animal and human tumors contain high levels of prostaglandins, particularly 
those of the E series that have been shown to significantly affect cell proliferation and tumor 
growth and suppress immune responsiveness. DNA synthesis of hepatocytes in primary 
culture was significantly enhanced by addition of PGE, (2-200 nmol/L). Intracellular cAMP 
level in the hepatocytes increased during culture, and cAMP increase was enhanced by 
PGE2. Prostaglandin E2 production in the liver increases hepatic regeneration and PGE2 
enhances the proliferation of hepatocytes by a seemingly cAMP-dependent specific 
receptor-mediated process21. At concentrations of 10'12-10"9 mol/L, PGFia and PGF2cc very 
intensely stimulated both the DNA-synthetic and mitotic activities of hepatocytes in 4-day-
old primary cultures of neonatal rat liver. DNA replication was more intensely enhanced by 
PGF2a than PGF[a, whereas mitotic activity was nearly equally affected by the two 
prostaglandins6. Thus enhanced PGE2 and PGF2a may promote hepatocarcinogenesis by 
stimulating DNA synthesis and proliferation of hepatocytes. 
A high level of PGE, in the portal vein suppresses liver-associated immunity and 
promotes liver metastases22. Some in vitro experiments showed a similar phenomena. The 
ability of Syrian hamster tumor cells of the same origin but with different degrees of 
malignancy to secrete prostaglandin E was studied following their in vitro contact with 
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Syrian hamster natural killer cells (NK cells). Syrian hamster NK cells were shown to lose 
cytotoxic activity significantly after their contact with malignant tumor cells. Short-term in 
vitro contact of malignant tumor cells with human and Syrian hamster NK cells resulted in a 
rapid PGE secretion into the culturing medium. Therefore, PGE2 may promote tumor 
progression by inhibiting immune function. The effect of PGFia on NK cells is still not clear. 
The regulatory effects of prostaglandins on immune response appear to be mediated by the 
production of cyclic AMP23. PGE2 activates adenylate cyclase with a subsequent rise in 
cyclic AMP24, which acts as a "second messenger". Cyclic AMP itself is an inhibitor of 
lymphocyte activation24"25. The presence of receptors for PGEi and PGE, on the lymphocyte 
surface had been demonstrated, while there were no binding sites for PGA, PGFia or PGF2a 
. Henney and Lichtenstein, using splenic lymphocytes from mice immunized with an 
allogeneic mast cell tumor26, suggested that elevated cyclic AMP content of cytolytic 
lymphocyte might inhibited their ability to kill target cells. As a test of this hypothesis, 
prostaglandins were shown to inhibit lymphocyte cytolytic activity27. The relative potency of 
seven prostaglandins in inhibiting cytolytic activity correlated very well with their potency in 
stimulating cyclic AMP accumulation in lymphocytes: E|=E2>A^=A2>F^F2a — 028. But 
effects of PGs on NK cells could be mediated in other ways. 
We suggest that prostaglandin regulation of immune response might partly explain 
some previous findings of gender and strain difference in susceptibility to carcinogenesis. 
Effects of PGFia on NK activity have not been well characterized. To that end, we 
hypothesize that high levels of PGF2a, as found in female rat liver, may inhibit liver 
associated NK activity, an effect similar to that of PGE2. 
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MATERIALS AND METHODS 
Animals 
Experimental procedures were approved by the Iowa State University Animal Care 
Committee. Six week old male and female F344/N and Sprague Dawley rats were given 
free access to diets (AIN-93G) and water for 3 weeks in an animal facility with a 12-h 
light/dark cycle maintained at 22-25°C and 50% humidity. Body weight and feed intake 
were recorded weekly. 
Preparation of liver-associated mononuclear cells 
Rat livers were perfused with 40ml of Hank's Balanced Salt Solution (HBSS, 
supplemented with 25mM Hepes and 0.1% EDTA). Approximately 12 ml of perfusate was 
concentrated to 3 ml and laid on 3 ml Accupaque (Accurate Chemical Co., Westbury, NY), 
then centrifuged at 1500rpm for 10 minutes. The mononuclear cells at the interface were 
collected, and washed two times, once with HBSS(with 25mM Hepes) and once with 
complete medium (RPMI-1640, supplemented with 50|ig/ml gentamicin, 25 mM Hepes, 
2mM L-glutamine, and 10% fetal bovine serum (FBS)). Cells were enumerated on a 
Celltrack II (Nova Biomedical, Waltham, MA). 
Natural killer cell assays 
Natural killer cell assays were performed as previously described using liver-
associated mononuclear cells from both rat strains and genders29. Cells were plated in 
triplicate at the following effector to target ratios in 96 well plates: 25:1, 12.5:1, 6.25:1, 3 : 
1. The target cells for the assay were YAC-1 ce!ls(ATCC Co, Rockville, MD). Each well 
contained 6xl06 YAC-1 cells which had been labeled with 200gCi 51Cr. The amount of 5ICr 
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released by dying cells was counted using a Gamma Trac 1191(TM Analytic, Inc., Elk 
Grove village, IL). Lytic units were calculated using a computer program based on the 
equation of Pross and Maroun30. 
Effects of prostaglandins on natural killer cell activity 
Prostaglandin E2 and prostaglandin F2a were obtained from Sigma Chemical 
Company(St.Louis, MO) and stored in sealed desiccated vials at -20°C until use. For each 
assay PGE2 and PGF2a was diluted to 2.5 mg/ml in absolute ethanol and subsequently 
diluted in RPMt-1640 complete medium for use in culture. PGE2 or PGF2a were added at 
the start of the NK assay in 50 (J.1 aliquots to wells containing each effector to target ratio 
of cells, and cocultured with NK and YAC-1 cells for 4.5 hours. The final concentration are 
10, 25ng/ml for PGE2 and 50, 100 for PGF2a. Cells incubated with PGs were processed in 
parallel with baseline NK activity. 
Prostaglandin assays 
Prostaglandin E2 and PGF2ot were determined in a radioimmunoassay as described by 
McCosh et al3'. Anti-PGE2 antiserum ( 0.2ml /per assay tube ) and anti-PGF2a antiserum 
(0.2ml / per assay tube) were obtained from Sigma Co.(St Louis, MO). H3-PGE2 ( 10"VCi/ 
per aliquot) and H3- PGF2a(10"6jiCi/ per aliquot) was obtained from NEN Products 
(Boston, MA). PGE2 and PGF2ct were quantified by using a computer program based on a 
logit transformation of the standard curve32. 
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Statistical analysis 
A two-way ANOVA was used to assess strain and gender relationships for hepatic 
PGE2 or PGFia- Repeated-measures ANOVA was used to analyze the effects of PGE2 or 
PGF2a on the in vitro hepatic NK activity from F344/N and SD rats. For all statistical tests 
of significance, a was set at P< 0.05. 
RESULTS 
The concentration of hepatic PGE2 and PGF2ain F344/N and SD rats 
The average concentration of hepatic PGE2 for F344/N rats was 34 ± 10 ng/g, and 
42 ± 1 lng/g for SD rats, which was not significantly different between the strains. Also, the 
average concentration of hepatic PGE2 was 43 ± 1 lng/g for males and 33 ± 12ng/g for 
females, with no significant difference between male and female rats (Figure 1). There was 
no gender by stain interaction. F344/N and SD rats exhibited similar hepatic PGF2a 
concentration, which were 106 ± 9 ng/g and 81 ± 8ng/g respectively. But the concentration 
of PGF2(X in females was twofold greater than in males in both strain (PcO.Ol) (Figure 2). 
There was no strain by gender interaction. 
In vitro effects of PGE2 and PGF2a on hepatic NK activity of F344/N and SD rats 
Prostaglandin E, significantly decreased hepatic NK activity in a dose-dependent 
manner in cells from both F344/N and SD rats (p<0.05) (Figure 3). Prostaglandin E2 
(10ng/ml) significantly inhibited hepatic NK activity compared with hepatic NK activity 
from both rat strains(p<0.05). Hepatic NK activity at 25ng/ml PGE2 was significantly 
inhibited compared with liver-associated mononuclear cells from both rat strains treated 
with 10ng/ml PGE2(p<0.05). There was no significant strain by concentration or gender by 
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concentration interaction. PGF2a has been reported to have no effect on NK lytic activity of 
rabbit peripheral blood at a concentration of 50 ng/ml33. Our results showed that PGFia 
significantly increased the hepatic NK activity of F344/N and SD rats of both genders at 
both 50 and 100 ng/ml in comparison with the control hepatic NK activity (p<0.05)(figure 
4), but the hepatic NK activity was not significantly different between 50 and 100ng/ml 
PGF2ain both F344/N and SD rats of either genders. No strain by gender, strain by 
concentration or gender by concentration interaction was observed. 
DISCUSION 
There was no strain or gender difference in hepatic PGE2. Thus, difference in PGE2 
is very unlikey to be responsible for strain or gender difference in hepatic cancer promotion. 
Significantly increased PGF2a was observed in females compared with males in both F344/N 
and SD rats. This has been reported previously5. The growth of hepatic preneoplastic 
lesions has been shown to be greater in females than in males. Under the effect of some 
hepatic carcinogens, females are more susceptible to liver tumors than males in both SD and 
F344/N strains3'34. Sprague-Dawley rats were initiated by DEN, and additional weekly 
application of ploychlorinated biphenyl (50 or 100 mg/kg body wtVweek, for 7 weeks) 
enhanced the number of ATPase-deficient islands 3-fold in males and 9-fold in females. The 
total area was increased 4-fold in males and 15-fold in females. Number and area of GGT-
positive islands were similarly enhanced35. The volume of GGT-positive AHF in livers of 
F344/N males initiated with DEN and promoted with phenobarbital(PB) was significantly 
less than in females36. It may be that the greater promotability of preneoplasia in females is 
related to the greater prostaglandin F2a production. Several other studies have demonstrated 
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that tumor promoters, such as phénobarbital stimulated hepatic PGF2a production37 and 
greater PGE2 and PGF2a levels and prostaglandin synthetase activity have been reported in 
7, 12-dimethylbenzanthracene or methylnitrosourea induced rat mammary tumors38. PGF2oc 
had been demonstrated to stimulate very intensely both the DNA-synthetic and mitotic 
activities of hepatocytes in 4-day-old primary cultures of neonatal rat liver6. It might be 
expected that greater PGF2a concentration in females may contribute to the greater 
incidence of tumor formation or greater growth rate of tumors in females compared with 
males because of the cell proliferative effects of PGF2a. 
Several studies have revealed that natural cellular defenses in mice bearing 
spontaneous or transplanted tumors is severely compromised by the immunosuppressive 
effects of prostaglandins of the E series secreted by host macrophages appearing in 
lymphoid organs as well as at the site of a tumor39. Certain tumor cells can also produce 
high levels of prostaglandins in vivo. When a choline deficient (CD) diet, an efficient liver 
tumor promoting regimen, was fed to SD rats, PGE2 levels were increased 2-2.5 fold, and 
the GGT positive hepatocyte foci in the liver of rats initiated with a single dose of 
diethylnitrosamine after 8 weeks of the dietary promotion significantly increased40. 
Fumonisin B1, a tumor promoter, has been shown to increase hepatic PGF2a concentration 
compared with control groups11. High levels of NK, and lymphokine-activated cell activity 
can not be generated in the presence of PGE241. To elucidate the correlation between 
hepatic NK cell activity and prostaglandin, cells were cultured with PGE, or PGF2a. With 
increased PGE2 concentration, hepatic NK activity in both F344/N and SD and male and 
female rats was inhibited in a dose-dependent relationship. But we also observed that 
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increased exogenous PGF2c can increase the hepatic NK activity in both F344/N and SD 
and male and female rats. This result seems different from our previous in vivo study which 
showed the coexistence of increased PGF2a and decreased NK activity11.We assume that 
one of the reasons for the difference between in vivo and in vitro conditions might be that 
the rats were exposed to both PGE2 and PGF2c simultaneously during in vivo study, and the 
two PGs counteracted effect of each other. The experimental results also suggested that the 
decreased NK activity previously observed by Lu et al11, may not be directly mediated by 
prostaglandins. Further study of in vivo function of PGF2a and the combined effect of PGE2 
and PGF2aon NK activity in vitro might be helpful to explain this phenomena. Further 
investigation of the role of prostaglandin and NK cell activity in development of 
hepatocellular carcinogenesis, as well as the direct determination of prostaglandin 
production at a tumor site, are required . 
In summary, we examined the hepatic concentration of PGE2 and PGF2a as well as 
the effect of these PGs in vitro on hepatic NK cell in both F344/N and SD rats. Our results 
suggested that PGE2 is not responsible for strain and gender differences in hepatic tumor 
promotion. The greater PGF2a may partially explain greater hepatocarcinogenesis in 
females than male rats under some condition. 
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F344/m F344/f  SD/m SD/f 
Figure 1 : The comparison of PGE? concentration in liver tissue in F344/N and SD rats 
( N=8/group). The concentration was expressed as ng PGE? per gram liver tissue, 
/m=male, /f=female. 
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Figure 2: The hepatic PGF?a concentration in F344/N and SD rats ( N= 8/ group). The 
concentration of PGFza is expressed as ng per gram liver tissue, /m=male, Zf=female. 
"significantly different compared with F344/m and SD/m groups , (PcO.Ol) 
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Figure 3: The effect of PGE? on hepatic NK acitivity of F344/N and SD rats was 
expressed as lytic units at different concentrations of PGE% ( N=3/group). 0, 10 and 
25ng/ml three concentration were set as the final concentration in respective wells. 
/m=male, /f=female. 10ng/ml PGE? significantly inhibited the hepatic NK activity 
compared with untreated hepatic cells from both rat strains(p<0.05), and the hepatic NK 
activity at 25ng/ml PGE? was significantly inhibited compared with hepatic cells from 
both rat strain treated with 10ng/ml PGE2(p<0.05) 
a: The NK activity in both strains and genders was significantly different from the controls 
b: The NK activity at 25 ng/ml PGEo was significantly different from the control and 
10ng/ml PGE? groups. 
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Figure 4: The effect of PGFaa on NK activity of F344/N and SD rats was expressed as 
lytic units at different concentration (N=3/group). 0, 50 and 100ng/ml were set as the final 
concentration in respective wells. /m=male, /f=female. PGFia significantly boosted the 
hepatic NK activity of F344/N and SD rats at both 50 and 100 ng/ml in comparison with 
the control hepatic NK activity (p<0.05). 
a: The NK activity of both strain and gender was significantly different from control 
groups. 
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REACTION OF FUMONISIN WITH GLUCOSE PREVENTS PROMOTION OF 
HEPATOCARCINOGENESIS IN FEMALE F344/N WHILE MAINTAINING 
NORMAL HEPATIC SPHINGANINE: SPHINGOSINE 
A paper accepted by the Journal of Agricultural and Food Chemistry 
Hongjun Liu1, Yun Lu1, Joseph S. Haynes2, Joan E. Cunnick3, Patricia Murphy1 , 
Suzanne Hendrich 
ABSTRACT 
The reaction of the primary amine of fumonisin B| (FBi) with glucose was 
hypothesized to detoxify this mycotoxin. Eighty 10-day old female F344/N rats were 
injected intraperitoneal^ with diethylnitrosamine (DEN, 15mg/kg body weight). At 4 
weeks of age, the weaned rats were randomly assigned to one of the 4 treatment groups 
with 20 rats each. At 9 weeks of age, 4 rats from each treatment group were killed. At 12 
weeks, another 5 rats from each group were killed. At 20 weeks of age, remaining rats 
were killed. In comparison with the rats fed basal diet or FB [-glucose (containing 25ppm 
FBj), rats fed 8 ppm (residual amount of free FB[ in the FB [-glucose mixture) or 25 ppm 
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FB[ had greater alanine aminotransferase activity at 9 and 20 weeks of age(P<0.001), 
greater endogenous hepatic prostaglandin E? production at 20 weeks of age(Pc0.05), and 
significantly lower plasma cholesterol at 20 weeks of age(p<0.01). Placental glutathione S-
transferase-positive (PGST) and y-glutamyl transferase (GGT)-positive altered hepatic foci 
occurred only in rats fed 25 ppm FB [ at 20 weeks of age. Hepatic natural killer (NK) cell 
activity was similar among the four groups, but the percentage of total liver-associated 
mononuclear cells exhibiting the NKR-Plbnght marker was significantly greater in rats fed 
FB i-glucose , FBi(8ppm) and FBi (25ppm) than in control rats at 9 weeks of age, and FB[-
glucose treated rats had significantly lower NKR-P1bnght cells as a percentage of total 
liver-associated mononuclear cells than in rats fed 25ppm FBi at 20 weeks of age(P<0.05). 
PGST- or GGT-positive AHF were not detected in any treatment group at 9 or 12 weeks of 
age. At 20 weeks of age, half of the rats fed 25ppm FB, had PGST and GGT- positive 
AHF. The sphinganine (Sa) concentration as well as the Sa/sphingosine (So) ratio were 
significantly greater in the rats fed 25 ppm FB i diet as compared with the control groups 
respectively at 12 or 20 week age. Therefore, modifying FB, with glucose seems to 
prevent FBi-induced hepatotoxicity and promotion of hepatocarcinogenesis. S a/So ratio 
was not the most sensitive bio marker of FB, toxicity. 
INTRODUCTION 
The carcinogenic and toxic effects of fumonisin B, (FBi) , a mycotoxin produced by 
the commonly occurring corn fungi, Fusarium moriiliforme and Fusarium proliferation, 
have been studied intensively. Fumonisin Bi (69.3|±M/kg, 50ppm) was hepatocarcinogenic 
in rats fed the toxicant for approximately two years (/). The incidence of F. moriiliforme in 
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corn for human consumption has been correlated with the incidence of esophageal cancer 
in Transkei, Southern Africa (2) and in China (J) .The concentration of FBi in com reached 
approximately 11.1 (imol/kg in areas of southern Africa where human esophageal cancer 
rate was high(4). Com products for human and animal consumption were determined to 
have FBi concentration between 0.3-4.2 ^.mol/kg in the U.S. (5, 6, 7). 
Several bio markers have been used to study FBt hepatocarcinogenicity. Fumonisin 
B %-promo ted rat hepatocarcinogenesis was readily quantified by measuring placental 
glutathione S-transferase (PGST) positive altered hepatic foci (AHF) (8) and y-
glutamyltransferase (GGT)-positive AHF (9). Plasma alanine aminotransferase (ALT) 
activity was increased during fumonisin hepatotoxicity (JO), and hepatocarcinogenesis in 
rats (77). Increased plasma total cholesterol was observed in FBi-treated vervet monkeys 
(12), and in rats (II) in short term studies. Greater hepatic prostaglandin F2a production 
was also observed in FBi tumor promotion in rat liver (13). In vivo administration of 
50ppm FBi significantly suppressed hepatic natural killer (NK) cell activity while 
stimulating hepatic preneoplasia (13). Natural killer cell activity suppression by FBi during 
tumor promotion may be mechanistically significant, but this remains to be determined. 
Thus numerous possible bio marker of FBt toxicity and tumor promotion may be used to 
probe mechanism of action of mycotoxin. 
Recent studies regarding the biological effects of fumonisins indicated that they 
selectively inhibit ceramide synthase, a key enzyme in the sphingolipid biosynthetic 
pathway (14). It was suggested that the subsequent accumulation of the sphingoid bases, 
sphinganine (Sa) and sphingosine (So), could have an important role in the toxicological 
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effects of fumonisin in the kidney and the liver of rats (75, 76). In addition, as the sphingoid 
bases are important regulators of cellular growth and differentiation (77), the continued 
disruption of sphingolipid biosynthesis has been implicated in the hepatocarcinogenicity of 
fumonisin (78). 
Currently, there has been increased attention directed at reducing the human and 
animal exposure to these fungal toxins. Biological, chemical, and physical processes have 
been explored to salvage fumonisin-contaminated corn. Thermostability of FBi proved to 
be great. When dry corn was heated at 50, 75, 100 and 125°C for 40 minutes, only a small 
amount of FBi was lost (79). Treatment of fumonisin-contaminated com with 2% ammonia 
for 4 days, a process that detoxified aflatoxin B%, led to slight reduction in the 
concentration of FBi without decreasing its toxicity in rats (75). Nixtamalization, the 
traditional process to produce masa or tortilla flour, reduced the amount of FBi by 
hydrolyzing FB, to hydrolyzed FB; (HFBi ), but HFBi was similar in toxicity to FBi when 
the nutritional status of rats was adequate (77). In vitro toxicity studies of several FBt 
analogs showed that the analogs containing FBt amine groups and the tricarballylic side 
chains were more toxic than analogs containing only the tricarballylic side chains (20), and 
naturally occurring N-acetyl —FBt was not toxic (27). Therefore, the primary amine of FBt 
is likely to be critical for its toxicity. Murphy et al. (22) reported a method to detoxify FBt 
by derivatizing the amine group with a reducing sugar, fructose, in a nonenzymatic 
browning reaction. Diethylnitrosamine-initiated (15 mg/kg body weight) male F344/N rats 
were fed for 4 weeks either 69.3 fiM FBt or 69.3 jiM FBt reacted with fructose (FBt -
fructose). Rats fed FBt had significantly increased levels of several markers of 
I l l  
hepatocarcinogenicity, while rats receiving FBi — fructose showed no signs of 
hepatocarcinogenicity or hepatotoxicity(/J). A more practical and efficient method to 
block FBi's amine group by reacting the amine group with glucose had been developed in 
Dr. Murphy's lab (23) .The FB,-glucose reaction was more complete than the reaction with 
fructose, and the reaction products were more easily isolated than FBi-fructose products. It 
was hypothesized that modifying FB[ with glucose would prevent promotion of 
hepatocarcinogenicity by FB i. Our experiment was designed to test the effectiveness of 
this detoxification method by examining effects of FB,-glucose on several markers of FB, 
promotion of hepatocarcinogenesis. 
MATERIALS AND METHODS 
Preparation of Fumonisin Bi-glucose adduct 
FB,-glucose was prepared by heating 1.39 mM FB, (total 8.1 mmol) with 0.1M D-
glucose in 50 mM potassium phosphate buffer, pH 7.0 at 80°C . After 48 hours, the pH of 
the reaction mixture was adjusted to pH 2.7 to stop the reaction. Re versed-phase C,s SPE 
cartridges (Supelco, Bellefonte, PA) were preconditioned with 50 ml 100% methanol at 
apparent pH 2.7 followed by 100 ml deionized water at apparent pH 2.7. An aliquot of 50 
ml of the 1.39 mM FB,/0.1 M D-glucose reaction mixture was loaded on the cartridge. 
The cartridge was washed with 100 ml deionized water and 100 ml 30% methanol at an 
apparent pH of 2.7. The D-glucose was washed out at this step. The FB,-glucose was 
eluted with 50 ml of 40% methanol and 100 ml 100% methanol at apparent pH 2.7. The 
eluant was evaporated to dryness with Brinkmann rotavapor R110 (Westbury, NY) at 
35°C. The residue was redissolved in Milli Q water, and brought to 10.0 ml in volumetric 
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flask. The unreacted free FBi was quantified with HPLC OP A derivative method (5). The 
solution was freeze-dried and the total mass was determined on an analytical balance. The 
amount of FBrghicose was determined by subtracting the free FB[ mass from the total 
mass. 
Diets 
Four experimental diets were fed to rats. The control group was fed basal diet AIN-93G 
(American Institute of Nutrition, 1993). The FB, group was fed a diet containing highly 
purified FB[ which was prepared by incorporating 25ppm FBt into basal diets. The FBt -
glucose group was fed a diet in which purified FB t reacted with glucose was incorporated 
into the basal diet at a level equivalent to 25 ppm FBt diet. Analysis of the FB t -glucose 
products showed that approximately 8ppm unreacted FBt remained in the FBt-glucose 
containing diet. Thus another control group was fed 8ppm FBi. 
Animals 
The experimental procedures were approved by the Iowa State University Animal 
Care Committee. Eighty 10-day old female F344/N rats obtained from Harlan Sprague-
Dawley (Madison, WI) were injected intraperitoneal^ with diethylnitrosamine (DEN, 
15mg/kg body weight) in 0.1 ml com oil. At 4 weeks of age, the weaned rats were 
randomly assigned to one of the 4 treatment groups with 20 rats each. At 9 weeks of age, 4 
rats from each treatment group were killed. At 12 weeks, another 5 rats from each group 
were killed. At 20 weeks of age, remaining rats were killed. The carcasses of the rats were 
store at -20°C freezer. Before scanned by dual-energy X-ray absorptiometry (QDR 2000, 
Ho logic Inc. Waltham, MA), the carcasses were thawed at 0°C for about 2 hours, the 
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composition of soft tissue lean, and fat in the body were expressed as the percentage of the 
body weight (24). Rats were given free access to the experimental diets and with a 12-h 
light/dark cycle maintained at 22-25°C and 50% humidity. Body weight and feed intake 
were recorded weekly. 
Plasma and liver samples preparations 
Before the liver was perfused, 1ml sodium chloride solution (contain 100 unit of 
heparin) was injected into the abdominal vein, and about 3ml blood was drained out into 
the syringe. Part of the plasma obtained from heparinized blood was analyzed within 24 
hours for alanine aminotransferase(ALT) activity. The remaining plasma was stored at -
80°C for later plasma total cholesterol analysis. 
Rat livers were perfused with 40ml of Hank's Balanced Salt Solution (HBSS, 
supplemented with 25mM Hepes and 0.1% EDTA). Approximately 12 ml of perfusate was 
concentrated to 3 ml and laid on 3 ml Accupaque density gradient media (Accurate 
Chemical Co., Westbury, NY), then centrifuged at 1500rpm for 10 minutes. The 
mononuclear cells at the interface were collected, and washed two times, once with 
HBSS(with 25mM Hepes) and once with complete medium (RPMI-1640, supplemented 
with 50p.g/ml gentamicin, 25 mM Hepes, 2mM L-glutamine, and 10% fetal bovine serum 
(FBS)). Cells were enumerated on a Celltrack H (Nova Biomedical, Waltham, MA), in 
preparation for the NK cell activity and cell surface immunofluorescence analysis. 
Each of the left, median, and right lateral lobe of the livers was sliced into lcm 
slices. Three slices, one from each lobe, were immediately frozen as a block on dry ice and 
store at -80°C. From each of the frozen liver blocks, 5 10-jim serial sections were cut with 
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a Histostat Microtome (Model 855, Leica Inc., Deerfield, IL) for later staining of GGT and 
PGST. 
For each rat, 0.5 g minced liver portion were immediately homogenized in an ice 
bath with 10 passes of a Potter-Elvehjem homogenizer in 5ml, PH 7.4, 50 mM potassium 
phosphate buffer containing 4.2 mM acetyl salicylic acid (Sigma Chemical Co., St. Louis, 
MO). The liver homogenates were frozen at -80°C for later analysis of endogenous hepatic 
PGEz and PGF?a -
Plasma Total Cholesterol Concentration and Alanine Aminotransferase Activity 
Plasma total cholesterol concentration was determined by using Sigma diagnostic 
kit, procedure 352-3 ( Sigma Chemical Co., St. Louis, MO). Plasma ALT activity was 
measured by using Sigma diagnostic kit for glutamate/pyruvate transaminase optimized for 
the ALT assay (Sigma Chemical Co., St. Louis, MO). 
Determination of Sphingosine (So) and Sphinganine (Sa) 
Thawed liver tissues were homogenized in 4 volumes 0.05 M potassium phosphate 
buffer. Homogenate (0.1 ml) was transferred to a cold (13 X 100mm) glass tube with a 
Teflon lined screw cap. The extraction method was perforemed as described by Riley et al 
(25). Sphingosine and sphinganine were quantified by HPLC as described by Riley et al 
(25) but using Cl7-phytosphingosine (Sigma Chemical Co., St. Louis, MO ) as the internal 
standard. Sphinganine and So standard (Sigma Chemical Co., St. Louis, MO) mixture at 
different concentrations (1, 3, 5, 7 9 nmol) were prepared for standard curves. 
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Prostaglandin assays 
PGE2 and PGF2a were determined in a radioimmunoassay as described by McCosh 
et al (26). Anti-PGE? antiserum ( 0.2ml /per assay tube ) and anti-PGFia antiserum (0.2ml 
/ per assay tube) were obtained from Sigma Co.(St Louis, MO). H3-PGE2 ( lO^gCi/ per 
aliquot) and H3- PGF2a(10"6jiCi/ per aliquot) was obtained from NEN Products (Boston, 
MA). PGE2 and PGF2a were quantified by using a computer program based on a logit 
transformation of the standard curve (27) 
Natural killer cell assays 
Natural killer cell assays were performed as previously described (28). Cells were 
plated in triplicate at the following effector to target ratios in 96 well plates: 25:1, 12.5:1, 
6.25:1, 3:1. The target cells for the assay were YAC-1 cells(ATCC Co, Rockville, MD) 
(8xl03/well) which had been labeled with 200|i.Ci 5ICr. The amount of 5lCr released by 
dying cells was counted using a Gamma Trac 1191(TM Analytic, Inc., Elk Grove Village, 
IL). Lytic units were calculated using a computer program based on the equation of Pross 
and Maroun(1984). 
Fluorescent staining of lymphoid cells 
Leukocyte suspensions were diluted with an equal volume PBS/0.1 %azide (cold) 
and incubated at 4°C (5min). Separate aliquots were stained with 
0.2jig/2x 105(mononuclear cell) of anti-rat NKR-PlA-Biotin(mAb 3.2.3), or an equivalent 
amount of isotype control (murine IgGl-biotin). A second step of 0.1|ig/2xl05 
(mononuclear cell) Strep-AvidinCychrome was used(All from Pharmingen, San 
Diego,CA). All incubations were performed at 4°C in the dark for 30min, and washed with 
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PBS/O. l%azide. The contaminating red blood cells were lysed using 10% ammonium 
chloride buffer (pH=7.4). Cells were fixed with PBS/1 % paraformaldehyde prior to 
analysis using an EPICS-XL-MCI flow cytometer (Coulter, Miami, FL). According to the 
density of fluorescence, three cell populations were distinguished: NKR-Plbnght, NKR-
Pldim and negative, and gates were set to help measure the percentage of different 
populations (29)(Fig 1). 
Immunohistochemical Staining 
One of the frozen serial sections was stained for the presence of PGST-positive 
altered hepatic foci (AHF). Placental glutathione S-transferase was detected by the 
peroxidase-anti-peroxidase (PAP) method using a Vectastain ABC avidin-biotin universal 
rabbit PAP kit (Vector Laboratories, Burlingame, CA). Anti-PGST antiserum was prepared 
as described previously (30). The second frozen serial section was stained for GOT activity 
as described by Rutenburg et al. (31). The substrate for GGT was glutamyl-4-
naphthylamide (GMNA) ( United States Biochemical Corp., Cleveland, OH). Altered 
hepatic foci were quantified via computerized stereology. A Sony 3-chip color video 
camera DXC-3000A took the images of the liver section stained for GGT and PGST, 
which were digitally transferred from the camera to an Apple Power Mac G3 computer 
(Apple computer, Inc., Cupertino, CA), and analyzed with IP Lab image analysis software 
(version 3.2.3, Scanalytics, Fairfax, VA). Lung, kidney, brain, tibia and additional liver 
samples were processed by routine histopathological methods for hematoxylin-eosin 
staining (32). 
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Statistical analysis 
Multi-variant regression analysis was used to compare the four growth curves. One­
way ANOVA was performed to analyze plasma total cholesterol, alanine aminotransferase 
activity, the percentage of leukocytes that carry NKR-Plbnght and NKR-P1 dim population 
markers as well as the amounts and ratio of S a/So. The hepatic NK activity was compared 
using one-way ANOVA combined with covariance for the percentage of NKR-Plbnght 
population. Two-way ANOVA was performed to analyze endogenous PGE? and PGFia at 
different ages. Student's t-test was performed to compare all possible group differences 
after ANOVA. A p-value of <0.05 was considered to be statistically significant. 
RESULTS 
Effect on body weight gains, relative liver weight and body mass composition 
The body weights and food intake did not differ among treatments. Relative liver 
weights were not different among the four treatment groups at any time point, and body 
composition (%fat) was similar among all groups at 20 weeks of age. Body weight and 
food intake did not differ among treatments (Table l).The growth curves of four treatment 
groups were similar over a period of 20 weeks (Data not shown). 
Plasma total cholesterol levels and alanine aminotransferase activity 
At 9 weeks of age, the total plasma cholesterol concentration was not different 
among the four treatment groups. At 12 weeks of age, in comparison with the rats fed basal 
diet and the rats fed FB,-glucose, the rats fed 25ppm FBi diet had significantly greater 
plasma total cholesterol concentration (p<0.05). At 20 weeks of age, in comparison with 
the rats fed basal or FB,-glucose diets, the rats fed 8ppm or 25ppm FB, diets had 
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significantly decreased plasma total cholesterol (p<0.05) (Figure 1). Alanine 
aminotransferase activity of the rats fed 8ppm or 25ppm diet was significantly greater than 
the rats fed basal or FB[-glucose diet at 9 weeks age. At 12 weeks of age, only the rats fed 
25ppm FBi exhibited significantly greater ALT activity than did other groups. At 20 
weeks of age, the rats fed 8ppm or 25ppm FBi exhibited greater ALT activity compared 
with rats fed basal or FB;-glucose diet at 20 weeks of age ( Figure 2). 
Hepatic NKR-Plbri8th and NKR-Pldim population 
Flow cytometric analysis using mAb 3.2.3 (natural killer cell receptor protein 1 
(NKR-P1) ) revealed two distinct subsets of hepatic mononuclear cells expressing variable 
levels of NKR-P1. The NKR-Plbnght population, which expresses a high level of NKR-P1, 
has been identified as the population causing NK associated lytic activity (33). The NKR-
Pldim population, which expresses a low level (2-10 fold lower) of NKR-P1, has been 
linked to a subset of T lymphocytes that have NK-like cytolytic function under activation 
by interIeukin-2 (34). The results showed that all three treatment groups had greater 
percentage of NKR-Plbnght population at 9 weeks of age than did the control group. FB[-
glucose lowered the percentage of NKR-Plbnght mononuclear cells as compared with the 
group fed 25 ppm diet at 20 weeks of age (Figure 3A). The NKR-Pldim population was 
not different among each group at three time points, but with increasing age, each group 
had a greater percentage of NKR-Pldim mononuclear cells as compared with the same 
group at 9 weeks of age (Figure 3B). 
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Hepatic natural killer cell activity 
Before covariation with the percentage of NKR-P1bnght population, all groups of 
rats exhibited similar NK lytic activity at 9 and 12 weeks of age. The rats fed FB i — 
glucose exhibited significantly lower NK lytic activity as compared with the rats fed 
25ppm FBi diet at 20 weeks of age (Figure 4A). After covariation with the percentage of 
NKR-Pibnght mononuclear cells, all treatment groups exhibited similar NK lytic activity at 
each age (Figure 4B). 
Hepatic concentration of PGE 2 and PGE 2 a 
The hepatic PGE 2 concentration was similar among each group at both 9 and 12 
weeks of age, but hepatic PGE 2 concentration in rats fed both 8ppm or 25ppm diet was 
significantly increased by approximate 50% as compared with the control group at 20 
weeks of age. With the age increase, PGE 2 concentrations in rats at 12 or 20 weeks of age 
were significantly greater than that of rats fed the same diets at 9 weeks of age ( Figure 5) . 
The PGF 2a concentration were not different among treatments at any time. Hepatic PGE 2a 
was greater in all treatments at 12 and 20 weeks of age than at 9 weeks of age (Figure 6). 
Altered hepatic foci indicated by PGST or GGT staining 
There were no detectable PGST- or GGT-positive AHF in any treatment group at 9 
or 12 weeks of age. At 20 weeks of age, half of the rats fed 25ppm FB, had PGST and 
GGT- positive AHF. The average PGST-positive AHF area percentage was 0.4 ± 0.7, and 
the average GGT-positive AHF area 0.6 ± 0.8. There were no detectable PGST- or GGT-
positive AHF foci in the groups fed 25ppm FBi reacted with glucose, 8ppm FB 1, or basal 
diet at 20 weeks of age ( Table 2). Histopathology studies showed that all the groups 
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exhibited similar mild fatty change in periportal hepatocytes and mild increase of bilirubin 
in epithelium of proximal convoluted tubules. No lesions was found in lung, brain or tibia. 
Sphingolipid analysis 
The levels of Sa, So, and the ratio S a/So were not affected in any treatment group at 
9 weeks of age. The Sa concentration as well as the ratios of S a/So were significantly 
greater in the rats fed 25ppm FB i diet as compared with the control group at 12 or 20 
weeks of age. The So concentration was unaffected among all treatment groups at 12 or 20 
weeks of age (Table 3). 
DISCUSSION 
This study demonstrated that subjecting FB, to a nonenzymatic browning reaction 
with glucose avoid FB, toxicity as reflected in plasma total cholesterol concentration, ALT 
activity, development of GGT- and PGST-positive AHF , concentration of endogenous 
hepatic PGE2, accumulation of Sa , or S a/So ratio. These results agreed with the findings 
of Lu et al (13) in which FB[ was detoxified by reaction with fructose. Because the FB,-
fructose and FB, — glucose products are likely to be similar, both reactions probably had 
similar detoxification effects. The present study showed a lack of toxicity of FBi -glucose 
over 15 weeks treatment, compared with a lack of toxicity over 4 weeks in an earlier FB, — 
fructose detoxification study (13) 
The effectiveness of the detoxification of FB, by reaction with glucose is probably 
not explained by diminished bioavailability. FB, when reacted with fructose had much 
greater absorption than did FB, (35). Because FB,-fructose and FB,-glucose products are 
likely to be similar, it is likely that FB,-glucose products were also absorbed. The 
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addition of glucose to FB, may have prevented the inhibitory binding of FB, to ceramide 
synthase, thought to be a pathway of FBI toxicity (14). The observation that sphingolipid 
ratios remained at control values in the rats exposed to FB,-glucose in this study further 
supports this assumption. 
The rats fed 25ppm FB, diet had noticeably greater plasma total cholesterol 
concentration as compared with the control group and with rats fed FB,-glucose at 12 
weeks of age in the present study. The observation of FB,-induced hypercholesterolemia 
was reported in vervet monkeys (12), as well as in rats (7/, 13). The reason that the 
increase of cholesterol in our experiment was not as great as the reported in earlier 
experiments might be that basal diets contained only 7% fat, which was much less than the 
fat content (20%) used by Lu et al. (13). The mechanism underlying the effect of FBI on 
plasma cholesterol is unknown. The increase in plasma total cholesterol by FB, might 
result from stimulation of cholesterol synthesis in hepatocytes, or impaired cholesterol 
removal by liver. We also observed that the rats fed 8ppm FB, or 25 ppm FB, diet had 
significantly lower plasma total cholesterol level as compared with controls or rats fed 
FB,-glucsoe at 20 weeks of age. The cholesterol levels in primary rat hepatocytes were 
decreased under the effect of 500 jiM FB, (36), The mechanism of the decrease in the 
levels of cholesterol is not clear, but it could be the result of decreased level of 
sphingomyelin (SM) in cell membranes which influenced cholesterol synthesis and/or 
metabolism. 
The plasma ALT activity was significantly increased in rats fed 8 and 25ppm FB, as 
compared with the control group at 9 weeks of age. At 12 weeks of age, only the rats fed 
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25 ppm FBi exhibited greater ALT activity as compared with the control group. This result 
is partially in agreement with the finding of Lu (37), in which ALT activity in rats fed 
25ppm FBi for 4 weeks increased significantly compared with controls, but ALT did not 
increase in rats fed 12.5ppm FBi diet. This difference between our results and the results 
obtained by Lu may be explained by the greater time of FB, exposure in the present study, 
which might have caused more hepatocellular damage, the sphigomyelin synthesis. In 
contrast, FB[ treatment increased the hepatocellular concentration of phosphatidylcholine 
(PC) and phosphatidylethanolamine (PEA). 
Groups fed 8 or 25ppm FBi but not the group fed FB [-glucose showed significantly 
greater endogenous hepatic PGE, as compared with the control group at 20 weeks of age. 
This result differed from the findings of Lu (37), in which rats fed 50ppm FB, showed 
greater amount of PGEi and PGF2a, but no significant increase of PGE, or PGF,a was 
observed in rats fed 25 or 12.5ppm FB [. As with ALT, the longer period of FB, exposure 
in the present study may have permitted a lower dose of FB% to increase PG levels. Also, as 
with ALT, we have previously proposed that increased PG production was a hallmark of 
promotion of rat hepatocarcinogenesis caused by FB [ (/J). But in our experiment, only 
rats fed 25 ppm FB , showed induction of AHF in the liver, yet rats fed 8 ppm FB l also 
exhibited greater amounts of PGE,, but had no induction of AHF. This suggests that the 
increase of PG production may precede the occurrence of preneoplasia. 
The NKR-Plbnsht population in rats fed FBi or FBi -glucose was significantly 
greater than in the control group at 9 weeks of age. This might reflect a general immune 
response of the host to exogenous antigen. In vitro experiments have shown that NK 
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percentage significantly increased under the effect of antigen (38). At 12 weeks of age, all 
four groups had similar NKR-P lbnght percentage. At 20 weeks of age, both FBi-fed groups 
had similar percentages of NKR-P lbnght cells compared with the control group. But the 
percentage of NKR-P lbnghl mononuclear cells in FB [-glucose treated rats was significantly 
decreased as compared with 25 ppm FB [ —treated group. Before covariation with the 
percentage of NKR-P lbnght population, all groups exhibited similar lytic activity at 9 or 12 
weeks of age, but FB [-glucose-treated rats had significantly decreased NK lytic activity as 
compared with 25 ppm FB[-treated rats. After covariation with the percentage of NKR-
p ^ bnght population ^ all four groups had similar NK lytic activity per NK cell. Thus, FB|-
glucose was not metabolically inert. It remains to be seen whether the suppression of NK 
cells by FB [-glucose is physiologically significant, and if so, by what mechanism this 
occurs. The inhibition of NK lytic activity in rats fed FB,-glucose at 20 weeks of age 
probably resulted from the decreased percentage of NKR-P lbnght population. 
Our results do not agree with the findings of Lu et aI.(/3), which showed that 
hepatic NK lytic activity was significantly inhibited when rats were fed 50ppm FB i as 
compared with control group. Lu et al. (13) proposed that the inhibition of NK activity 
might be through the effect of increased PG production (39, 40). A dose-response 
inhibition by PGE? of NK activity had been reported by Liu et al.(41) in in vitro 
cocultures of hepatic NK cells with PGE,. In our experiment, we observed the increased 
production of PGE? by FB, feeding, but NK activity was not affected . The reason that we 
did not observe the inhibition of NK lytic activity might be that less (25ppm) FB[ as well 
as less fat (7%) was fed to the rats as compared with the experiment of Lu et ai.(73) 
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(SOppmFBi and 20% fat in the diet). The possible explanation for the lack of effect of 
FBi on NK activity in our study may lie in interactions between carcinogenesis and NK 
activity. Lee et al. (42) showed that, in male F344/rats given 40ppm DEN in drinking 
water for 10 weeks, as PGST-positive AHF developed, splenic NK activity changed. After 
5 weeks, DEN treated and control rat spleen NK activity was similar, but at 10 weeks, NK 
activity was significantly greater in DEN treated rats compared with control rats. At 20 
weeks, DEN-treated rats had significantly lower NK activity than did control rats. Lower 
NK activity was accompanied by PGST-positive AHF. Lu et al.(73) showed 20-fold 
greater area of PGST-positive AHF as compared with our study, which implies that with 
greater extent of carcinogenesis , NK lytic activity was affected adversely. 
In the present study, only half of the rats fed 25 ppm FB, showed PGST- and GGT-
positive AHF, in comparison with Lu (37) in which 11 of 12 animal fed 25 ppm FB 1 
showed PGST and GGT-positive AHF. The area occupied by AHF was much greater than 
in our study. The fat content of the diet was 20% (37), which was much greater than the 
7% fat content in our experimental diet. It has been shown that high levels of dietary fat 
markedly shorten the time between ultraviolet exposure and its induction of skin tumor 
(43). Many studies have shown that dietary fat is a tumor promoter (44, 45). In our study, 
although the feeding time was longer than in the study by Lu (37) , the lesser dietary fat in 
the present study might have produced fewer and smaller GGT- and PGST-positive AHF. 
The increase in free sphingosine and sphinganine in animal tissue, serum and urine 
have been used extensively as an experimental bio marker for fumonisin exposure (46). In 
our study, the accumulation of Sa and increase of S a/So ratio only appeared in rats fed 25 
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ppmFBi at 12 and 20 week age. This did not agree with previous observations that 
animals exposed to FB, developed altered S a/So ratio before other signs of intoxification 
were observed (47, 14). In the present study, we observed increased ALT in both FB, 
treated groups at 9 weeks of age and in rats fed 25 ppm FB, at 12 weeks of age, but we did 
not observe the S a/So ratio change at 9 weeks of age. Our study agreed with Gelderblom 
et al. (48) who indicated that no significant change in S a/So ratio was observed at the 
lowest dietary level of FB, that induced cancer promotion and inhibition of cell 
proliferation. Further studies are needed to determine the role of S a/So ratio in fumonisin 
toxicity and how the effect of FB, on this ratio interacts with other dietary components. 
It was noticed that both FB,-glucose and FB,(8ppm) diets contained the same 
amount (8ppm) of free FB,, but only FB,(8ppm) treated rats exhibited adverse effects, 
which was reflected in increased ALT activity, and total cholesterol and PGE, 
concentrations. FB,-glucose which contain 8ppm free FB, treated rats exhibited similar 
effect as control rats. It seemed that FB,-glucose can prevent the adverse effect of FB, 
when FB, and FB,-glucose were fed together. Perhaps the FB,-glucose prevented the free 
FB [ from interacting with its site of action. 
In conclusion, reaction of FB, with glucose can detoxify FB, in a rat 
hepatocarcinogenesis modeLThe mechanism might be that binding ability of FB,-glucose 
to ceramide synthase was inhibited, as was reflected in the lack of accumulation of Sa 
when FBI-glucose was fed. S a/So did increase when the same amount of FB, was fed 
(25ppm). Further study is needed to determine the bioavailability of FB,-glucose and to 
determine its effects in other animal models. 
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Table 1 
Body weight LW/BW(x 102) Body Composition Food intake 
( g ) ( % fat ) ( g/day) 
Control 204 ±12 4.1 ± .5 32.8 ± 3 13.5 ±3 
FBI-glucose 205 ± 12 3.9 ± .6 34.2 ±5 14.5 ±2 
FB 1 (8ppm) 198 ± 15 3.9 ± .4 33.4 ±3 12.8 ±2 
FBl(25ppm) 197 ± 16 3.7 ± .5 31.5 ±2 11.5 ±2 
Table 1: Comparison of the final body weight, body mass composition, relative liver 
weight and food intake among four treatment F344/N female rats. No difference was found 
in these four indicators among these groups under each treatment over 20 weeks (N=10/ 
group). The data entries in the table were expressed as mean ± standard error of mean 
(SEM). 
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Figure 1 : Comparison of the total plasma cholesterol concentration at three time points. At 
9 weeks of age, no difference was found among four treatment groups. At 12 weeks, the 
rats fed 25ppm FB[ exhibited significantly greater cholesterol concentration as compared 
with FBi-glucose group. At 20 weeks of age, both the rats fed with 8ppm and 25ppm FBi 
exhibited significantly lower cholesterol concentration as compared with control group. 
The error bar represented the SEM. 
a: significantly different as compared with FBi(25ppm) group at 12 weeks of age (N= 
5/group). 
b: Significantly different as compared with control group at 20 weeks of age 
(N=10/group). 
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Figure 2: Comparison of the alanine aminotransferase (ALT) activity at three age points. 
At 9 weeks of age, both the rats fed 8ppm and 25ppm FB t showed significantly greater 
ALT activity as compared with control group. At 12 weeks of age, the rats fed 25ppm FB [ 
showed significantly greater ALT activity as compared with control group. 
At 20 weeks of age, both the rats fed 8ppm and 25ppm FBi showed significantly greater 
ALT activity as compared with control group. The error bar represented the SEM. 
a: Significantly greater than control group at 9 weeks of age (N= 4/group) 
b: Significantly greater than control group at 12 weeks of age (N= 5 /group) 
c: Significantly greater than control group at 20 weeks of age (N=10/group) 
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Figure 3 A: Comparison of the percentage of hepatic NKR-P lbnght mononuclear cells at 
three time points. At 9 weeks of age, all the rats fed FB^-glucose , 8ppm FB[ or 25ppmFB[ 
exhibited greater NKR-P lbnght percentage as compared with control group. No difference 
was found among treatment groups at 12 or 20 weeks of age. The error bar represented the 
SEM. 
a: Significantly greater than control group at 9 week age (N= 4/group). The error bar 
represented the SEM. 
135 
Control FB1-glucose FB1 (8ppm) FB1 (25ppm) 
09 wks 
• 12 wks 
D20 wks 
Figure 3B: Comparison of the percentage of hepatic NKR-P ld,m cells at three time points. 
All the rats showed similar percentage among treatment within the same time point, 
a: Significantly greater than control group at 9 week age (N= 4/group). The error bar 
represented the SEM. 
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Figure 4A: Comparison of hepatic NK activity at three time points prior to covariation 
with the percentage of NKR-P lbnght mononuclear cells. Activity was expressed as lytic 
units, calculated from the specific lysis curve. At 9 and 12 weeks of age, all the rats 
exhibited similar NK lytic activity. At 20 weeks of age, the rats fed FBi-glucose exhibited 
significantly lower NK activity as compared with the rats fed 25ppm FB[. The error bar 
represented the SEM 
a: Significantly different as compared with the group fed 25ppm FBi (N=10 /group) 
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Figure 4B: Comparison of hepatic NK activity at three age stages after covariation with the 
percentage of NKR-P lbnght population. At three age stages, no difference was found 
among treatment within each age stage. The error bar represented the SEM. 
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Figure 5: Comparison of the hepatic PGE2 concentration in four treatment groups at three 
time points. The concentration of PGE, is expressed as ng per gram liver tissue. At 9 weeks 
of age, there is no difference among the treatment groups. At 12 weeks of age, no 
difference was found among the treatment groups. At 20 weeks of age, the rats fed 8ppm 
or 25ppm FB 1 exhibited significantly greater concentration of PGE% as compared with 
control group. Rats at both the 12 and 20 weeks of age had greater PGE2 concentration as 
compared with same treatment at 9 weeks of age. The error bar represented the SEM. 
a: significantly greater than control group at 20 weeks of age (N=10 /group), 
b: Significantly greater than 9 weeks of age group of the same treatment 
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Figure 6 : Comparison of the hepatic PGFaa concentration in four groups at three time 
points . The concentration of hepatic PGFza was expressed as ng per g liver tissure. The is 
no difference among treatment groups at three time points. Both the rats at 12 and 20 
weeks of age had greater hepatic PGFia concentration as compared with same treatment at 
9 weeks of age. The error bar represented the SEM. 
a : Significantly different as compared with rats of 9 weeks of age within the same 
treatment. 
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Table 2: Placental glutathione S-transferase (PGST) and y-glutamyl transferase 
( GGT)-positive altered hepatic foci (AHF) 
#of rats with 
PGST AHF 
% PGST Area # of rats with 
GGT AHF 
% GGT Area 
Control 0 0 0 0 
FBI-glucose 0 0 0 0 
FBl(8ppm) 0 0 0 0 
FBl(25ppm) 5 0.4 ± 0.7 5 0.6± 0.8 
The AHF occurred only in rats fed 25 ppm FB i at 20 weeks of age. The data entries in 
the table were expressed as mean ± standard error of mean (SEM). 
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Table 3: Comparison of sphingosine (nmol/ml) (So), sphinganine (nmol/ml) (Sa) 
as well as the ratio of Sa/So at three time points 
9 weeks of age 12 weeks of age 20 weeks of age 
(nmol/ml) (nmol/ml) (nmol/ml) 
So Sa Sa/So So Sa Sa/So So Sa Sa/So 
Control 5.6±1.2 0.7±0.2 0.1+0.1 6.5±2.2 0.9+0.3 0.12±0.1 5.9+2.5 1+0.5 0.15±0.1 
FBI-Glucose 6.5+1.5 0.6+0.2 0.1±0.1 5.7+2.5 0.8+0.2 O.Î2+O.Î 5.8±1.5 0.8+0.5 0.12+0.1 
FBl(8ppm) 5.4±2.3 0.8+0.2 0.15+0.1 6.3+3.0 1.3+0.5 0.18+0.2 6.5±2.9 l.2±O.8 0.2+0.1 
FBl(25ppm) 5.5±2.8 I.l±0.3 O.2+O.Î 7.5±3.5 3.5±1.5a 0.5 ±0.2a 5.8+Î.6 4.5±1.5b0.8±0.3b 
The concentration of the sphingolipids was expressed as nmol per g liver tissue. At 9 
weeks of age. The Sa, So and the ratio were similar among treatment groups. At 12 weeks 
of age. The rats fed 8ppm or 25ppm FBi diet exhibited greater Sa concentration and 
increased ratio of Sa/So as compared with control group. At 20 weeks of age, the rats fed 
8ppm and 25ppm FB[ diet exhibited greater Sa concentration and increase ratio of Sa/So as 
compared with control group. The data entries in the table were expressed as mean ± 
standard error of mean (SEM). 
a: Significantly different as compared with control group at 12 weeks of age (N= 5/group) 
b: Significantly different as compared with control group at 20 weeks of age (N= 10/group) 
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INCREASED DIETARY FAT AND ENERGY INTAKE DURING FUMONISIN 
PROMOTED HEPATOCARCINOGENESIS INCREASE HEPATIC 
PROSTAGLANDINS, SPHINGANINE, AND DEVELOPMENT OF PLACENTAL 
GLUTATHIONE TRANSFERASE (+) FOCI, WHILE INHIBITING NATURAL 
KILLER CELL NUMBER 
A paper to be submitted to Carcinogenesis 
Hongjun Liu, Joan E. Cunnick*, Patricia A. Murphy and Suzanne Hendrich** 
ABSTRACT 
We propose that greater dietary fat and energy intake promotes FBi carcinogenesis, 
inhibition of NK cell activity parallels the enhanced development of preneoplasia by 
greater dietary fat, and the endogenous production of prostaglandins and sphingolipids are 
involved in the modulation of NK cell activity. In our previous studies, we observed 
that rats fed 50ppm FBi and 20% dietary fat for four weeks developed preneoplasia, and 
the liver-associated natural killer (NK) cell activity was inhibited compared with a control 
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group, but, when rats were fed 25ppm FBi and 7% fat for 20 weeks, only half of the rats 
developed preneoplasia, and NK activity did not change compared with a control group. In 
the present study, 24 10-day old female F344/N rats were injected intraperitoneally with 
die thy In itrosamine (DEN, 15mg/kg body weight). At 4 weeks of age, rats were randomly 
assigned to AIN93G, AIN93G modified to contain an additional 13% beef tallow (by 
weight) substituted for com starch, or either diet supplemented with fumonisin B[ ( FBi. 
50mg/kg). At 9 weeks of age, in comparison with rats fed high- or low-fat control diets, the 
groups fed FBi showed greater alanine aminotransferase activity (ALT), total plasma 
cholesterol, endogenous hepatic prostaglandin E? (PGE?) and F2a (PGFaa), accumulation 
of sphinganine (Sa), increased ratio of S a/So (sphingosine), and significantly less natural 
killer (NK) cell activity and total percentage of liver-associated NKR-Plbnsht cells. The 
group fed a high fat diet and FB i exhibited greater total plasma cholesterol, PGE2 , and 
lower NK cells as a percentage of liver-associated lymphocytes than the group fed a low 
fat diet and FB;. Placental glutathione S-transferase-positive (PGST) and y-glutamyl 
transferase (GGT)-positive altered hepatic foci (AHF) occurred only in rats fed FBi. The 
same number of animals developed preneoplasia in these two groups, but the group fed a 
high fat diet and FB% had greater average hepatic area occupied by PGST (+) AHF than did 
the group fed low fat and FB[. From these findings, high fat and greater energy 
consumption promoted FB, carcinogenesis in comparison with the low fat diet. The 
inhibition of total NK activity paralleled the development of preneoplasia, and sphinganine 
did not seem to be a factor modulating the hepatic NK cell activity. Prostaglandin E2 
seemed to be a key factor of NK cell activity modulation in the present study. But in one of 
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our previous study, we found the increase of PGE2. we did not see the inhibition of NK 
activity. Our results implicated some other factors than PGE2 produced by neoplasms as 
down-regulators of NK activity accompanying growth of preneoplasia. 
INTRODUCTION 
Fumonisin Bi (FBi ) and related compounds occur in grain and grain products as the 
result of infestation and growth of fungi of the Fusarium species ( 1). FBi was identified as 
the major toxic substance produced by cultures of Fusarium moniliforme (2), which caused 
equine leukoencephalomalacia (ELEM) (3), porcine pulmonary edema (PPE) (4), and was 
hepatotoxic and hepatocarcinogenic in rats (5, 6). 
FBi toxicity and carcinogenicity were evaluated in female F344/N rats (7), initiated 
by diethylnitrosamine (DEN, 15mg/kg body weight) at 10 days of age, and given free 
access to the control diet (AIN93, 7% soybean oil + 13% beef tallow) or treatment diet 
(AIN93, 7% com oil + 13% beef tallow + 50ppm FBi) for 5 weeks, FB; - fed rats 
developed altered hepatic foci (AHF), and hepatic NK activity in FBi —fed rats was 
significantly inhibited as compared with the control group. When female F344/N rats were 
initiated by DEN (15mg/kg bw), and given free access to control diet (AIN93, 7% soybean 
oil) or the same diet containing 25ppm FBi for 16 weeks, only half of the animals of the 
FB % —fed rats developed GGT- and PGST-positive foci (8), and no difference in hepatic 
NK cell activity was observed between control and FB 1 -fed rats. These two experiments 
suggested that there was an interaction between dietary fat and FBi carcinogenesis, as 
reflected in the altered hepatic foci and hepatic NK activity. 
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Evidence from experimental animal models strongly suggests that liver-
associated NK cells and Kupffer cells are the first line of defense against blood-borne 
metastasizing solid tumor cells invading the liver. Thus NK cells protect the parenchyma. 
The primary role of NK cells in neoplasia is directed against blood-borne tumor cells 
during the intravascular phase of tumor metastasis(9). In male F344/N rats given 40ppm 
DEN in drinking water for 10 weeks, as GST-P+foci developed, splenic NK activity 
changed. After 5 weeks, DEN-treated and control rat spleen NK activity was similar, but 
at 10 weeks, NK activity was significantly greater in DEN treated rats compared with 
controls. At 20 weeks, DEN-treated rats had significantly lower NK activity than did 
controls (10). This suggests an interaction between chemical carcinogenesis and NK 
activity, at the very early stage of carcinogenesis, the NK cell activity may not change or 
even increase, with the progression of neoplasia, the inhibition of NK cell activity 
occurs, and may parallel the development of neoplasia. 
Increased dietary fat increased the development of mammary tumors induced by 
chemical carcinogens in rats (11, 12). Hopkins and Carrol (13) reported that in rats 
initiated with 7,12-dimethylbenz[a]anthracene one week before dietary treatment, rats fed 
3% sunflower seed oil and 17% of either tallow or coconut oil developed twice as many 
tumors as those fed 3% sunflower seed oil. Rats were first intubated with 
diethylnitrosamine (DEN, 10 mg/kg) 20 hr after partial hepatectomy; 1 week later, rats 
were fed one of three purified diets (a low-fat diet similar to the AEN-76 diet, a high 
saturated fat diet, or a high polyunsaturated fat diet) with or without 0.05% 
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phénobarbital in the diet for 10 months. Increasing the fat level of the diet did not increase 
the number of GGT-positive foci arising spontaneously or induced by DEN alone. When 
phénobarbital was present in the diet, both high-fat diets enhanced the induction of GGT-
positive foci. Increasing the dietary fat level enhanced promotion of hepatic AHF by 
phénobarbital (14). We hypothesized that greater dietary fat and energy intake promotes 
FB[ carcinogenesis, the inhibition of NK cell activity parallels the development of 
preneoplasia, and the inhibition of NK activity may be modulated by prostaglandins and/or 
sphingolipids which had been observed to accumulate in previous experiments of FB, 
promotion of hepatocarcinogenesis (7, 8). 
MATERIAL AND METHODS 
Diets 
Four experimental diets were fed to rats (Table 1) : AIN93G (American Institute of 
Nutrition, 1993, which contain 7% soybean oil), AIN-93G supplemented with 13% beef 
tallow ( in substitution for corn starch), and both low and high fat diet supplemented with 
50mg FB i /kg diet. Fumonisin B i was purified from liquid cultures of F. proliferatum 
strain M5991, which predominantly produces FBi (15). Fumonisin B, was purified by the 
same procedure as described by Dantzer et al. (15). The purity of the FB, was >95%. 
Animals 
The experimental procedures were approved by the Iowa State University Animal 
Care Committee. Twenty-four 10-day old female F344/N rats obtained from Charles River 
(Wilmington, MA) were injected intraperitoneal^ with diethyInitrosamine (DEN, 15mg/kg 
body weight) in 0.1 ml com oil. At 4 weeks of age, the weaned rats were randomly 
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assigned to one of the 4 treatment groups with 6 rats each. At 9 weeks of age, all the rats 
were killed by cervical dislocation. Rats were given free access to the experimental diets 
and maintained at 22-25°C and 50% humidity with a 12-h light/dark cycle. Body weight 
and feed intake were measured weekly. 
Plasma and liver samples preparations 
Before the liver was perfused, 1ml sodium chloride solution (0.1%, containing 100 
units of heparin) was injected into the abdominal vein, and about 3ml blood was removed 
by syringe. Part of the plasma obtained from heparinized blood was analyzed within 24 
hours for alanine aminotransferase(ALT) activity. The remaining plasma was stored at -
80°C for later plasma total cholesterol analysis. 
Rat livers were perfused with 40ml of Hank's Balanced Salt Solution (HBSS, 
supplemented with 25mM Hepes and 0.1% EDTA). Approximately 12 ml of perfusate was 
concentrated to 3 ml and laid on 3 ml Accupaque density gradient media (Accurate 
Chemical Co., Westbury, NY), then centrifuged at 1500rpm for 10 minutes. The 
mononuclear cells at the interface were collected, and washed two times, once with 
HBSS(with 25mM Hepes) and once with complete medium (RPMI-1640, supplemented 
with 50|ig/ml gentamicin, 25 mM Hepes, 2mM L-glutamine, and 10% fetal bovine serum 
(FBS). Cells were enumerated on a Celltrack II (Nova Biomedical, Waltham, MA), in 
preparation for the NK cell activity and cell surface immunofluorescence analysis. 
Each of the left, median, and right lateral lobe of the livers was sliced into 1cm 
slices. Three slices, one from each lobe, were immediately frozen as a block on dry ice and 
store at -80°C. From each of the frozen liver blocks, 5 10-|j.m serial sections were cut with 
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a Histostat Microtome (Model 855, Leica Inc., Deerfield, EL) for later staining for gamma 
glutamyl-transferase (GGT) and placental glutathione-transferase (PGST). Additional liver 
samples were processed by routine histopathological methods for hematoxylin-eosin 
staining (16). 
For each rat, 0.5 g minced liver portion were immediately homogenized in an ice 
bath with 10 passes of a Potter-Elvehjem homogenizer in 5ml, PH 7.4, 50 mM potassium 
phosphate buffer containing 4.2 mM acetyl salicylic acid (Sigma Chemical Co., St. Louis, 
MO). The liver homogenates were frozen at -80°C for later analysis of endogenous hepatic 
PGEi and PGF?a. 
Plasma total cholesterol concentration and alanine aminotransferase activity 
Plasma total cholesterol concentration was determined by using Sigma diagnostic 
kit, procedure 352-3 ( Sigma Chemical Co., St. Louis, MO). Plasma ALT activity was 
measured by using Sigma diagnostic kit for glutamate/pyruvate transaminase optimized for 
the ALT assay (Sigma Chemical Co., St. Louis, MO). 
Determination of sphingosine (So) and sphinganine (Sa) 
Thawed liver tissues were homogenized in 4 volumes 0.05 M potassium phosphate 
buffer. Homogenate (0.1 ml) was transferred to a cold (13 X 100mm) glass tube with a 
Teflon lined screw cap. The extraction method was performed as described by Riley et al. 
(17). Sphingosine and sphinganine were quantified by HPLC as described by Riley et al. 
(17) but using C17-phytosphingosine (Sigma Chemical Co., St. Louis, MO ) as the internal 
standard. The HPLC system include two Beckman model 110B pumps (Beckman, San 
Ramon, CA), a Dynamax® - 100 A pore size, 3 g particle size, CI8, 4.6 x 50 mm column 
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(Varian Chromatography Associates, Walnut Creek, California), and a Waters model 470 
scanning fluorescence detector (Waters, Milford, MA). Sphinganine and So standard 
(Sigma Chemical Co., St. Louis, MO) mixture at different concentrations (I, 3, 5, 7 9 
nmol) were prepared for standard curves. 
Prostaglandin assays 
PGE2 and PGF2a were determined in a radioimmunoassay as described by McCosh 
et al (18). Anti-PGE2 antiserum ( 0.2ml /per assay tube ) and anti-PGF2a antiserum (0.2ml 
/ per assay tube) were obtained from Sigma Co.(St Louis, MO). H3-PGE2(10"6|j.Ci/ per 
aliquot) and H3- PGF2A(10"6jiCi/ per aliquot) was obtained from NEN Products (Boston, 
MA). PGE2 and PGF2a were quantified by using a computer program based on a logit 
transformation of the standard curve (19) 
Natural killer cell assays 
Natural killer cell assays were performed as previously described (20). Cells were 
plated in triplicate at the following effector to target ratios in 96 well plates: 25:1, 12.5:1, 
6.25:1, 3 :1. The target cells for the assay were YAC-1 cells(ATCC Co, Rockville, MD) 
(8xl03/well) which had been labeled with 200p.Ci 3lCr (NEN, Boston, MA). The amount 
of 5lCr released by dying cells was counted using a Gamma Trac 1191(TM Analytic, Inc., 
Elk Grove Village, IL). Lytic units were calculated using a computer program based on the 
equation of Pross and Maroun(1984). 
Fluorescent staining of lymphoid cells 
Leukocyte suspensions were diluted with an equal volume PBS/0. l%azide (cold) 
and incubated at 4°C (5min). Separate aliquots were stained with 
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0.2(ig/2x 105(mononuclear cell) of anti-rat NKR-P1 A-Biotin(mAb 3.2.3), or an equivalent 
amount of isotype control (murine IgGl-biotin). A second step of 
0.1 |ig/2x 105(mononuclear cell) Strep-AvidinCychrome was used(All from Pharmingen, 
San Diego,CA). All incubations were performed at 4°C in the dark for 30min, and washed 
with PBS/0. l%azide. The contaminating red blood cells were lysed using 10% ammonium 
chloride buffer (pH 7.4). Cells were fixed with PBS/1% paraformaldehyde prior to analysis 
using an EPICS-XL-MCI flow cytometer (Coulter, Miami, FL). According to the density 
of fluorescence, three cell populations were distinguished: NKR-Plbnght, NKR-Pld,m and 
negative, and gates were set to help measure the percentage of different populations. 
Immunohistochemical staining 
One of the frozen serial sections was stained for the presence of PGST-positive 
altered hepatic foci (AHF). Placental glutathione S-transferase was detected by the 
peroxidase-anti-peroxidase (PAP) method using a Vectastain ABC avidin-biotin universal 
rabbit PAP kit (Vector Laboratories, Burlingame, CA). Anti-PGST antiserum was prepared 
as described previously (21). The second frozen serial section was stained for GGT activity 
as described by Rutenburg et al. (22). The substrate for GGT was glutamyl-4-
naphthylamide (GMNA) ( United States Biochemical Corp., Cleveland, OH). Altered 
hepatic foci were quantified via computerized stereology. A Sony 3-chip color video 
camera DXC-3000A took the images of the liver section stained for GGT and PGST, 
which were digitally transferred from the camera to an Apple Power Mac G3 computer 
(Apple computer, Inc., Cupertino, CA), and analyzed with IP Lab image analysis software 
(version 3.2.3, Scanalytics, Fairfax, VA). 
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Statistical analysis: 
One-way ANOVA was performed to analyze the final body weight, plasma total 
cholesterol, alanine aminotransferase activity, the percentage of leukocytes that carry 
NKR-Plbngbt and NKR-P1 d,m population markers as well as the amounts and ratio of 
S a/So. Two-way ANOVA was performed to analyze fat and fumonisin main effect as well 
as their interaction on the above-mentioned bio markers. The correlation among total 
cholesterol, prostaglandins, and the area of AHF was analyzed by Pearson test. The hepatic 
NK activity was analyzed by analysis of covariance (ANCOVA) by taking the NKR-
p jbnght population as covariable . Student's t-test was performed to compare all possible 
group differences after ANOVA. A p-value of <0.05 was considered to be statistically 
significant. 
RESULTS 
Effect on body weight gains, relative liver weight and feed intake 
The food intake did not differ among treatments (Table 1). But the final body 
weight in groups fed FBi was significantly lower than in the control group fed a high fat 
diet (Table 1). Relative liver weights were not different among the four treatment groups, 
and the average daily food consumption was similar among the four groups (Table 1). The 
average daily energy intake was much greater for rats fed a high fat diet than for rats fed a 
low fat diet (Table 1). 
Plasma total cholesterol levels and alanine aminotransferase activity 
Alanine aminotransferase (ALT) activity of the rats fed 50ppm FBi diet was 
significantly greater than that in the rats fed low or high fat control diets. Alanine 
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aminotransferase activity was not different between the two groups fed FBi ( Figure 2). In 
comparison with the rats fed a low fat diet, the control group fed a high fat diet and both 
FB[ -fed groups had significantly greater total plasma cholesterol concentration. The total 
cholesterol concentration in rats fed a low fat diet and FB[ was significantly greater than in 
rats fed high fat control diet, and rats fed a high fat diet and FBi had significantly greater 
total cholesterol concentration as compared with rats fed a low fat and FBi (Figure 1). 
There was no interaction between fat and fumonisin effects on ALT or total cholesterol 
(data no shown). 
Hepatic natural killer cell activity and NKR-Plbristh and NKR-P ldan population 
Flow cytometric analysis using murine antibody 3.2.3 (natural killer cell receptor 
protein 1 (NKR-P1 )) revealed two distinct subsets of hepatic mononuclear cells 
expressing variable levels of NKR-P 1. The NKR-P lbnght population, which expresses a 
high level of NKR-P 1, has been identified as the population causing NK associated lytic 
activity (23). The NKR-P 1dim population, which expresses a low level (2-10 fold lower) of 
NKR-P 1, has been linked to a subset of T lymphocytes that have NK-like cytolytic 
function under activation by interIeukin-2 (24). The results showed that two FBi treatment 
groups had significantly lower per NK cell activity as compared with both basal diet and 
high fat diet control groups. Per NK cell activity was not different between two FBi 
treatment groups (Figure 3). The percentage of NKR-Plbnght population in both FB, fed 
groups was significantly lower than in either control groups, and the percentage of NKR-
Plbnght mononuclear cells in the rats fed 50ppm FB| and high dietary fat was significantly 
lower those fed 50ppm FB% and low fat ( Figure 4). The NKR-P ldim population was not 
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différent among each group (data now shown). Based on the percentage of NKR-P lbnght in 
leukocytes and the total leukocytes in the hepatic perfusate, we calculated the total hepatic 
NK cells in each group. After covariance of the total hepatic NK cell number with liver 
weight, the rats fed FB% had lesser total NK cell numbers as compared with either control 
groups, and the rats fed high fat diet and FBi had lesser total NK cell numbers than those 
fed low fat diet and FB 1 ( Figure 5) 
Hepatic concentration of PGE2and PGE2a 
The hepatic PGE 2 was greater in rats fed FB 1 and high fat diet than the rats fed FB 1 
and low fat diet. The rats fed FB 1 and low fat diet had greater hepatic PGE 2 than the rats 
fed high fat diet. The rats fed high fat diet had greater hepatic PGE 2 concentration than the 
rats fed low fat diet, there is no interaction between fat and FBi- They had additive effect 
on the increase of hepatic PGE?(Figure 6). Hepatic PGF20C was greater in rats fed FBi and 
high fat diet or low fat diet than rats fed high fat diet. The rats fed high fat diet had greater 
hepatic PGF^a than rats fed low fat diet. Hepatic PGF2 was not different between FBi -
fed groups (Figure 7). There was no interaction between fat and fumonisin effect on the 
either PGE, or PGF20C. 
Altered hepatic foci indicated by PGST or GGT staining 
There were no detectable PGST- or GGT-positive AHF in either control group. 
Five out of six rats fed 50ppm FB% and basal diet had PGST-positive AHF, and four out 6 
rats fed 50ppm FBi in basal diet had GGT- positive AHF. The average PGST-positive 
AHF area was 3.8 ± 1.3 percent of the total hepatic area, and the average GGT-positive 
AHF area was 1.4 ± 0.9 percent of the total hepatic area. Five out of 6 rats fed 50ppm FBi 
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in high fat diet had PGST- or GGT- positive AHF foci, and the average PGST-positive 
AHF area as a percent of total hepatic area was 6.1 ± 1.7, whereas the average GGT-
positive AHF area was 1.3 ± 0.8 percent of the total hepatic area ( Table 2). The average 
PGST-positive AHF area in the rats fed 50ppm FB i in high fat diet is significantly greater 
than in the rats fed 50ppm FBi and low fat diet. 
Sphingolipid analysis 
The levels of Sa, So, and the ratio S a/So were not affected by dietary fat content of 
control diets. Both FB, —fed groups had similar hepatic Sa and S a/So ratio, which was 
greater than either control group (Table 3). There was no interaction between fat and 
fumonisin effect on Sa, So, or S a/So ration (data not shown). 
DISCUSSION 
The present study showed that rats fed high fat diet without FB] had greater total 
plasma cholesterol concentration than did rats fed a low fat control diet (Figure 2). This is 
consistent with previous findings that high dietary beef tallow intake can increase the total 
cholesterol concentration. Six-week-old male Fischer 344 rats were placed on a high-fat 
[7% (wt/wt) soybean oil + 15% (wt/wt) beef tallow] or a normal-fat (7% soybean oil, AIN-
93G) diet. At 10 weeks of age, the rats fed a high fat diet showed increased blood 
cholesterol as compared with the rats fed a low fat diet. The observation of FBi-induced 
hypercholesterolemia was reported in vervet monkeys (25), as well as in rats (26, 7). In the 
present experiment, both FBi -fed groups had greater total cholesterol concentration than 
either control group. 50ppm FBi seemed to have similar ability to increase the total 
cholesterol as did feeding a high fat diet without FBi, FB, and high fat showed a additive 
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effect on cholesterol concentration (no interaction between fat and FB, based on two-way 
ANOVA test, data not shown). The mechanism of FBi increasing plasma cholesterol is not 
clear yet. Increase in low density lipoprotein cholesterol (LDL) probably accounted for the 
major part of the increase in plasma total cholesterol, because only LDL, but not high 
density lipoprotein cholesterol (HDL) or very low density lipoprotein cholesterol (VLDL), 
was significantly raised in vervet monkeys fed a diet containing 0.25-1% of F.moniliforme 
culture material (25). It was therefore proposed that impaired removal from the plasma 
rather than increased cholesterol synthesis in the liver probably occurred (25). 
The plasma ALT activity was significantly increased in FBi —fed groups compared 
with the two control groups (Figure 1). This result is in agreement with the finding of Lu 
(7), in which ALT activity in rats fed 50ppm FB[ and 20% total dietary fat for 5 weeks 
increased significantly compared with controls. Elevated plasma ALT activity indicated 
hepatocyte membrane damage which led to the leakage of ALT into the blood. Such 
damage was associated with the development of AHF caused by FB, (26). The ALT 
activity was not different between two FB, —fed groups suggesting that quantity of total 
dietary energy intake did not affect FB, hepatoxicity per se. 
Groups fed 50ppm FB, with high or low dietary fat intake showed significantly 
greater endogenous hepatic PGE2 and PGF2a than the control groups (Figure 6, 7). This 
result is consistent with the findings of Lu (7), in which rats fed 50ppm FB, and 20% 
dietary fat showed greater amount of PGE, and PGF,^. Liu et al (8) reported that F344/N 
female rats fed AIN93G diet supplemented with 25ppm FB, showed greater hepatic PGE, 
in the rats fed control diet (AIN93G). In the present study, the group fed 50 ppmFB, and 
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high dietary fat had greater hepatic PGE? than rats fed 50ppm FB, and a low fat diet. It 
was also observed that the total hepatic area occupied by PGST-positive AHF was greater 
in rats fed 50ppm FB, and high dietary fat than in rats fed 50ppm FB, and low dietary fat. 
The development of preneoplasia was highly correlated with the PGE, metabolism in this 
study (data not shown). Gupta et al. showed that feeding a choline deficient (CD) diet, an 
efficient liver tumor promoting regimen, to male Sprague-Dawley rats initiated by a single 
dose of diethylnitrosamine induced 2-2.5 fold increased levels of PGE, in the liver. The 
addition of indomethacin to a CD diet suppressed the diet-induced elevations of PGE, and 
a substitution of fats in a CD diet with menhaden oil had the same effect. Furthermore, 
both indomethacin and menhaden oil added to a CD diet suppressed the induction of GGT-
positive hepatocyte foci in the liver of rats . Lin et al.(27) showed greater PGE, in NZB/W 
F1 mice fed diets containing 200 g dietary fat/kg (equal amount of lard and soybean oil) 
than in mice fed 50 g dietary fat/kg (equal amount of lard and soybean oil) respectively. 
The study suggested that greater amount of PGE, might be produced by macrophages 
under the situation of high fat intake. Parhar et al. (28) showed that PGE, production by 
tumor-host-derived macrophages was significantly greater than that produced by normal 
splenic macrophages. All our studies (7, 29) observed that increased production of 
prostaglandins accompanied the development of FB, carcinogenesis. This suggests that 
prostaglandins may play a important role during FB, carcinogenesis, and the inhibition of 
immune function by prostaglandins might be one of the factors that promote the FB, 
carcinogenesis, as observed by Lu et al. (7) and the present experiment. 
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The observation of the inhibition of total NK activity by FB, as compared with both 
control groups (Figure 3,4,5) is consistent with previous findings in which rats fed 50ppm 
FB [ and 20% dietary fat showed significant lower total NK activity than the control group 
(7). In another experiment, when F344/N rats were fed 25ppm FBi and 7% dietary fat, the 
total NK activity was not changed, but the production of endogenous PGE 2 was much 
greater than in control groups(29). Although NK activity per cell was similar between the 
two FBi-fed groups, the total mature NK population was greater in rats fed 50ppm FB% and 
low dietary fat than in rats fed 50ppm FB 1 and high dietary fat, which paralleled the 
production of PGE? and the extent of the neoplasia in these two groups. These results 
suggested that the PGE? might be a factor modulating NK activity during the development 
of neoplasia. Parsha et al.(30) reported NK cells are progressively inactivated during tumor 
development by PGE% secreted by host macrophages. Parhar et al.(28) also revealed that 
tumor-host-derived macrophages derived from CBA mice bearing 21-day intraperitoneal 
Ehrlich ascites tumors or C3H/HeJ mice bearing 21-day subcutaneous T58 mammary 
adenocarcinomas (but not normal macrophages) markedly suppressed NK activity. 
Indomethacin and anti- PGE? antibody prevented the suppression of NK activity in this 
model. This finding ran parallel with high levels of PGE? production by tumor-host-
derived but not normal splenic macrophages, and pure PGE? (lO^M ) but not PGF?a 
(lO^M ) mimicked these suppressor effects. Another in vitro experiment also showed 
similar results that the hepatic NK cell activity was inhibited with the increase of PGE? 
concentration from 0 to 25ng/ml, but NK activity was enhanced with the increase of 
PGF?a from 0 to 50ng/ml (29). Our experiment further verified these in vivo and in vitro 
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findings, the present stud^ showed greater PGE2 and decreased NK activity in rats fed FB [ 
and high fat diet, but the concentration of PGFoa was similar in both FBi-fed groups. This 
implied that PGE? overwhelmed the effect of PGF?a in the group fed FBi and high fat diet, 
and caused the inhibition of NK activity in this group. It has been showed that PGE? 
activates adenylate cyclase with a subsequent rise in cyclic AMP (31), which acts as a 
"second messenger". Cyc lie AMP itself is an inhibitor of lymphocyte activation (31, 32). 
The presence of receptors for PGE[ and PGE? on the lymphocyte surface had been 
demonstrated, while there were no binding sites for PGA, PGFia or PGF?«. The relative 
potency of seven prostaglandins in inhibiting cytolytic activity correlated very well with 
their potency in stimulating cyclic AMP accumulation in lymphocytes: 
Et =E?> Ai =A?>F%a=F?a = 0 (33). But effects of PGs on NK cells could be mediated in 
other ways. In the present study, we observed the NK activity per cell was similar between 
two groups, but the percentage of NK population paralleled the change of PGE? between 
two FBi -fed groups, and the total NK cell number (Figure 5), after adjusting by their liver 
weight, was much lower Ln rats fed high fat diet and FB, than those fed low fat diet and 
FB[. This suggested that total NK activity was much lower in rats fed high fat diet and FB; 
than those fed low fat diet: and FBi. The present study seemed to suggest that PGE? may 
play a role in the NK cell activity modulation, but in our previous study (8), we did not 
observe the inhibition of NK cell activity while the endogenous production of hepatic 
PGE? increased under effect of FBi. Further study is needed to clarify the effect of PGE? on 
the NK cell activity during FB 1 carcinogenesis. It was noticed that percent of PGST (+) 
AHF in rats fed FBi and high fat diet was 2 fold of the rats fed FBi and low fat diet, and 
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was 12 fold of the percent of PGST (+) AHF in the previous study (8). This suggested that 
key difference between these two studies seemed to be that tumor developed had 
progressed further in the present study, which had greater preneoplasms in the present 
study than the previous study (8). This was probably part due to feeding less FB, in the 
previous study (25ppm) than in the present study. A similar FBi dose/response was 
observed by Lu et al.(7). The suppression of NK activity were probably mediated 
significantly by the products of the preneoplasms than PGE?, because PGE? was increased 
in both the studies whereas preoneoplasms were much greater in the present study than in 
the previous study. This implies that some other factors than PGEz produced by 
preneoplasms seem to be more important down-regulators of NK activity during 
development of carcinogenesis. 
In our study, the accumulation of Sa and increase of S a/So ratio agreed with 
previous observations that animals exposed to FB, feeding increased Sa and altered S a/So 
(34). Sphinganine is a known inhibitor of protein kinase C (PKC) (35), and PKC is 
considered to play an essential role in the lytic mechanism of NK cell-mediated cytolysis 
(36). We hypothesized that accumulated sphinganine might inhibit the NK activity through 
inhibition of the PKC. In the present study, although we observed change of total NK cell 
activity between the groups fed FB t and different dietary fat, we did not see the difference 
of Sa and the ratio of Sa/So between these two groups. Thus Sa might have played some 
role in the inhibition of NK activity, but Sa did not play a role in the difference of total NK 
activity between groups fed FBi and differing dietary fat contents. 
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The same number of animals (5/6) developed neoplasia in two FB, treatment 
groups, but the average area of PGST-positive AHF in rats fed a high fat diet was greater 
than in the rats fed a low fat diet. There was no difference in the area of GGT-positive 
AHF between the two groups fed FB%. It is hard to explain why PGST (+) foci were 
stimulated by high fat diet, but not GGT (+) foci. It had been observed that when female 
F344/N rats dosed with diethylnitrosamine (DEN) 24 h after partial hepatectomy were 
treated with the promoting agents, phénobarbital (PB) or 3,4,7,8-tetrachlorodibenzo-p-
dioxin (TCDD), or the peroxisome proliferating agent, WY 14,643, for 6 months, PGST 
scored more foci in all groups than GGT (37). The greater area of PGST-positive AHF 
indicated that the group fed a high fat diet and FBi had more preneoplasia than did rats fed 
low dietary fat and FBi.Birt et al., (38) compared diets of different fat content and 
composition during pancreatic carcinogenesis. Pancreatic cancer was induced with N-
nitrosobis(2-oxopropyl)amine (BOP) 20 mg /kg body wt, hamsters were assigned to one of 
five diet treatments: (i) 4.3% com oil (control); (ii) 20.5% com oil (high com oil); (iii) 
0.5% com oil + 3.8% beef tallow (low beef tallow); (iv) 0.6% com oil + 19.9% beef tallow 
(high beef tallow); and (v) 5.1% com oil + 15.4% beef tallow (high fat mixture). These 
diets were fed until the study ended 84 weeks after BOP treatment. Hamsters were pair fed 
to consume the same calorie allotment as the control com oil group. Pancreatic adenoma 
incidence and multiplicity (no./effective animal) were higher in hamsters fed beef tallow 
than in those fed com oil diets. Carcinoma in situ multiplicity was elevated in hamsters fed 
high-fat diets irrespective of the nature of fat fed. Pancreatic adenocarcinoma multiplicity 
was elevated in hamsters fed the low- or high-beef tallow diets compared with the low- or 
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high-corn oil diets. This study showed that high saturated fat (beef tallow) intake promoted 
the carcinogenesis when fed isocalorically compared with a lower fat diet. In our study, it 
is possible that increased fat intake promoted that carcinogenesis not only by increased 
energy intake, but that the fat per se promoted FBi carcinogenesis by increasing the 
cholesterol concentration. It has been suggested that increased cholesterol concentration 
correlated with the development of neoplasia (39). Gregg et al. (40) measured GGT (+) 
AHF and 3-hydroxy-3-methyl glutaryl CoA reductase (HMG) activity in rat liver after 
treatment with DEN, phénobarbital and partial hepatectomy. Increased [I4C] acetate 
incorporation into cholesterol and HMG reductase activity were associated with high levels 
of gamma-glutamyl transpeptidase and foci formation. Elevated cholesterol levels and 
enhanced cholesterogenesis were consistent observations in proliferating normal, 
preneoplastic and neoplastic cells (41). In addition, the cholesterol biosynthetic pathway 
and the hexose monophosphate pathway were found to be stimulated in proliferating cells. 
In deed, the NADPH generated by this pathway is presumed to be needed for cholesterol 
and DNA synthesis and, in addition, the pentose phosphates generated by this pathway are 
utilized for DNA synthesis. Based on this evidence, it has been suggested that cholesterol 
and DNA synthesis are linked (42), but the exact nature of this linkage is not established. 
Perhaps some intermediates of the cholesterol synthesis pathway are mediators of DNA 
synthesis (43) 
Increased caloric consumption instead of the high fat intake per se has also been 
shown to enhance the development of tumors. In carcinogen-treated rats, reducing energy 
consumption by 25% or as little as 12% of that consumed ad libitum-fed control negate the 
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significant mammary tumor stimulation of a high-fat diet (44, 45). Furthermore, 
carcinogen-treated rats fed low- and high-fat diets and restricted in food consumption to a 
level equivalent to that consumed by the animals consuming the least amount of food 
showed no differences in mammary tumor development (46). All these studies suggested 
that reducing caloric intake strongly inhibited carcinogenesis. In our present study, because 
animals were fed ad libitum, the rats fed the high dietary fat also consumed more calories. 
Overall, this study showed that the consumption of a high-fat/high-calorie diet increased 
FB[ carcinogenesis compared to the consumption of a low-fat/low-calorie diet. Greater 
hepatic area occupied by PGST-positive AHF in rats fed FBi and high fat might be caused 
by the enhancement of focal lesion DNA synthesis and inhibition of apoptosis. Mice were 
initiated by DEN (35 mg DEN/kg body weight injected intraperitoneally, twice per week 
for 8 weeks), then placed into four groups: NIH-07 control diet/no PB (group 1); NIH-07 
diet/500 mg PB per liter of drinking water (group 2); diet restricted NIH-07 diet/no PB 
(group 3); and diet restricted NIH-7 diet/ 500 mg PB per liter of drinking water (group 4) 
(47). The unrestricted group with PB in drinking water had enhanced hepatic focal lesion 
volume and number compared with the control group. Mice fed PB and an unrestricted diet 
had inhibited apoptosis in normal and focal hepatocytes compared with the control group. 
In contrast, mice fed PB and a restricted diet exhibited a significantly lower focal lesion 
volume and number compared with mice given PB and unrestricted diet. Restricted mice 
did not show inhibition of focal apoptosis, in fact, the incidence of focal apoptosis was 
increased in these mice compared with unrestricted mice. These results suggest that 
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inhibition of focal lesion DNA synthesis and enhancement of apoptosis may be a 
mechanism for the inhibition of cancer by the diet restriction. 
In summary our study suggested that high fat/high caloric intake enhanced FB i 
carcinogenesis. Inhibition of total NK activity paralleled the development of PGST-
positive preneoplasia (highly correlated, data now shown). Sphinganine and PGF?^did not 
seem to modulating NK cell activity, because they did not differ between the group fed 
high fat and FBi and the group fed low fat and FBi. Hepatic PGE? might be one of the 
factors modulating NK activity in the present study (highly correlated, data not shown), 
because the change of NK activity came along with the change of PGE? in the present 
study. In our previous study, we did not observe the NK activity change along with 
increased PGE?. The key difference between the present study and previous study was that 
much greater preneoplasia in the present study. This implied that some other factors might 
be important down-regulators of NK activity. 
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Table 1. The rats fed FBi had significantly lower final body weight than the rats fed high 
fat diet. Average daily food consumption was similar among four treatments at any time 
point. The daily total energy intake was greater in rats fed high fat diet. 
Food Consumption, g/day/animal Energy intake Kcal/animal /day 
Week 5 Week 7 Week 9 Diet group 
Low fat 
High fat 
Low fat/FB 1 
High fat/FBI 
Final BW 
142 ± 4 b 
147 ± 5 b 
137+4 a 
139 ±4 a 
11.5 + 2 
10.6 ±2 
11.4+2 
12.5+2 
12.5 + 2 
13.2 ±2 
12.5 ±3 
11.5+2 
13.3 ±3 
12.8 ±2 
12.2 + 2 
12.5 ±3 
Week 5 
48 ±5 c 
54 + 6 b 
44 + 4 o 
60 ±4 a 
Week? 
50 + 5 b 
62±6 a 
47 + 6 b 
57 ±4 a 
Week 9 
51 +5 b 
60 ±4 a 
48 + 5 b 
6 2 ± 7  a  
Comparison of the final body weight, average daily food consumption, and daily total 
energy intake at 5, 7, and 9 weeks of age. The data entries in the table were expressed as 
mean ± standard error of mean (SEM). Treatments with different letters were significantly 
different. 
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Figure 1 : Comparison of the alanine aminotransferase (ALT) activity at 9 weeks of age, 
both the rats fed 50ppm FBi and low or high-fat diet showed significantly greater ALT 
activity as compared with two control groups. No difference was found between two 
control group, and no difference was found between two FB i treatment group. Vaules are 
means ± SEM. Treatments with different letters were significantly different. 
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Figure 2: Comparison of the total plasma cholesterol concentration at 9 weeks of age.The 
two FBi treatment group and high diet control group exhibited significantly greater 
cholesterol concentration as compared with control group, and two FBi treatment group 
exhibited significantly greater cholesterol concentration as compared with high fat control 
group, and the group fed 50ppm FBi and high fat had greater amount of cholesterol than 
the group fed 50ppm FB; and low fat diet. The error bar represented the SEM. Treatments 
with different letters were significantly different. 
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Figure 3: Comparison of hepatic NK activity at 9 weeks of age by adjusting with the 
percentage of NKR-Plbnght mononuclear cells. Activity was expressed as lytic units/per 
cell, calculated from the specific lysis curve. The rats fed FBi and high or low fat diet 
exhibited significantly lower NK activity as compared with the two control group. No 
difference was found between two FB i treatments, and no difference was found between 
two control groups. The error bar represented the SEM. Treatments with different letters 
were significantly different. 
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Figure 4: Comparison of the percentage of hepatic NKR-Plbnght mononuclear cells at 9 
weeks of age. Both the rats fed SOppm FB [ and low or high fat diet exhibited significantly 
lower NKR-Plbnght percentage as compared with two control groups. No difference was 
found between two control groups, the group fed SOppm and high fat diet had significantly 
lower NKR-Plbnght percentage than the group fed SOppm FB i and low fat diet. The error 
bar represented the SEM. Treatments with different letters were significantly different. 
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Figure 5. Comparison of the total hepatic NK cell number at 9 weeks of age. Both the rats 
fed low or high fat diet and 50ppm FBi and exhibited significantly lower total NK cell 
numbers compared with either control groups. No difference was found between two 
control groups, the rats fed high fat diet and 50ppm FBi had significantly lower total 
hepatic NK cell numbers than the rats fed 50ppm FB i and low fat diet. The error bar 
represented the SEM. Treatments with different letters were significantly deferent. 
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Figure 6: Comparison of the hepatic PGEz concentration in four treatment groups at 9 
weeks of age. The concentration of PGEi is expressed as ng per gram liver tissue. Both 
FBi treatment group and high fat control groups had greater hepatic PGE% than low fat 
control group, two FBi treatment groups had greater hepatic PGEo than high fat control 
group, and the group fed FB,and high fat diet had greater hepatic PGE? than the group fed 
50ppm FB[ and low fat diet. The error bar represents the SEM. Treatments with different 
letters were significantly different. 
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Figure 7 : Comparison of the hepatic PGFza concentration in four groups at 9 weeks of 
age.  The concentrat ion of  hepatic  PGFza was expressed as ng per  g  l iver  t issure.  Both FBj 
treatment and high fat control groups had greater hepatic PGFza than low fat control 
group, and the group fed 50ppm FB, and high fat diet had greater hepatic PGFia than 
group fed 50ppm FB, and low fat diet and the high fat control group. There was no 
difference between the group fed 50ppm FBi and low fat diet and the high fat control 
group. The error bar represented the SEM. Treatments with different letters were 
significantly different. 
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Table!. The rats fed FBi developed PGST- and GGT- positive AHF. 
#of rats with % PGST Area 
Treatment PGST AHF 
# of rats with % GGT Area 
GGT AHF 
Low fat 0/6 
High fat 0/6 
Low fat/FBI 5/6 
High fat/FBI 5/6 
0 
0 
3.8 ± 1.3 b 
6.1 ± 1.7 a 
0/6 
0/6 
4/6 
5/6 
0 
0 
1.4 ± 0.9 b 
1.3 ±0.8 a 
Placental glutathione S-transferase (PGST) and y-glutamyl transferase (GGT)-positive 
altered hepatic foci (AHF). The AHF occurred only in two FBi treatment groups at 9 
weeks of age. The average area of PGST-positive AHF was significantly greater in the 
group fed 50ppm FBi and high fat diet than that fed 50ppm FBi and low fat diet, no 
difference was found for the GGT-positive AHF between two FB, treatment group. The 
data entries in the table were expressed as mean ± standard error of mean (SEM). 
Treatments with different letters were significantly different. 
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Table 3. The rats fed FBI had greater hepatic sphinganine (nmol/g) and Sa/S ratio 
Than two control groups 
Treatment Sphingosine (So) Sphinganine (Sa) S a/So 
Low fat 45 ±4 9±2b 0.12±0.1 b 
High fat 57± 6 8 ± 2 b 0.12±0.1 b 
Low fat/FBI 63± 7 13± 3 a 0.21±0.2 a 
High fat/FBI 75 ±11 15±5a 0.28 ±0.2 a 
Comparison of sphingosine (nmol/g) (So), sphinganine (nmol/g) (Sa) as well as the ratio of 
S a/So at three time points. The concentration of the sphingo lipids was expressed as nmol 
per g liver tissue. At 9 weeks of age, the hepatic So were similar among four groups. The 
rats fed 50ppm FBi diet exhibited greater Sa concentration and increased ratio of S a/So as 
compared with two control groups, and the group fed 50ppm FBi had greater Sa and S a/So 
ratio than the group fed 50ppm FB; and low fat diet. The Sa, So and S a/So ration were not 
different between two control groups. The data entries in the table were expressed as mean 
± standard error of mean (SEM). Treatments with different letters were significantly 
different. 
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GENERAL CONCLUSION 
Natural killer cells are known to help the body fight cancer metastasis and certain 
viral infections. Their role at earlier stages in carcinogenesis is uncertain. Our studies 
showed that the development of fumonisin-promoted neoplasia in rat liver was 
accompanied by suppression of liver-associated NK activity and increased liver 
prostaglandin PGE2 levels. Unknown factors other than PGEi produced by preneoplasms 
seemed to be more important down-regulators of NK activity as they occurred during 
development of carcinogenesis, because we did not observe inhibition of NK activity in a 
previous study, but we did see the inhibition of NK activity in the present and other 
studies, and the hepatic PGEi increased to a similar extent in all studies. 5 out 6 rats 
developed AHF in the study showing the inhibition of NK activity, but only half the 
animals developed AHF in the study that did not show inhibition of NK activity, and the 
area of AHF was much greater in the former study than the latter study. This suggested 
that the inhibition of NK activity paralleled the development of preneoplasia. The down-
regulation of NK activity might be a signal or biomarker of developing preneoplasia. This 
could potentially be used for human cancer diagnosis, and might permit easier and earlier 
cancer screening. 
Previous studies had suggested that Sprague-Dawley rats were much less 
susceptible to fumonisin promotion of carcinogenenesis than F344. The comparison of 
immune function between F344/N and SD rats suggested that SD rats would experience 
greater total liver-associated NK activity may partly explain their lesser cancer 
susceptibility than do F344/N rats under the condition of fumonisin promotion of 
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carcinogenenesis. In vitro observation that PGE% and PGFia had opposite effect of on NK 
activity respectively, may suggest that these two prostaglandins can negate the effect of 
each other on NK cell in viv. Our latest study suggested that increasing PGE? may 
overwhelm effect of PGFze, causing net suppression of NK activity. 
Reacting FBi with glucose eliminated FB, toxicity as reflected in plasma total 
cholesterol concentration, ALT activity, development of GGT- and PGST-positive AHF , 
concentration of endogenous hepatic PGE2. the accumulation of Sa, as well as the ratio of 
SaI So. This work also suggested that fumonisin-induced increased PGE? did not inhibit 
liver associated NK activity, although increased PGE% accompanied fumonisin promotion 
of carcinogenesis. The histopathology examination indicated that the tumor development 
stayed at the preneoplasia stage. 
Greater dietary fat and energy intake can promote FB [ carcinogenesis, and caused 
inhibition of NK cell activity. The findings suggested that high fat and greater energy 
consumption promoted FBi carcinogenesis in comparison with the low fat diet. The 
inhibition of total NK activity paralleled the production of PGE2 and the development of 
preneoplasia. Increased PGE?, and some other factors produced during further 
development of preneoplasia may be crucial down-regulators of hepatic NK activity. 
Future studies are needed to understand the mechanism of FB[ hepatotoxiciy and 
hepatocarcinogenesis, as well as the role of NK cell during the hepatocarcinogenesis. The 
immunomodulation factors during the development of preneoplasia as well as the effect of 
PGE2 on the NK cell activity during carcinogenesis are needed to be investigated too. 
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